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Abstract
An Escherichia coli-based collagen-production process was used to investigate several
process optimization objectives for use at the industrial scale. The effect of cooling
on fermentation growth kinetics was studied, with preliminary results indicating that
cooling an early to mid-batch phase fermentation (OD600 = 2–4) to 10
◦C for up to
40 hours was not detrimental to the recovery of fermentation growth or the culture’s
ability to reach high cell density (OD600> 50). A cost-effective assay of collagen-like
polymer was examined under high-cell density conditions (as opposed to previously-
studied low density conditions) and an experimental design for tailoring the assay
to high cell density fermentation samples is presented. In addition, a dual-plasmid
strain of E. coli was designed for use in a novel process for the mass production
of collagen-like polymers: one plasmid contains a thermally inducible recombinant
collagen gene (CLP3.1-his), and the other contains an arabinose-inducible lytic gene
(bacteriophage T4 t-holin) along with the basally expressed T7 lysozyme gene from
the pLysS plasmid. A methodology for the optimization of the sequential induction of
CLP3.1-his followed by induction of the t-holin is presented; a review of the literature
suggests that decreased growth rate is detrimental to lytic efficiency (both the time
required for lysis and the degree of lysis). The resulting process will enable lysis
to take place in the bioreactor, thus avoiding the extra time and monetary cost of
a separate cell homogenization step for E. coli disruption and endogenous protein
release.
Thesis Supervisor: Jean-Franc¸ois P. Hamel
Title: Lecturer
Thesis Supervisor: Karen K. Gleason
Title: Professor
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Chapter 1
Introduction
The field of bioprocess engineering is concerned with the mass production of organic
products. A bioprocess is based on the same paradigm as chemical production pro-
cesses implemented by chemical engineers: chemical reactants are fed into a reactor,
in which the reaction takes place, and the reaction products are monitored. The host
organisms used in a bioprocess can be thought of as the catalyst for the reaction,
which produces a complex organic molecule or enzyme.
The work in this thesis is concerned with the optimization of an E. coli process
that produces a collagen-like polymer. Collagen is a ubiquitous structural protein
that is used for a wide variety of biological purposes, including acting as a drug
delivery carrier, a part of artificial skin, and surgical suture strand. There are 19
types of naturally-occurring collagen, but the most ubiquitous (and consequently the
most commercially available) are type I and type II, which are present in cells as
striated fibrils that serve a structural purpose [50]. Collagen obtained from animal
sources is at risk for contamination by infectious agents residing in the host animal
(e.g. bovine spongiform encephalopathy, BSE) [67]. These risks, in addition to high
maintenance costs and regulations on animal production, make recombinant E. coli
an attractive alternative to animal sources for obtaining collagen [72].
Gelatin is the denatured, degraded form of collagen, and has applications in the
biomedical industry where it is used in matrix implants, drug delivery microspheres,
and the production of photographic film. Single-stranded collagen-like polymers are
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most similar to gelatin. Collagen-like polymers are defined by the repeating triple-
peptide sequence of glycine followed by two variable amino acids (Gly–X–Y). In
nature, proline and hydroxyproline (post-translationally modified proline, augments
triple helix stability [67]) are the most common X and Y constituents, and collagen
exists as a left-handed triple helix. Thus, another motivation for the development of
recombinant collagen-like polymers is that applications in which they are used need
not be constrained by the properties of naturally-occurring collagen sequences [72].
See Section 3.1 for a complete description of the recombinant product, CLP3.1-his.
Convenience was the main reason for basing the project on a collagen-producing
strain rather than using another type of protein product; significant work had already
been done with the strains and assay methods by D.I.C. Wang, Jin Yin, and colleagues
in the Bioprocess Engineering Center (BPEC) at MIT, and it was straightforward to
restart work on this project [72, 73]. However, many of the contributions of this thesis
are independent of the identity of the product protein, and can potentially be applied
to other E. coli-based processes as well.
The Hamel Lab, in which this thesis work was done, serves as both a research
and teaching lab. Some of the lab’s research is done through liaisons with industry.
In particular, several of the projects are focused on the analysis of new instruments
which can be used to engineer better, more highly-controlled bioprocesses. Many of
the experimental results for these projects came from the E. coli processes that were
used for this thesis, and are thus presented here.
In accordance with the teaching function of the lab, this thesis work was incor-
porated into two courses in the Chemical Engineering department in order to teach
undergraduates the fundamentals of bioprocess engineering. Through its association
with these courses, this thesis work gained the benefit of a large amount of state of
the art equipment and many more sets of hands to implement the experiments than
I could have done alone.
In order to orient the reader to the context of the work done in this thesis, the next
section begins with a brief history of recombinant DNA technology and its importance
in the field of bioprocess engineering. The specific motivation for this thesis project
16
and its contributions are then described, and the chapter concludes with a roadmap
for the rest of the thesis.
1.1 Overview of bioprocess engineering
After Watson and Crick discovered DNA in 1953 [65], two decades passed before re-
combinant DNA technology had advanced sufficiently to make it possible to engineer
organisms capable of producing a recombinant protein product. In 1972, Jackson,
Symons, and Berg created the first recombinant plasmid, which contained genes from
Simian Virus 40, λ-phage genes, and the galactose operon of E. coli [26]. In 1973, Co-
hen, et al. created the first genetically engineered organism: E. coli transformed with
plasmids engineered to confer antibiotic resistance [12]. Because of its genetic sim-
plicity and its rapid growth rate relative to other organisms, E. coli became the most
popular host organism for the mass production of recombinant proteins. Approved
by the FDA in 1982, human insulin produced by recombinant E. coli became the first
genetically engineered drug to enter the market [15]. Mammalian cells, yeast, and in-
sect cells are also widely used as host organisms. In 1987, human tissue plasminogen
activator, made by Genentech, became the first product produced by mammalian cells
to be approved by the FDA [71, 15]. (It is important to note that the central dogma
of molecular biology—the processes by which DNA is replicated and transcribed then
translated into protein—is universal across all organisms; thus, the primary peptide
sequence corresponding to any gene sequence can theoretically be manufactured by
any organism, provided that the organism is provided with a copy of the gene and an
appropriate regulation mechanism. Thus, prokaryotic E. coli can be made to produce
a eukaryotic peptide sequence.)
The ensuing advances in the fields of genetics and microbiology combined with
the progress made by the human genome project have led to an explosion in the
number of new recombinant products that are under development and on the market.
In general, since these products are most often used therapeutically in humans, they
are eukaryotic proteins. For some products, E. coli ’s lack of the cellular machinery
17
needed to fold and secrete a eukaryotic product correctly does not pose a problem
to protein biochemists who can coax the linear peptide strand from an E. coli har-
vest into the correct correct biologically active conformation. However, E. coli-based
production is sometimes not feasible for specific products. In addition, concurrent
advances in protein purification and analysis technology have shown that the efficacy
of many proteins is dependent on the environment in which they were produced. The
host organism used is a major environmental factor, but more subtle factors such as
growth conditions can have a large effect on a protein’s glycosylation state, which can
dramatically affect product quality [11]. Consequently, even though E. coli processes
have the potential to make several orders of magnitude more protein than more slowly
growing host organisms (e.g. mammalian cells, insect cells, yeast), product quality
considerations related to host organism have come to the forefront. The drive for ho-
mogeneous, well-folded, biologically active products of maximum purity has boosted
support for processes that use mammalian cells. The rapid growth in the total num-
ber of bioprocesses, as well as the increase in mammalian relative to E. coli processes
is shown in Figure 1.1.
Despite the fact that mammalian cells have replaced E. coli as the most common
host organism, E. coli remains a major workhorse for the bioprocess industry. In
a traditional industrial process that uses E. coli, a strain is created by inserting
the gene of interest into a plasmid, which is then inserted into the E. coli. The
plasmid usually contains a gene that confers resistance to a specific antibiotic (called
the selection marker antibiotic), an origin of replication (so the plasmid is copied
during each chromosome replication cycle and persists in successive generations), and
an inducible operon which has a specific site into which the product gene can be
inserted so that expression of the product can be controlled. The expression systems
used in this thesis include the IPTG1-inducible lac operon, the arabinose-inducible
pBAD system, and a thermally-inducible system (cIts). These expression systems are
discussed in further detail in Chapters 3 and 6.
The bacterial culture is grown in a vessel called a bioreactor (or “fermenter”),
1isopropyl-β-D-thiogalactoside.
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Figure 1-1: Total number of approved and manufactured pharmaceuticals by year for
popular host organisms [64].
which contains a nutrient rich culture medium; by convention a process that uses E.
coli or yeast is called a “fermentation,” even if it is aerobic. The vessel is equipped
with sensors and controllers that maintain a constant, ideal growth environment in
its interior. A typical fermentation designed for production consists of three phases:
batch, fed-batch, and induction. Shake flasks (typically 100 mL working volume) are
inoculated with a small amount of a frozen stock solution of E. coli and incubated until
the nutrient supply is depleted. This inoculum is added to a bioreactor containing
sterile medium. The first phase of the fermentation is called the “batch” phase
because the culture grows until the energy source (usually a carbon source such as
glucose) is depleted. Nothing is added or removed from the system during this phase,
which allows the culture to adjust to the bioreactor environment and to begin steady
growth. To improve process efficiency and net yield, the culture must be grown to a
higher cell density than can be reached during the batch phase. Hence, during the fed-
batch phase, an energy source (often glucose for E. coli) is fed to the culture to achieve
higher cell densities. At the end of the fed-batch phase, once the culture has reached
the optimum cell density and growth rate for the particular process, expression of
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the recombinant gene is induced, and the induction phase begins. At the end of the
induction phase, the culture is harvested and the protein product purified.
In this thesis, the fermentation harvest was routinely disrupted by sonication in
order to break open the E. coli and release the intracellular recombinant product,
CLP3.1. By means of a series of centrifugation and endogenous protein precipitation
steps, CLP3.1 was purified. The purified product was assayed using a collagenase
and ninhydrin2-based assay developed by Yin, et al. which was a cheap and rapid
alternative to a standard immunobased assay [73].
1.2 Motivation
The development of therapeutic products is an expensive process, costing approxi-
mately one billion dollars to develop, produce, and market a successful product [20].
In this context, the development of novel bioprocesses, such as the one proposed in
this thesis, is a worthwhile approach to keeping production costs as low as possible.
This thesis aims to optimize the cell disruption step of downstream processing by
designing a strain of E. coli conferred with the recombinant ability to lyse. Achieving
cell disruption by inducing lysis would obviate the need for the current industry
standard method of cell disruption: high pressure homogenization. Homogenizers
are major pieces of equipment and the samples must be passed through the system
several times to achieve complete disruption because of the resilience conferred by
the tough E. coli cell wall.
Any process optimization methodology requires rigorous empirical characteriza-
tion in order to make the process as reproducible and efficient as possible. In addition
to the industrial motivation for such empirical rigor, the use of the processes studied
in this thesis in an undergraduate bioprocess engineering course strongly motivates
the development of a robust and reproducible process. Thus, the results of an in-
depth quantitative analysis of the fermentations performed in this thesis are vital to
the design of robust fermentations that will be successful and predictable in a course
2triketohydrindenhydrate
20
setting, in which there is a high degree of experimental variability. Furthermore, the
limitations on what students may be exposed to during the strictly-scheduled lab-
oratory hours of a course3 motivate the development of flexible fermentations that
may be manipulated to “perform” during lab hours. This thesis explored the use of
cooling phases in fermentations to arrest their growth in between laboratory sessions,
so that students could view a larger fraction of each process than just the four hour
window they would observe in an uninterrupted fermentation.
In order to study the production efficiency of a process, a product-specific assay
must be at the process engineer’s disposal. Immuno-based assays, which take ad-
vantage of the highly specific affinity of particular antibodies for particular proteins,
have high sensitivity and specificity. However, these assays are expensive and time
consuming. Yin, et al. developed a low-cost and relatively fast assay for the detection
of collagen-like polymers in E. coli crude lysate from shake flask cultures [73]. Use
of this assay to analyze samples from high cell density fermentations is desirable in
order to transfer the benefits of the low cost and rapidity of the assay to fermentation
analysis. As described in this thesis, though, the form of the assay published by Yin,
et al. is not directly transferable to shake flasks. Hence, there is strong incentive for
the study (and improvement) of the assay’s performance on high cell density samples.
1.3 Contributions of this thesis
The work done in this thesis comprises several necessary steps towards the implemen-
tation of a novel, optimized collagen-production and assay process. These steps are
described below:
3For example, MIT course 10.28 meets twice a week, with four hours per lab session.
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1.3.1 Robust Escherichia coli fermentation protocol for aca-
demic use
Because this research was conducted in close association with MIT courses 10.28
(Biological Engineering Laboratory) and 10.26 (Chemical Engineering Projects Lab-
oratory) in the Chemical Engineering Department at MIT, it was essential to develop
a robust high cell density fermentation protocol. The sheer number of fermentations
carried out over the course of this project (about 25) enabled the collection of a large
amount of data from a variety of conditions. This data has enabled the development
of a sturdy fermentation setup and protocol that will be heavily used in future E. coli
studies motivated by this project.
1.3.2 Analysis of collagenase assay in high cell density con-
ditions
The E. coli densities of fermentation induction samples are up to two orders of magni-
tude greater than the densities studied in the original collagenase assay experiments.
In addition, there are other major differences between the shake flask and stirred-tank
culture methods. Data from this thesis’ experiments imply that the collagenase assay
protocol, developed using shake flask experiments [73], is insufficient for the analysis
of fermentation samples from bioreactors. Several hypotheses regarding the failure of
the current collagenase protocol as well as an experimental plan for the improvement
of the assay are proposed. In addition, the prescribed use of the bicinchoninic acid
(BCA) assay in conjunction with the collagenase assay to quantify collagen produc-
tion was based on oversimplistic assumptions about protein reactivity and must be
reevaluated.
1.3.3 Bioreactor cooling
Ubiquitously, fermentation processes are run without interruption from inoculation
to harvest. High cell density processes are often at least fifteen hours long, mak-
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ing the task of monitoring a fermentation grueling. This thesis work experimented
with arresting the kinetics of a fermentation by cooling it to 10◦C.4 Further study
is required for accurate quantification of the effect of cooling on product production,
but initial results suggest that growth kinetics (once the culture has been warmed
back up) are unaffected by cooling when cell densities are relatively low. Successful
fermentations implemented in course 10.28 that included a period of arrested growth
demonstrate the potential of the cooling technique for humanizing the bioprocess en-
gineer’s schedule in the classroom and research settings. Use of a cooling phase has
enabled the prolongation of course fermentations to increase bioprocess engineering
students’ exposure time to live processes over noncontiguous laboratory sessions.
1.3.4 Design of lytic strain
A plasmid containing the λ-phage R-gene (a lysozyme: transglycosylase) and used in
a published E. coli system with both recombinant product and lytic capabilities [74]
was tested with BL21(DE3), the host strain optimized for collagen production by Yin,
et al. [72]. The resultant R-gene-based system yielded unsatisfactory lytic behavior,
which lead to the development of the lytic strain design described in this thesis.
The final strain design is named BL21(DE3)[pLysS-t][pJHL], containing a thermally-
inducible collagen gene (pJHL) and a modified version of the pLysS plasmid (named
pLysS-t) which produces a T7 lysin at low basal levels. This strain design will be
implemented for use in a process engineering project to optimize its lytic efficiency
at high cell densities in MIT course 10.26 during the Spring 2005 term.
1.4 Roadmap
Chapter 2: Literature review summarizes prior efforts in the production of re-
combinant collagen and collagen-like polymers, summarizes work that has been
4Wurm, et al. obtained positive results experimenting with the cooling of Chinese Hamster Ovary
(CHO) cell cultures. When temperature ranges from 10◦C to 25◦C were used, cooling periods of
3–4 days could be imposed with minimal negative effect on transfection and protein production
performance. Lower temperatures (0–4◦C) caused a rapid drop in viability [70].
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done with mechanical, chemical, and recombinant methods for disrupting E.
coli to release intracellular products, reviews the current understanding of the
bacteriophage lytic mechanism, and gives the theoretical underpinnings of the
collagenase and BCA assay mechanisms.
Chapter 3: Experimental setup contains technical information and protocols for
recombinant E. coli techniques, a description of the bioreactor apparatus, and
details of the analytical protein assays.
Chapter 4: Quantitative fermentation results presents experimental fermenta-
tion results in order to define a robust and repeatable CLP production process.
Chapter 5: Analysis of quantitative protein assays analyses results of the col-
lagenase and BCA assays in the context of their reaction mechanisms, reevalu-
ates the assumptions governing their use and reliability, and outlines an experi-
mental approach to studying the assays with the intention of changing them to
make them more accurate.
Chapter 6: Design of lytic E. coli strain motivates the construction of a lytic
strain, describes the experiments with λ-phage DNA that prompted the de-
sign of a new lytic mechanism, and presents the design for the lytic strain
BL21(DE3)[pLysS-t][pJHL].
Chapter 7: Conclusion
Appendix A: Media and reagents contains a detailed description of the E. coli
growth media, collagenase assay reagents, and lysis buffers for use with strains
containing the λ-phage DNA fragment.
Appendix B: Thesis chronology and relation to undergraduate courses describes
the chronological and academic contexts for the experiments performed over the
course of this thesis.
Appendix C: Microscopic images of E. coli contains microscope slide images from
shake flask, fermentation, and sonication samples.
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Chapter 2
Literature review
This chapter begins with a review of previous work that has been done with the
production of recombinant collagen. This chapter then summarizes techniques for
releasing intracellular products from E. coli and elucidates the need for the studies
with lytic phage enzymes at high cell densities discussed in this thesis. In addition,
the mechanism by which bacteriophages lyse E. coli is presented, and the mechanisms
of the collagenase and bicinchoninic (BCA) assays are described.
2.1 Recombinant collagen production
A variety of expression systems have been designed for the production of both nat-
ural and synthetic collagens. Table 2.1 presents a summary of the production levels
achieved by each system based on information compiled by Yin, et al. [72]. It is
clear that production levels several orders of magnitude higher can be achieved using
expression systems that produce single-chain collagen-like polymers rather than nat-
ural triple-helical collagens. For applications in which the triple-helical form is not
necessary (discussed briefly in Chapter 1), yeast or bacterial expression systems are
the clear choice for maximum production.
The inability of E. coli to add post-translational modifications to eukaryotic pro-
teins, the propensity for production of inclusion bodies (solid protein aggregates),
and the likelihood of incomplete folding have been cited as disadvantages to E. coli
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Natural triple-helical collagens (type I-III)
Host organism Collagen quantity (mg/L) Reference No.
Mammalian cells 0.6-20 [72]
Yeasts 15-600 [72]
Insect cells 10-60 [72]
Plants 30 (mg/kg) [72]
Single-chain collagen-like polymers
Host organism CLP quantity (g/L) Reference No.
Pichia Pastoris (single-copy transformant) 4-5 [72]
Pichia Pastoris (15-copy transformant) 14.8 [72]
Bacillus brevis 0.5 [72]
E. coli 50 (mg/L) [50]
Table 2.1: Variation in quantity of collagen-like polymers (CLPs) produced with
different host strains.
expression systems in general [50]. However, considering that the target product
of this thesis (CLP3.1) is intended to be a soluble, single-stranded polypeptide, the
post-translational modification, folding, and inclusion body considerations are likely
to be irrelevant [72]. In their E. coli expression systems, Ruggiero, et al. expressed
several fragments of a natural collagen gene. One fragment, from the heparin binding
domain (contains one glycine every three amino acids), was produced at a level of
0.05 mg per 1 mL of bacterial culture.1 Other fragments that were less glycine-rich
were produced with yields up to 0.5 mg per 1 ml of bacteria. It was theorized that
bacterial levels of GlytRNA might be too low to express large amounts of collagen rel-
ative to other recombinant proteins [50]. However, based on the results of Yin, et al.,
where expression levels of glycine-rich CLP3.1 were achieved, lack of GlytRNA does
not appear to be a limiting factor in E. coli expression systems. Yin, et al. claimed
that the low production levels in E. coli systems seen up to the time of their study
were most likely due to the lack of studies optimizing the expression system [72].
Werten, et al. achieved 3-6 g/L levels of artificial CLP production using single-copy
Pichia Pastoris transformants that secreted the CLP into the fermentation broth.
They designed their P4 gelatin to be especially hydrophilic relative to natural colla-
1The OD600 value at the time of induction was not given.
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gens and to have an isoelectric point similar to that of natural cattle bone gelatin by
controlling the number of basic lysine residues. The P4 gelatin was a 36.8 kDa pro-
tein [67]. In a previous study, Werten, et al. achieved expression levels up to 14.8 g/L
of recombinant gelatins based on mouse type I and rat type III collagen sequences [66].
Their 5 copy and 15 copy transformants produced 11.3 g/L, and 14.8 g/L of gelatin,
respectively. A disadvantage of the yeast expression system is that proteases can
degrade the collagen product (both extra- and intracellular proteases). In the high
copy number systems, Werten, et al. suppressed some degradation by conducting the
fermentation at very low pH (3.0 rather than 5.0). However, based on the results of
their P4 system, Werten, et al. speculated that arginine residues (which were inten-
tionally limited in the P4 gelatin) increased its susceptibility to proteolytic cleavage
(site-directed mutagenesis of the sequence Met–Gly–Pro–Arg to Arg–Gly–Pro–Met
resulted in the disappearance of cleavage products).
In another system for the extracellular secretion of collagen-related proteins, Ka-
jino, et al. inserted PHI and NEU subunits of human αI collagen into Bacillus brevis,
obtaining production levels of 0.5 g/L [29]. In recombinant systems where the product
gene has a large number of short, repeating sequences, stability of the foreign gene
can be a problem. The Bacillus brevis system was found to be a less stable system
than E. coli for expressing such genes [29].
As alluded to above in Ruggiero’s theory that lower expression levels of glycine
rich fragments were seen because of a lack of glytRNA in E. coli systems [50], a
protein’s amino acid composition and coding sequence can significantly affect the
achievable level of protein expression. If significant amounts of rare proteins are
required, and furthermore if they are coded for by rare codons, expression levels in
E. coli systems will suffer. In natural proteins with highly repeated sequences such
as structural proteins, rare codons are likely to appear in the gene. Based on these
observations, Martin, et al. created an E. coli system for the expression of a synthetic
human tropoelastin (STEL). By modifying the human tropoelasin sequence using a
codon adjustment model suitable to E. coli, Martin, et al. achieved expression levels
of 20–30% [36]. An awareness of the amino acid needs and presence of rare codons is
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necessary for the design of CLP expression systems in general, despite the fact that
Yin, et al. did not experience such difficulty with their E. coli expression system for
CLP3.1 (see below).
In the work leading up to the strains and plamids used in this thesis, Ferrari,
et al. patented a system for the creation of large polypeptides with repeating se-
quences. They addressed the problem of decreased stability of repetitive genes by
replacing specific codons with alternate codons [19].2 Cappello and Ferrari subse-
quently patented designs for high molecular weight, synthetic collagen-like polymers
with low proline content (< 45%) and created E. coli plasmid vectors for the expres-
sion of these genes [7]. Yin, et al., on whose work much of this thesis is based, created
the pJHL vector for the thermally-inducible expression of CLP3.1-his from a plasmid
described in Cappello and Ferrari’s patent. Yin, et al. also constructed the pJY-1 and
pJY-2 plasmids for the IPTG-inducible expression of CLP3.1-his (see Section 3.1.1
for plasmid information) [72].
2.2 E. coli disruption methods
Since E. coli rarely secrete recombinant products, protein remains intracellular. Con-
sequently, at some step in the product purification process the E. coli must be de-
stroyed. In mechanical and chemical disruption processes, the cells may be washed
with a buffer of choice (e.g. Phosphate Buffer Saline) as the first step in product
purification prior to lysis. On the other hand, a recombinant system that causes
rapid lysis within the bioreactor does not have this advantage, but is more time and
energy efficient. The induction of E. coli autolysis—lysis due to self-originating lytic
processes—has been studied but generally determined to be inefficient. Mechanisms
for induced autolysis include osmotic shock, aging, increasing temperature, and addi-
tion of organic compounds such as butanol, ethyl acetate, or toluene (this final method
of inducing autolysis could also be classified as a chemical disruption method) [61].
Since autolytic methods are not efficient and therefore are not industrially-viable op-
2Codon alternates exist due the phenomenon of codon redundancy.
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tions, the following sections review more competitive techniques for disrupting E. coli
for the release of intracellular products.
2.2.1 Mechanical disruption
This category of cell disruption techniques is the most widely used in industry because
of its practicality. Unlike chemical disruption methods, no additional compounds
must be introduced to the E. coli harvest which must then be extracted during the
downstream purification process. The most common mechanical means of cell dis-
ruption are sonication, French Press, and high pressure homogenization. Because
the cell wall makes E. coli quite difficult to lyse,3 the disruption processes must be
vigorous [37].
Sonication, which is the exposure of cells to high intensity ultrasound, is ideal for
use with small sample volumes (i.e. several mL to 50 mL). Thus, it is one the most
popular disruption techniques at the laboratory scale. A typical setup consists of a
power source connected to a converter (electrical energy → mechanical energy) that
drives a disrupter horn, which focuses the ultrasonic vibrational energy at its tip. If
the sample volume is small (several mL) the disruptor horn will likely have a microtip
that channels the mechanical energy into an even smaller diameter tip that fits easily
into the sample tube. Sonication generates large amounts of heat and sometimes
foam, so the sample must remain on ice throughout the process. (Refer to Figure C-3
in Appendix C to see images of a sample before and after sonication.)
The French Press technique is also a laboratory-scale disruption method. The
operating principle is similar to high pressure homogenization (see below), in which
a large pressure differential (7,000–10,000 psi) is applied over a small volume. The
sample is put into the French pressure cell which is then pressurized. The sample
slowly drains through the small aperture in the cell. Like high pressure homogeniza-
tion, the sample must be passed through the French Press machine several times to
achieve maximum disruption.
3Relative to E. coli, mammalian cells are much more sensitive to disruption techniques and yeast
(e.g. Pichia Pastoris) are even more difficult to break apart.
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High pressure homogenization is most widely used for processing large volumes [16].
Homogenization systems are designed to draw a continuous sample flow. The crux of
a homogenizer consists of a large pressure drop within a very small volume. Because
of the resilience conferred by its cell wall, an E. coli sample must be passed through
a homogenizer multiple times to attain thorough disruption. In an experiment with
yeast disruption, Dunnill and Lilly found that the amount of protein released, R,
after N passes through a homogenizer follows the relation
ln
Rm
Rm −R = KN (2.1)
where: K = κpα = first-order rate constant, κ, α depend on the microbe (e.g. yeast,
E. coli), p is the operating pressure, and Rm is the maximum achievable protein
release [14, 3].
2.2.2 Chemical disruption
As an alternative to mechanical disruption, cells may be treated with specific chem-
icals to disrupt the integrity of their plasma membranes and cell walls in order to
release intracellular proteins. A variety of chemical disruption mechanisms are avail-
able. In this discussion, “hybrid” methods that require the expression of a recom-
binant protein as well as the addition of a foreign chemical to effect the action of
that protein are classified as chemical disruption techniques (rather than recombi-
nant techniques) because they lose their efficacy without the addition of the extra
chemical and they introduce significant quantities of a the chemical to the culture
which must then be removed during the downstream purification process.
Chemical disruption techniques are useful when mechanical disruption machines
are not available and the protocol for the downstream processing of the lysate accounts
for the chemical composition of the lysate (i.e. the addition of lysis-causing chemicals
is not detrimental to the experimental results). The Quiagen Plasmid Purification
kit used in this thesis (Section 3.1.2) achieved lysis by suspending an E. coli pellet
in 200 mM NaOH (with 50 mM Tris·Cl, 10 mM EDTA (ethylenediamenetetraacetic
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acid), 100 µg/mL RNase A, and 1% SDS (sodium dodecyl sulphate) (w/v)) [23].
Cell wall hydrolyzing enzymes are also used to lyse bacteria. Hen egg lysozyme is the
most popular and least effective lysozyme. Mutanolysin (muramidase of Streptomyces
globisporus) and lysostaphin (peptidase of Staphylococcus staphylolyticus) are other
commercially-available enzymes (Sigma Chemical Co.). With gram-negative bacte-
ria, these cell wall hydrolases must be used with permeabilizing agents (e.g. EDTA [a
chelating agent that is thought to destabilize the bacterial outer membrane by remov-
ing divalent cations from it [16]], toluene, chloroform, thymol, other alcohols) that
disrupt the outer cell membrane so that the lysozyme may reach its substrate [61, 35].
In general, the energy state of the cell membrane is thought to affect the mem-
brane’s susceptibility to hole formation. Addition of cyanide or azide to Bacillus
subtillus cultures in stationary phase resulted in autolysis; these chemicals dissipate
energy gradients in the cell membrane which increases the likelihood of hole formation
and the passage of autolytic enzymes through the membrane to the cell wall [61, 28].
Along similar lines, hybrid recombinant and chemical methods have been devel-
oped that use specific chemicals to permeabilize the inner bacterial cell membrane in
order to allow recombinant lysozyme to pass through the membrane and hydrolyze
the cell wall. These methods use a chemical permeabilizing agent to mimic the effect
of phage holin proteins. Yin, et al. expressed the λ-phage R-gene lysozyme in a poly-
β-hydroxybutyrate-producing strain of JM109. Because there was no membrane-
permeabilization agent in the growth medium, the culture did not lyse. Complete
lysis was achieved after resuspension in a “lysis buffer” containing 50 mmol/L Tris,
2 mmol/L EDTA, and 0.1% Triton X-100 (v/v) [74].4 In his evaluation of different
uses of the phage LL-H holin and lysozyme for bacterial disruption, Vasala described
the use of thymol to mimic the membrane-permeabilizing effect of the LL-H hol (holin)
gene product in order to allow over-expressed LL-H mur (lysozyme) protein to reach
and degrade the cell wall. This combination of thymol and over-expressed lysozyme
caused efficient lysis of E. coli. Because inefficient lysis was observed when the LL-H
holin and lysozyme were coexpressed (presumably due to low levels of protein ex-
4These and related experiments were implemented in this thesis; see Section 6.1.
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pression at low growth rates), Vasala argued that the thymol method of membrane
permeabilization was applicable at all cell densities as long as the mur lysozyme had
been expressed in sufficient quantity prior to harvest [61].
Based on the representative examples presented in this section, chemicals that
permeabilize the cell membrane are often toxic and must be removed during the
downstream purification process. The extremely low tolerance for these toxic chem-
icals lends potential for the downstream purification process to become complicated
and risky should the tolerance level be inadvertently exceeded.
However, a relatively non-toxic method of chemical extraction does exist, which
uses only chemicals common to the inclusion body solubilization and protein refolding
steps of downstream processing. Falconer, et al. describe the use of high concentration
urea (6 M) and EDTA (> 0.3 mM) to extract intracellular protein from E. coli.
EDTA acts to destabilize the outer cell membrane, and urea is a chaotropic agent
which provides enough hydrogen bonds to compete with those of water, making it a
strong solubilizing agent for disruption of the cell wall. The process also describes
the use of 15 mM 2-hydroxyethyldisulfide (2-HEDS) to stabilize released inclusion
bodies5 while the sample is centrifuged, thus allowing for the selective purification of
product protein inclusion bodies. Levels of protein release comparable to mechanical
disruption techniques were attained. The protein extraction incubation times were
varied from 30–90 minutes [16, 17, 18, 10].
2.2.3 Recombinant cell lysis
As noted in Section 2.2.2, E. coli disruption systems that require the combined action
of a recombinant protein and a foreign chemical in order to effect lysis are classified in
this discussion as chemical disruption techniques. This section describes recombinant
lytic systems that are the most similar to the goals of this thesis: a strain of E. coli
capable of efficient induced lysis within the bioreactor without the addition of any
5The product protein in the studies of Falconer, et al. was Long-R3-IGF-I, an insulin-like growth
factor.
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chemicals other than an inducing agent.6
The use of the bacteriophage lytic mechanism is overwhelmingly the most popu-
lar and effective means of conferring recombinant lytic capability. Several different
well-defined phages have been studied and multiple patents obtained. Auerbach, et
al. placed the λ-phage S (holin) and R (lysozyme) genes under the control of a operon
sensitive to the thermally inactivated cI857 repressor [2]. Raising the culture temper-
ature above 38◦C allowed the phage gene products to be expressed, resulting in lysis.
Aurbach, et al. describe induction of the lytic genes at low cell density (OD650 ≈ 0.5)
and suggest concentrating the culture by filtration or centrifugation before inducing
lysis. Auerbach, et al. did not describe the use of their invention at industrial scales
or cell densities; rather, examples of the use of their invention utilized shake flask
cultures. They did not include a detailed analysis of the effect of growth rate on the
rapidity or efficiency of lysis.
Vasala developed a lytic system based on the Lactobacillus delbrueckii subsp. lac-
tis bacteriophage LL-H [61]. Experiments with the coexpression of LL-H genes hol
(membrane permeabilizing holin) and mur (cell wall hydrolase) resulted in lysis only
at low cell densities (because growth rates and protein synthesis activity are higher
at low cell densities); in addition the mur protein digests the cell wall inefficiently.
Because of inefficient lysis at “high” cell densities (OD600 > 0.5), Vasala developed a
method in which mur was accumulated during growth, after which the cell membrane
was permeabilized by treatment with thymol. Consequently, Vasala considered the
permeabilization method cell density independent.
The lysis mechanism of the lytic strain designed in this thesis was closely based
on the work of Tanji and Morita, et al., which used bacteriophage T4 lysis genes
as the means of conferring lytic capability to product-producing strains of E. coli
(see Section 6.2). Tanji, et al. created two plamid vectors, one containing T4 gene-e
(lysozyme) and one containing gene-t (holin) [58]. They found that growth of E.
coli JM109 transformed with the gene-e plasmid was not affected by induction of
6Arabinose is one such inducing agent. The design for the use of the pBAD system (araBAD
promoter) to control the expression of the bacteriophage T4 holin is described in Section 6.2.
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the lysozyme product, but they observed an immediate halt in cell growth when
the strain containing gene-t was induced. They speculated that accumulation of the
lysozyme did not affect cell growth because the inner cell membrane prevented the
gene-e product from reaching its substrate the murein layer (part of the cell wall). On
the other hand, the t-holin was immediately toxic because it disrupted the integrity
of the inner cell membrane, making it impossible to tightly control the intracellular
environment. Tanji, et al. then transformed E. coli BL21(DE3)[pLysS] with each
plasmid. When gene-e was induced, they observed a decrease in growth rate and a
morphological change in the cell shape (cells became “swollen ellipsoids”). A decrease
in viability was observed, and resuspension of the harvest in pure water resulted
in near-100% lysis. Induction of gene-t during the late-logarithmic growth phase
resulted in immediate and complete lysis; 90% β-galactosidase activity was observed
in the supernatant 20 minutes after induction began.7 Induction of gene-t later in
the log-phase of growth resulted in larger fragments of cellular debris, and partial cell
lysis was observed even with cultures induced in the stationary phase. Tanji, et al.
suggested that the disruption of inner membrane integrity by the basally-expressed T7
lysozyme (due to the presence of the pLysS plasmid) allowed the lysozyme to reach its
substrate and degrade the cell wall. In contrast with the inability of phage φX174 to
lyse bacteria during the late logarithmic and stationary growth phases, as well as the
general decreased efficiency of recombinant lysis mechanisms at lower growth rates
described by Vasala [61], the t-holin with T7 lysozyme system appears to be especially
potent, giving it promise as a lytic system for high cell density fermentations when
growth rate is decreased. In addition, their success with lysing strain BL21(DE3)
was an improvement over the inefficient lytic behavior of strain BL21(DE3)[pUC18-
S−RRz] created in this thesis (Section 6.1.1).
Based on the work of Tanji, et al., Morita, et al. created a dual plasmid E. coli
system for the production of β-glucuronidase (GUS). The plasmids constructed by
7The host strains used in these experiments produced β-galactosidase due to the presence of
IPTG (isopropyl-β-D-thiogalactoside), a lactose analog. By measuring the amount of β-galactosidase
activity due to e/t-gene action relative to the maximum achievable activity obtained by complete
disruption with chloroform, Tanji, et al. measured the fraction of the culture that was lysed.
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Morita, et al. [38] combined either the e-lysin or the t-holin bacteriophage T4 genes
with a plasmid containing the construction for the pLysS T7 lysozyme. They named
the resultant plasmids pLysSE (T7 lysozyme gene + e-gene) and pLysT (T7 lysozyme
gene + t-gene). E. coli JM109(DE3) was used as the two-plasmid host which was
transformed with either pLysSE or pLysT and the plasmid with the GUS gene. Tanji,
et al.’s results showed that growth rate was decreased by gene-e expression and rapid
lysis was achieved by gene-t expression. Cultures were grown in a minimal medium
lacking tryptophan so that GUS, regulated by the OPtrp operator, would be expressed
constitutively.8 Induction of gene-t in mid-log phase resulted in 100% lysis within
2 hours, while late-log phase induction required 6 hours to achieve complete lysis.9
Rather than isolating and expressing phage lytic genes using a plasmid vector,
the direct infection of E. coli with specially engineered phages has been investigated.
Park, et al. used λ-phage infection of E. coli to transform the bacteria with a protein
product gene (β-galactosidase), which was then thermally induced to enter the lytic
cycle, produce recombinant product, and lyse [30, 33, 44]. The system consisted of
two bioreactors. In the first bioreactor, E. coli were infected with a strain of bac-
teriophage λ containing the desired product gene. Conditions in the first bioreactor
were optimized for cell growth in the lysogenic state (< 32◦C). When it was time for
the cells to be induced, they were transferred to the second bioreactor and thermally
induced to enter the lytic cycle (> 38◦C). During the lytic cycle, the gene product
(along with the bacteriophage lytic enzymes) was produced.10 Once a critical amount
8This thesis argues that for an industrial scale process, control over product expression by means
of a specific induction event is necessary; by delaying product protein expression during the batch
and fed-batch phases, higher growth rates and therefore less culture time may be necessary because
cellular resources are used solely for growth rather than being shared for product production through-
out low cell density growth. However, constitutive expression of GUS in Morita, et al.’s experiments
made the assay of GUS production throughout the growth and T4 gene induction processes more
straightforward.
9It must be emphasized that the experiments described here with the T4 phage genes were done
with shake flask cultures, at cell densities 1–2 orders of magnitude lower than densities reached in
bioreactors. Implementing these studies in bioreactors (as described in Section 6.3), in which the
growth rate can be precicely controlled and monitored, will give a precise ranges of growth rates for
efficient lysis.
10Expression of the product gene was not under the control of an independent expression system;
by virtue of its association with the phage’s lytic cycle genes, the product gene was expressed when
the phage entered the lytic cycle.
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of lytic enzymes were manufactured, the cells lysed. This process was optimized and
protein levels at 30 times the lysogenic (non-induced, basal) levels were achieved.
An advantage of this system is that the recombinant genes were more stable since
they were directly inserted into the bacterial chromosome rather than into a separate
plasmid, thus avoiding the plasmid stability problem of long-running continuous cul-
tures [52]. However, protein product induction and lysis were entirely coupled, and
the only way to increase protein production for a given strain would be to genetically
modify the virulence of the lambda phage. In addition, without discussing the level
of basal protein expression relative to other production systems, the absolute produc-
tion magnitude of “30 times the lysogenic levels” may be significantly less than other
production systems.
As an alternative to the phage holin lytic mechanism, the use of colicins as mem-
brane spanning proteins to aid in lysis has been studied. Colicins are antibiotic
proteins native to E. coli that span the cell membrane and form ionpermeable chan-
nels which cause a host of problems for bacterial health. The toxicity and instability
of colicin clones is so high, that combined with their inefficiency for catalyzing cell
wall hydrolysis, colicins are not an efficient and therefore viable option for E. coli
lysis [61].
2.3 Lytic mechanism of bacteriophage lysis enzymes
“Autolysis” mechanisms, by which E. coli are induced to lyse of their own accord, are
generally inefficient. In contrast, by nature, bacteriophages cause efficient lysis. This
work takes advantage of the lytic capability of the bacteriophage, a bacteria-infecting
virus (an obligate bacterial parasite).
In general a phage consists of a protein coat called the “capsid” that contains
phage DNA. When a bacterium is infected, the phage attaches to the cell surface and
injects its DNA into the bacterium. Synthesis of host DNA and RNA is halted and
the manufacture of phage DNA and proteins begins. At the end of this “lytic” cy-
cle, phage lytic enzymes are expressed and fully assembled phages are released from
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Phage Holin Lysozyme Lysozyme type
λ gene S gene R transglycosylase
T4 gene T gene E muramidase
T7 not included here gene 15 amidase
LL-H hol mur N-acetylmuramidase11
Table 2.2: Phage lysis genes and lysozyme mechanisms.
the bacterium. Some phages can also exist in a second, “lysogenic” life cycle. In
this cycle, phage DNA is incorporated into the bacterial chromosome and the phage
lies dormant, replicating with the rest of the chromosome during the DNA synthesis
phase of each cell cycle. The lytic cycle is usually repressed by suboptimal growth
conditions, and initiated in response to a growth-promoting environment (e.g. abun-
dance of nutrients) [35]. (Hence, the BL21(DE3) host strain is called a λDE3 lysogen
because DNA from the λ-phage is incorporated into the BL21 chromosome.)
There are two classes of lytic enzymes that work together to lyse a bacterium.
The holin enzyme makes the inner cell membrane permeable to the lysozyme (en-
dolysin/lysin), which degrades the cell wall. If the lysozyme is produced but the
holin is not present, the lysozyme can not come in contact with its substrate, and
consequently can not degrade the cell wall. Table 2.2 lists the holin-lysozyme pairs
and lysozyme categories for phages λ, T4, T7, and LL-H [61].
2.4 Quantitative protein assays
An important quantifier of process efficacy is the percentage of total protein comprised
by the product of interest. Thus, it is necessary to quantify both CLP and the total
protein throughout the course of the process. In the work leading into this project,
as well as in the beginning of this project, it was assumed that the results of the
collagenase assay for CLP quantification and the bicinchoninic acid (BCA) assay
for total protein quantification could be directly related. Based on the mechanisms
described below, Chapter 5 argues that the assumptions governing the use of these
11Effective on cell walls of Lactobacillus delbrueckii, Lb. helveticus, Lb. acidophilus, and Pedio-
coccus damnosus. Inefficient for digestion of E. coli cell walls [61].
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assays are oversimplistic.
2.4.1 Collagenase assay mechanism
Yin, et al. developed the collagenase assay studied in this thesis as a cheap, rapid
alternative to immuno-based assays or other assays that require extensive purifica-
tion of the collagen or gelatin prior to performing the assay [73]. The steps of the
assay are discussed in detail in Chapter 5 and the reagent compositions are listed
in Appendix A, but a brief description of the protocol is given here for reference.
After disrupting the E. coli harvest by sonication and removing the cell debris by
centrifugation, Yin, et al. propose the removal of approximately 80% of the excess
proteins with a high temperature (80–100◦C) precipitation step. The purified sample
(containing mostly collagen-like polymer or gelatin standard) is then digested with a
bacterial collagenase (see below) which liberates many polypeptide fragments. The
digest is incubated with a ninhydrin (triketohydrindenhydrate) reagent that reacts
with free amino groups to form a purple complex that is assayed colorimetrically by
measuring the absorbance at 570 nm. Thus, despite the presence of interfering factors
(whose effect is measured with a blank sample), the liberation of a large amount of
amino groups by hydrolysis of the collagen-like substrate is intended to overwhelm
the colorimetric signal resulting from the ninhydrin reaction.
There are a variety of collagenases that vary based on substrate and origin.
Type VII collagenase is the type used in this protocol, which is derived from Clostrid-
ium histolyticum, an anaerobic bacterium that invades tissue by using its collagenases
to degrade them structurally [56]. The type VII collagenase cleaves the sequence
Pro—X—Gly—Pro between the neutral amino acid X (e.g. leucine or alanine, R
groups are hydrocarbons) and Glycine, and is inhibited by metal chelating agents (e.g.
EDTA, cysteine; bacterial and most mammalian collagenases are metalloproteinases,
which require metal ion cofactors such as Ca2+ for Type VII collagenase) [54, 31, 32].
Ideal conditions for the collagenase reaction include the presence of Ca2+ ions and
physiological pH (7.5).
Ninhydrin reacts with most compounds that contain amino groups such as α-
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amino acids, imino acids, amino alcohols, primary amides, urea, ammonia, and am-
monium ion (because they are secondary amines, proline and hydroxyproline give a
yellow color). Relative to free leucine, ammonia results in 60% color yield. Stannous
chloride acts as the reducing agent for the reduction of ninhydrin to form the colored
complex (a conjugated pi-bond system). The ninhydrin reagent is 50% methyl cello-
solve (ethylene glycol monomethyl ether), which solubilizes ninhydrin. The ninhydrin
binding reaction is carried out at pH 5 and 80–100◦C [49, 13].
Since the collagenase assay results are used in conjunction with the results of
the BCA assay, the relative reactivities of gelatin and CLP3.1 in the BCA assay are
important (see Section 2.4.2 for the assay mechanism and composition of the BSA
protein standard). Type IV gelatin from bovine skin is a 46.3 kDa protein with the
following selected amino acid compositions (mole %): 3.75% cystine (17 residues),
1.99% tyrosine (9 residues), and 1.10% tryptophan (5 residues) [60]. CLP3.1 does
not contain any of these three residues (see Section 3.1.1); this difference between
natural gelatin and artificial CLP may be a significan source of error if it is not taken
into account by the assay (discussion in Section 5.4).
2.4.2 Bicinchoninic acid (BCA) assay mechanism
Developed in 1985 by Smith, et al. [55], the BCA assay is highly sensitive and easily-
implemented. In this thesis, a BCA assay kit manufactured by Pierce Biotechnology
was used (Part No. 23225).
The BCA assay reaction involves a multi-step mechanism that begins with a biuret
reaction. In the first step, 4–6 peptide bonds (from polypeptides of any length greater
than 1–2 peptides) form a coordination complex with a Cu2+ ion. The complex is blue
and absorbs light at 540 nm. In the alkaline reaction mixture, the protein reduces
Cu2+ to Cu+, which is then chelated by BCA. Two molecules of BCA react with one
Cu+ ion to form the coordination complex, which absorbs light at 562 nm. Relative
to the biuret reagent, the BCA reagent is 100 times more sensitive in the lower limit
of detection. Residues that are particularly reactive in the reduction of Cu2+ are
cystine (R-group: —CH2SH), tyrosine(R-group: —CH2–Ph–p-OH), and tryptophan
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(R-group: —CH2–C
2=CH–NH–Ph; ortho single bond between C2 and Ph); all are
basic residues, but experimental evidence suggests that the peptide bond also reduces
copper at increased temperatures. Copper chelating and reducing agents will interfere
with the assay [45, 59].
Bovine Serum Albumin (BSA) is the protein standard provided with the BCA
assay kit. Its molecular weight is approximately 66.4 kDa with the following com-
position of selected amino acids (mole %): 5.8% cystine (35 residues), 3.5% tyrosine
(21 residues), and 0.5% tryptophan (3 residues) [69].
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Chapter 3
Experimental setup
The apparati, techniques, and materials used to carry out each part of this project are
described in this chapter. The experimental components of this project can be broken
up into three general categories: basic recombinant E. coli techniques, fermentations,
and analytical protein assays (downstream processing, process analysis). It is not the
intent of this chapter to give continuity to the experiments and a chronological history
of their use in this thesis; it is a reference for protocols and technical specifications.
Experimental data is also included in this chapter when it can make the protocol
more clear or when it was used to develop or improve the protocol itself.
3.1 Recombinant E. coli techniques
The techniques described in this section implement very basic biological concepts
that are taught in any introductory biology lab course. The sections below, then,
focus on the vital information necessary to reimplement these experiments assuming
familiarity with molecular biology and fermentation implementation.1
1For example, MIT courses 7.02 (Introduction to Experimental Biology and Communication) and
10.28 (Biological Engineering Laboratory) would provide useful background knowledge.
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3.1.1 Vector design: strain and DNA information
Prior to this project, Yin, et al. found the optimal combination of host strain and
plasmid expression system for the production of collagen. Their study quantified the
expression level of collagen-like polymer (CLP3.1) when the gene was inserted into
different plasmid vectors and used with different versions of the BL21 family of E.
coli [72]. In another project whose results were also studied here, Yin and colleagues
in China worked on a lytic process using the JM109 strain of E. coli with a λ-phage
fragment that contained a lytic gene. Chapter 6 contains more detailed information
about the host strains, plasmid vectors, and their operating mechanisms. A concise
description of the characteristics of each strain and plasmid as well are listed below.
Host strains
All BL21-derived strains were studied by Yin, et al. at MIT [72], and the JM109-
derived strain was studied by Yin, et al. at Tsinhua University, China [74].
BL21 Base strain used in the construction of other host strains. Analyzed by Yin,
et al. but low productivity results with the plasmids used. Relevant properties:
F− ompT hsdSB(r−B) gal dcm (Novagen, [72]). Not used in this thesis.
BL21(DE3) A λDE3 lysogen of BL21. The included λ DNA contains a gene for
bacteriophage T7 RNA polymerase under the control of the lacUV5 promoter.
Designed to work with pET expression vectors in which the product gene is
placed under the control of a T7 promoter. Addition of IPTG induces the
expression of T7 RNA polymerase, which transcribes the product gene. There
is a small amount of basal (“leakage”) expression of T7 RNA polymerase, which
leads to basal expression of the product protein [21].
BL21(DE3)[pLysS] The pLysS plasmid confers chloramphenicol resistance and has
a T7 lysozyme gene that is always expressed at low basal levels (tet promoter).
By binding to T7 polymerase, the T7 lysozyme has an inhibitory effect on the
activity of T7 RNA polymerase, thus decreasing basal expression of the product
42
gene. Amidase activity of the T7 lysozyme is retained when the enzyme is
bound and inbibiting T7 RNA polymerase [9, 75]. The use of pLysS for the
basal expression of T7 lysozyme is a technique for repressing basal expression
of the product gene under the control of the T7lac system.
JM109 A common strain with which high transformation efficiencies can be ob-
tained.
Structure of the product gene, CLP3.1
In each plasmid vector described below, the product gene sequence CLP3.1 is fused
with a 252 bp sequence that codes for a six-histidine tag (from the pET expression
vectors, Novagen) at the C-terminus of the protein, making it possible to perform an
immunodetection assay to identify the protein. CLP3.1 is a 95 kDa protein made up of
52 repeating peptide sequences with the sequence GAPGAPGSQGAPGLQ [72, 19, 7].
The amino acid composition of CLP3.1 is therefore 33.3% Glycine, 20% Alanine, 20%
Proline, 13.3% Glutamine, 6.7% Leucine, and 6.7% Serine. Since CLP3.1 is produced
by E. coli, the product is a single-stranded protein, contrasted with the triple helix
structure of naturally occurring collagen. CLP3.1 is a non-toxic product; its accumu-
lation in host cells will not hurt the cells. Gelatin is natural collagen that is partially
denatured and degraded, and was considered by Yin, et al. to be close enough in struc-
ture and composition to be an accurate standard for the quantification of CLP3.1 in
the collagenase assay [73]; this claim is considered in more detail in Section 5.4. In
the context of this thesis, “CLP3.1” and “collagen” are used interchangeably.
Plasmid vectors
The following information is given for each plasmid: antibiotic resistance, origin of
replication, total length. The names pJY-1, pJY-2, and pJHL are nicknames for more
descriptive names which are included below. Since this thesis is concerned with the
construction of a dual plasmid strain of E. coli, it is important to note that when mul-
tiple plasmids are present they must replicate by different mechanisms. Origins within
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the same compatibility group are not compatible. Compatibility groups relevant to
this thesis are: {colE1, pMB1} and {p15A} (groups listings are not exhaustive).
pJY-1 Antibiotic resistance: ampR, Origin: pMBR, Expression system/operon: lac,
Full name: pET-14b-CLP3.1-his, Parent vector: pET-14b (Novagen), Length:
7053 bp. Not used in this thesis.
pJY-2 Antibiotic resistance: ampR, Origin: pMBR, Expression system/operon: T7lac,
Full name: pET-15b-CLP3.1-his, Parent vector: pET-15b (Novagen), Length:
8090 bp.
pJHL Antibiotic resistance: kanR, Origin: pMB1 (from pBR322), Expression sys-
tem/operon: cIts, Full name: pPT0296-CLP3.1-his, Parent vector: pPT0296
(Protein Polymer Technologies), Length: 6447 bp [7, 72].
pUC18-S−RRz Antibiotic resistance: ampR, Origin: pMB1, Expression system/operon:
lac, Full name: pUC18-S−RRz, Parent vector: pUC18 (GE Healthcare, formerly
Amersham Biosciences), Lenth: ≈ 4120 bp [62].
3.1.2 Plasmid purification and verification
Plasmids were purified using QIAfilter Plasmid Maxi Kits (QIAgen, Inc.; Cat. No.
12262). To obtain maximum plasmid purity, strict adherence to the steps in the
kit’s manual was necessary. Following the instructions in the QIAgen kit manual,
inoculum tubes containing 3 mL Luria Bertani (LB) medium and the appropriate
antibiotic marker were inoculated with a single colony from a streaked plate, grown
for 12 hours, and 200 µL used to inoculate a 100 mL working volume LB shake
flask which was grown for another 12 hours. The shake flask broth was harvested,
pelleted, and the cells were chemically lysed using kit reagents. The plasmid DNA in
the lysate was purified using special columns from the kit. The plasmids pJY-1, pJY-
2, and pJHL were purified from BL21(DE3) hosts, and the plasmid pUC18-S−RRz
was obtained from a JM109 host; all strains were obtained from Jin Yin. The final
DNA stocks were dissolved in TE buffer (10 mM Tris, 1 mM EDTA).
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Lane 1: 0.5 µg 1 kb DNA ladder
Lane 2: (Lane 1) × 2 dilution
Lane 3: 1.25X dilution of stock (repurified) pJHL
Lane 4: (Lane 3) × 2 dilution
Lane 5: (Lane 4) × 2 dilution
Lane 6: (Lane 5) × 2 dilution
Lane 7: (Lane 6) × 2 dilution
Lane 8: (Lane 7) × 2 dilution
Notes: lanes are numbered from left to right and
wells are at the top of the image.
Figure 3-1: Agarose gel used to quantify the repurified pJHL plasmid stock.
The plasmid DNA concentration was quantified by performing agarose gel elec-
trophoresis on the purification eluate (0.8% agarose in 1X TAE buffer; running buffer
= 1X TAE; 100 Volts; 35 minute running time; 15-20 minute ethidium bromide stain;
5-10 minute dH2O destain). The gel was then imaged with a Kodak Gel Logic 200
(image capturer and analyzer) under UV light with a 590 nm filter (λ at which ethid-
ium bromide fluoresces), and the digital image was analyzed by the accompanying
Kodak image analysis software. The software’s quantification algorithm was based
on based on comparing the DNA band intensities with those of a DNA standard.
The concentration of purified pUC18-S−RRz was found to be 50 µg/mL. The pJY-2
stock was found to be 4 µg/mL2. The first pJHL stock was 125 µg/mL, but after
a necessary repurification of the stock,3 the final concentration was found to be 5.4
µg/mL. Figure 3-1 shows the repurified pJHL quantification gel. The length of the
DNA fragments is determined by comparison with the DNA ladder in lanes 1 and 2
(New England Biolabs 1kb ladder; Cat. No. N3232S). The brightest band in the
ladder is composed of 3kb fragments.
In order to verify that the purified DNA was indeed the plasmid DNA that was
expected, each plasmid was each digested with one single-cutting restriction enzyme
2This low concentration (relative to the other purifications) is probably due to overdrying of the
DNA pellet, which made it very difficult to redissolve the pellet in the TE storage buffer.
3Even though the stock was sufficiently concentrated, appropriate dilution of the stock resulted
in low transformation efficiencies, implying interference by RNA. Large amounts of RNA were also
visible in the quantification gel as bright, unexpected bands and smears.
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Lane 1: 0.5 µg 1 kb DNA ladder
Lane 2: (Lane 1) × 2 dilution
Lane 3: undigested stock (repurified) pJHL
Lane 4: (Lane 3) × 2 dilution
Lane 5: 10 µL of digestion mixture
Lane 6: (Lane 5) × 2 dilution
Lane 7: (Lane 6) × 2 dilution
Lane 8: (Lane 7) × 2 dilution
Notes: lanes are numbered from left to right and
wells are at the top of the image.
Figure 3-2: Digestion of plasmid pJHL with NcoI results in two fragments of length
6195 bp and 252 bp.
and agarose gel electrophoresis was performed on the digestion mixture using the
parameters listed above. Gels were again imaged using the Kodak analyzer. The gel
images for the digestions of pUC18-S−RRz and pJHL are shown in Figure 3-2. Since
the digestion times and restriction enzyme amounts depended on the concentration of
the plasmid DNA, the quantification step was carried out first. Restriction endonu-
clease NcoI (New England Biolabs, Cat. No. R0193S) was used to digest pJHL. As
seen in Figure 3-2, the lanes containing the digestion mixture contain two bands of
length 6.2 kb and < 0.5 kb (sum ≈ length of pJHL; the < 0.5 kb band is at the edge of
the bottom the gel and is very faint). Restriction endonucleases EcoRI (New England
Biolabs, Cat. No. R0101S) and HindIII (New England Biolabs, Cat. No. R0104S)
were used to digest pUC18-S−RRz. As expected, two fragments of length 2.7 kb and
1.4 kb resulted (sum = 4.11 kb ≈ length of pUC18-S−RRz). Also notice that lanes 3
and 4 of Figure 3-2 contain multiple bands (> 8 kb) which are not present in the
lanes containing digested DNA. These additional bands are due to conglomerations
of multiple circular plasmids which are not formed when the plasmids are digested to
form linear structures. The disappearance of these bands also suggests the presence
of one pure type of plasmid (pJHL).
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3.1.3 E. coli strains studied
With the exception of BL21(DE3)[pJY-1], all strains that were studied during the
course of this thesis were made “freshly” by transforming the appropriate host strain
with purified plasmid DNA. More detailed information on the use of and data related
to these strains is written in Chapters 4 and 6.
BL21(DE3) plasmids used: pJHL, pJY-1,4 pJY-2, pUC18-S−RRz
BL21(DE3)[pLysS] plasmids used: pJHL, pJY-1
JM109 plasmids used: pUC18-S−RRz
3.1.4 Transformation
Competent host strains BL21(DE3) and BL21(DE3)[pLysS] were obtained from No-
vagen, and competent host JM109 was obtained from Promega. Transformation
protocols from the manuals that accompanied the cells were followed as strictly as
possible in order to achieve maximum transformation efficiency [22]. Despite the fact
that this is a “protocols” chapter, some data from the transformations is discussed
here in order to give an experimental basis for successful transformation experiments
in the future.
Cells were chemically competent. The most frequently used means of preparing
chemically competent cells is by subjecting them to a cold, hypotonic CaCl2 shock
then mixing them with plasmid DNA while still cold. The cell and plasmid DNA mix-
ture is then transferred from ice to a hot water bath (42◦C) in order to incur a rapid
heat shock (30 seconds). The competency “window” for cells is quite short and very
sensitive to external conditions, and no DNA at all will be taken up if there are even
slight deviations from the optimal conditions [35, 22]. The protocols warned that any
warming of the cells before the heat shock would reduce transformation efficiency. It
is likely that the early transformation experiments done in this thesis were subject to
4BL21(DE3)[pJY-1] stock was obtained directly from Jin Yin and plasmid pJY-1 was not repu-
rified and inserted into competent BL21(DE3).
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this degradation of competency because the original stocks of BL21(DE3) and JM109
came in stock tubes from which aliquots for individual transformation reactions were
to be aliquoted. The pipette tips used were not chilled, which is likely to have
warmed up the cells before the DNA was added. In the subsequent transformation
experiments that were performed by students in course 10.28, the BL21(DE3) and
BL21(DE3)[pLysS] cells came in single-reaction aliquots, which removed the aliquot-
ing step that was previously detrimental to transformation efficiency. The data from
the transformation experiments supports the hypothesis that the transformation ef-
ficiency was dramatically reduced by the extra handling step: the repurified pJHL
plasmid DNA was used in the transformations of both the aliquoted and single use
transformation mixtures, and the number of colony forming units increased from 2-3
to several hundred.
Size, purity, and quantity of plasmid DNA also affect transformation efficiency.
These effects were also observed over the course of the experiments. The original stock
solution of plasmid pJHL was highly concentrated (125 µg/mL), but had significant
RNA contamination (note: Figure 3-1 shows the repurified pJHL; the original gel of
the contaminated pJHL stock had much darker smears of RNA outside of the band
expected of pJHL DNA). Only the competent BL21(DE3) that was transformed with
the repurified pJHL DNA resulted in colony forming units when plated on kanamycin-
containing plates, implying that the additional RNA contamination interfered with
the DNA receptors on the surface of the E. coli [35]. In addition, an order of magni-
tude more colony forming units were obtained when the same cells transformed with
the pUC18-S−RRz plasmid, which was much more pure. (However, a confounding
factor may be that the 4.12 kb pUC18-S−RRz plasmid is much shorter than the 6.45
kb pJHL plasmid, and the difference in size effects likelihood of plasmid uptake.)
Finally, the quantification method based on calculating band intensities of plasmid
DNA in agarose gels is not highly accurate; it is difficult to obtain an image in which
all serial sample dilutions correspond to serial multiplications of the calculated band
intensities. In order to get a sense of the degree of quantitative error of this image
analysis technique and its effect on the success of transformation protocols which
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are based on the concentration values it produces, experiments were done at widely
varying plasmid concentrations. For example, the Novagen protocol for transforming
BL21(DE3) called for 1-10 ng of plasmid DNA. Using the Kodak analyzer data,
0.5 ng, 5 ng, and 50 ng of pUC18-S−RRz were added to separate transformation
mixtures. The 5 ng reaction produced 2 colonies, the other mixtures produced zero.
This sparse data implied that the quantification provided by the Kodak analyzer was
accurate to within one order of magnitude, which was enough to achieve a successful
transformation. Based on this data, transformations in 10.28 (pJHL and pJY-2)
were performed under the assumption that the calculated stock concentrations were
accurate. For each type of DNA, teams were assigned one of three DNA quantities
(4-5 ng ± 2 ng) with which to perform their transformation. The overwhelming
transformation success (hundreds of colony forming units per plate) implies that the
Kodak analyzer’s accuracy to within roughly one order of magnitude is sufficient for
these experimental purposes. Because of the large number of transformants (as well
as resultant satellite colonies) on each plate, it was impossible to make quantitative
conclusions about the effect of DNA quantity on transformation efficiency.
The experimental data presented here proves the importance of following the
transformation protocols and gives a real experimental basis for future experimental-
ists to design experiments that continue this work.
3.1.5 Cell bank
A cell bank of genetically pure stock of each strain was prepared. A small amount
(several µL) of each E. coli stock obtained from Jin Yin was streaked on a separate
LB-agar-antibiotic plate (LB medium + 1.5% agarose, see Section 3.2.3 for LB com-
position). For each strain, a 500 mL baﬄed shake flask with 100 mL of LB medium
was inoculated with a single colony to insure genetic purity. The shake flask cultures
were grown for 10-12 hours, 220 rpm, 30/37◦C until somewhere within the log phase
of growth was reached (exact cell density not important, as long as the OD600 value
is within the range 1-5). The broth was then mixed with pure, sterile glycerol to
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make a 50% (v/v) solution5 which was then distributed to microfuge tubes in 1 mL
aliquots and frozen at -80◦C. This preparation followed the protocol in the 10.28 lab
manual [68].
3.2 Fermentation
The exact parameters for implementing a fermentation vary depending on the strain,
operating conditions, and goals of the experiment. The purpose of this section is
to give an overview of a typical fermentation in order to define a context for the
instrumentation and assays discussed in this chapter. Detailed information on how
to set up a bioreactor resides in the 10.28 lab manual [68]. Specific data from a large
number of fermentations is presented in Chapter 4.
3.2.1 Bioreactor setup
Fermentations were carried out in the BioFlo 3000 and BioFlo 110 bioreactors (New
Brunswick Scientific Co., Edison, NJ). The vessel sizes were 1L and 5L for the BioFlo
3000 reactors, and 0.9L and 10L for the BioFlo 110 units. The major differences
between the two models lies in the controllers. The BioFlo 3000 is a console-style
controller with a water-jacketed vessel, while the BioFlo 110 controllers are modular
boxes that are cabled together on a controller bus, and heat transfer is accomplished
with a cooling coil submerged in the culture broth.
Either pure air or oxygen-enriched air was filter sterilized (0.2 µm) and sparged
through the broth by means of a perforated sparging ring that extended to the bottom
of the vessel. The broth was agitated by two Rushton impellers driven by an electric
motor connected to the headplate. Inoculum, acid/base, glucose feed, bioreactor
samples, etc. were added through sampling/addition lines that passed through the
headplate. The headplate also contained a septum port which allowd for a sterile
connection to the interior of the vessel to be initiated with a syringe or needle with
5The formation of the crystal structure of frozen 50% glycerol is less disruptive to the cells than
that of a purely aqueous solution.
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Figure 1: Typical fermentation setup (BioFlo 110).
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Figure 3-3: Overall view of a typical fermentation setup used in course 10.28
(Fall 2004).
a tubing barb. Tubing generally had an Inner Diameter (ID) of 1/8” or 1/4”. A
minimum wall thickness of 1/16” was necessary to insure that the peristaltic pumps
could completely pinch seal the tubing as they rotated. Silicon tubing was used when
it was useful to see the progress of the fluid meniscus, but a major problem with silicon
is that it could be permanently pinched closed by a pump or clamp that was left in the
same position for too long. For this reason, Pharmed r© tubing was generally preferred
to silicon for use with pinch clamps and pumps. Barbed tubing connectors were
purchased from Cole Parmer; polypropylene and Teflon r© (PTFE) were the preferred
materials for their composition since they are very inert and can withstand autoclave
temperatures (121◦C). Tubing pushed onto the barbed connectors was secured with
tool-tightened cable ties. A picture of the overall setup for a course 10.28 bench
(which contains standard equipment used in all fermentations) is shown in Figure 3-
3, and a close-up picture of a 1 L BioFlo 110 headplate is shown in Figure 3-4. Both
figures are reproduced from the 10.28 lab manual [68].
A “process loop” is a fermentation parameter under the control of a P-I-D feedback
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Figure 2: Typical headplate setup (BioFlo 110).
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Figure 3-4: Close-up view of a BioFlo 110 headplate.
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controller. “Loop” values were recorded by NBS’s BioCommand Plus software which
was installed on a PC connected to the NBS controller. Following is a list of process
loops recorded during each fermentation, with some brief notes on the setup and
parameters associated with each loop (the maximum sampling frequency was once
every 12 seconds):
Agitation Ranged from 300-800 depending on the oxygen demand of the culture.
Could be controlled based on the dissolved oxygen process value, but controllers
were often not consistent so manual control of agitation was used.
Temperature Cold water (4–10◦) was supplied by VWR recirculating chillers (VWR
Part No. 13271-204). BioFlo 3000 consoles had a heating element that could
warm the chiller water before circulating it through the SS water jacket. BioFlo
110 controllers warmed the vessel with an electric heating blanket and allowed
chilled water to pass through a SS cooling coil. In general, the SS water jackets
of the BioFlo 3000 vessels delivered a faster temperature response because there
was much more heat exchange surface area and coolant flow. The water pressure
was regulated to 15-20 psi for the BioFlo 3000s and 2-4 psi for the BioFlo 110s
(silicon tubing was used in the flow path of the BioFlo 110s; high pressure would
burst the tubing).
Dissolved oxygen (DO) Measured by a Mettler-Toledo InPro 6900 polarographic
probe. Oxygen in the medium diffused through an oxygen permeable membrane
was reduced at a platinum cathode, and Silver was oxidized at the anode to form
Silver Chloride (AgCl). The probe was autoclaved with the bioreactor and con-
nected to the controller via its cable for at least 6 hours before calibration in
order to allow sufficient time for polarization (practically, though, the polar-
ization time did not make a noticeable difference). The probe was calibrated
at the operating temperature: the zero-point was calibrated by saturating the
medium with nitrogen, and the 100% point was defined as the saturation point
when air was sparged.
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pH Measured by a Mettler-Toledo probe (Order No. 10 405 4480). Calibrated before
bioreactor sterilization and autoclaved with the bioreactor. pH was controlled
by a P-I-D controller that could add acid or base. Since the fermentations
usually produced acidic biproducts, the acid pump was turned off to eliminate
the possibility of controller oscillation and over addition of acid and base.
Acid/Base/Feed pumps These pumps were two state (on or off) peristaltic pumps.
The controller achieved a variable flow rate by varying the percentage of the
time that the pump was on. The pumps could be controlled manually, by P-I-D
controllers, or by software programs created within BioCommand Plus. The
maximum pump rate achievable using 1/8” ID tubing was 3.13 mL/min.
Inlet gas composition The percentage enrichment of air with pure oxygen could
be controlled. Air came from the building’s air compressors, Oxygen came from
high pressure tanks, and Nitrogen came from the headspace of a liquid N2 dewar.
All gases were regulated to 3-10 psi and delivered to controller manifolds via
1/4” braided PVC (or braided rubber) tubing. Connections were made with Coil
Hose 1500 Series brass quick release connectors (New Hampshire Tool Outlet,
Salem, NH).
Foam probe This probe was unreliable and there was no effective way of pumping an
appropriate amount of viscous antifoam (polypropylene glycol) into the vessel.
The BioFlo setup was equiped with this functionality, but it was not used.
Fermentation exhaust gas composition was measured by a Perkin Elmer mass
spectrometer and/or an ARI Laser Gas Analyzer. Exhaust gas passed through a
10◦C condenser before traveling through Stainless Steel tubing to a rotary valve that
controlled which gas stream was sampled (see Section 3.2.2 for details on these instru-
ments). Cole Parmer variable area (ball and tube) rotameters were used to monitor
the flow through the sampling lines. Because SS is very inert and permeates very
little gas, as much of the length of the sampling system as possible was constructed
using stainless steel and Swagelock r© ferrule-based connectors. Silicon tubing is very
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permeable to oxygen, so these lengths were kept to a minimum. Teflon r© (DuPont)
tubing is permeable to water, but this effect is less pronounced than the Si/O2 ef-
fect [46].
3.2.2 Supporting instrumentation
Mass spectrometer This is the gold-standard instrument for measuring the com-
position of bioreactor off-gas. The exhaust gas from each bioreactor was piped
through a separate length of 1/4” Stainless Steel (SS) tubing to a rotary valve
(Hamilton-Sundstrand) which could be configured to automatically swith be-
tween lines. The rotary valve had one outlet which delivered the gas flow to
the mass spec. The residence time for gas in the tubing system varied from
approximately 40 seconds to 2 min, 40 sec, depending on the distance from
the bioreactor to the rotary valve (between 15 and 40 feet). It was important
to keep the fermenter’s exhaust condenser cold at all times in order to pre-
vent condensation from building up in the gas lines and putting the mass spec
in danger of getting wet (water destroys the system). Requires a flow rate of
≈ 100–120 mL/min.
Laser Gas Analyzer The first prototype manufactured by Atmosphere Recovery,
Inc. (Plymouth, MN) for use with bioprocesses (ARI’s instruments are usu-
ally used in industrial manufacturing plants). Used in one fermentation so far
(BL21(DE3)[pJY-1], October 4-6, 2004). Based on the principal of Raman
spectroscopy, specially configured to measure eight gases that are biologically
relevant: N2, O2, CO2, H2O, NH3, H2, CH4, and C2H5OH. The instrument has
only been used to measure N2, O2, and CO2 in experiments so far. Gas trans-
port system is setup the same as the Perkin Elmer, with 1/8” SS tubing and a
rotary valve.
Noninvasive biomass probe BugEye prototype manufactured by BugLabs, LLC.
(Danville, CA). Used on one E. coli fermentation so far (October 4-6, 2004).
The device is strapped to the outside of the glass vessel so that it has an
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unobstructed view of the broth inside. Measures the degree of scattering of
infrared laser light to calculate the biomass concentration.
UV-VIS spectrophotometer Models 1100pro and 2100pro were used to measure
OD600 (cell density), OD570 (collagenase assay), and OD562 (BCA protein as-
say). Manufactured by Amersham Biosciences (Piscataway, NJ).
3.2.3 Fermentation medium and feed components
A complete list of media and reagents, as well as notes on their preparation, is included
in Appendix A. All shake flask cultures were grown in Luria-Bertani (LB) medium
(10 g/L NaCl, 10 g/L Tryptone, 5 g/L Yeast extract). MR medium was used for
all fermentations (note that the optimal minimal medium varies with strain; since
the host strain used in all fermentations was BL21(DE3), no other minimal medium
was necessary). A note on media design: the media composition for optimal growth
varies with host strain. MR medium, designed for the BL21 family, does not work with
JM109; in a fermentation performed with JM109[pUC18-S−RRz] and MR medium,
the culture never grew past an OD600 of 2.
3.2.4 Typical fermentation chronology
After preparing the bioreactor for use according to the description in Section 3.2.1,
MR medium is added to the bioreactor. The bioreactor is then sterilized in the auto-
clave (121◦C, 45 min). After autoclaving, nitrogen is slowly sparged until just before
inoculation to deter growth of possible aerobic contaminants. Just before inoculation,
glucose and antibiotic are added through the septum and the DO probe is calibrated.
Table 3.1 describes the components that are added before and at inoculation (repro-
duced from the 10.28 lab manual [68]). The divergence of the pH probe is evaluated
by measuring a sample with an external pH meter. Throughout the process, samples
are taken every 1-3 hours, and the assays described in Section 3.3 are performed. The
BCA and collagenase assays are only performed on induction samples, though.
The initial inoculum volume for a fermentation is 10% of the total working volume.
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Medium component Volume (/L) Final concentration
“Partial” 1X MR medium 883.3 mL 1X
Antifoam (PPG) 0.4 mL 0.04% (v/v)
25 mg/ml ampicillin 2 mL 50 µg/mL
700 g/L glucose with 14 g/L MgSO4 • 7H2O 14.3 mL 10 g/L
Seed culture 100 mL 10% (v/v)
Total 1000 mL -
Table 3.1: Components of initial bioreactor medium per liter of final bioreactor work-
ing volume. Components in bold are added before autoclaving, the remainder are
added before and at inoculation (10.28, Fall 2004).
The night before inoculation, an appropriate number of 500 mL baﬄed shake flasks
with 100 mL of LB medium are inoculated with 100 µL of glycerol stock and grown
for 12-16 hours until the end of the log growth phase. Once the bioreactor has been
completely prepared, the inoculum is added through a sterile bottle connected to
tubing with a needle that pierces the septum. The BioCommand Plus software is set
to begin recording process values and the batch phase begins. The batch phase lasts
approximately 6 hours, and the end is signified by a sudden spike in the DO%: when
the glucose is completely consumed aerobic respiration can no longer occur resulting
in a sudden decrease in the consumption of oxygen. Fermentations in which bioreactor
cooling is done are most successful when the cultures are cooled midway through the
batch phase, when cell density is sufficiently low. The length of the “warm time”
batch phase for a culture that is cooled is usually only slightly shorter than the lengh
of the batch phase of an uncooled culture.
During the fed-batch phase, glucose/MgSO4 solution is fed to the culture until a
sufficiently high cell density is reached (> 40 OD600; > 15 g/L DCW). A primary goal
during this phase is to maintain the culture in a feed-limited state, rather than an
oxygen-limited state. Physical limits on the fermentation system make it impossible
to sustain the ever-increasing oxygen transfer rates (OTR) necessary to maintain
high growth rates at the high cell densities of the fed-batch phase. Overfeeding of
glucose and the consequent tendency towards an oxygen-limited state can lead to the
accumulation of acetate, which can be detrimental to product production [27].
One strategy to maintain a feed-limited state is called DO-stat feeding. In this
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strategy, a small amount of feed is added when the DO level rises, which immediately
causes the DO to drop. If the DO remains floored at zero, there is most likely an
excess of glucose. DO-stat feeding can be frustrating because a steady state is hard to
achieve and the DO-stat feeding algorithms that the NBS equipment is capable of can
be easily confounded by the delay of the DO probe and response time of the controller,
leading to erratic feeding. Section 4.1.2 describes the use of vigilant DO-stat feeding
to determine a range of acceptable feeding rates for a given set of process values,
which are then applied to subsequent processes in a prescribed, rather than reactive
feeding strategy. During the fed-batch phase, when relatively high cell densities are
reached, foaming is prone to occur. Foam is dealt with by using a syringe to add
about 5 drops of antifoam at a time through the septum port.
Once a sufficiently high cell density has been reached and while the culture is still
actively growing (usually OD600 ≈ 50, DCW ≈ 15-20 g/L), the culture is induced to
express the product gene. In the lac system, IPTG is added to a working concentra-
tion of 1 mM, and in the thermally-inducible system, the temperature is increased
from 30◦C to 41◦C. In most cases, it is ideal to have a high growth rate at the start
of induction. In a high-growth state, a high level of transcriptional and translational
machinery is present in a cell to support its growth activitity. Suddenly inducing the
culture can cause a major shift in the application of that machinery from the syn-
thesis of proteins required for cell replication to the synthesis of the product protein.
Consequently, a marked decrease in growth rate may be observed 30–45 minutes after
the start of induction [20]. After a 5 hour induction period, the process is stopped
and a final harvest sample is taken. Unused cells are killed with bleach. The BCA
and collagenase assays are used to analyze the induction samples for intracellular
protein content. E. coli is lysed by sonication (Branson Ultrasonics Sonifier 250D:
1/8” microtip, 70% intensity, 70% duty cycle, 1 second period, sample cooled in ice
bath) after washing twice with Phosphate Buffer Saline (PBS).
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3.3 Analytical assays and fermentation measure-
ments
Over the course of the fermentation, the assays listed below were performed. All
protocols for the following assays are described in detail in the 10.28 lab manual [68].
In addition, the theoretical background and techniques for measuring the volumetric
oxygen mass transfer coefficient (kLa) are given in Section 3.3.2.
3.3.1 Analytical assays
OD600 In order to quantify the cell density within a few minutes of sample-taking,
a sample was diluted in a 1.5 mL cuvette to within the linear range of the
UV-VIS instrument (between 0.1 and 1) and the absorbance at 600 nm was
measured. Since E. coli are particulate matter they scatter light. As a result,
the measured absorbance is affected both by scattering and absorbance of the
sample. This means that UV-VIS instruments with different physical setups
will measure different absorbances for the same sample: OD600 measurements
should not be used as the gold standard to compare different fermentations
with which different instruments may have been used. To be rigorous, optical
density measurements must be normalized for the interference due to medium
absorbance. However, relative to the OD600 values for most cell-containing
measurements, the medium’s absorbance is minimal: for LB medium OD600≈
0.014, and for MR medium, the value is even less.
Dry Cell Weight (DCW) 1.5 mL samples were washed twice with deionized water
and dried in an 80◦C oven to a constant mass (≈ 2 days). In contrast with the
OD600 measurement, DCW is an assay that can be used to compare cell densities
across fermentations and laboratories. Even with a balance with a sensitivity of
± 0.1 mg, the signal from the dry mass of the sample only began to dominate the
noise of the instrument when the DCW reached ≈ 20 g/L, and in the analysis of
the BL21(DE3)[pJY-1] data from the 10/4/04 fermentation, only samples with
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OD600 > 40 were considered in the quantitation of the relationship between
OD600 and DCW (Section 4.1.2). In the future, larger sample volumes should
be used to measure the DCW of lower cell densities. Major sources of error
are introduced in the washing and drying steps. If the samples are left in the
oven for too long, organic material will sublimate before the sample masses
are measured [20]. Sublimation will result in the underestimation of the DCW
associated with a specific OD600. In the washing step, if cell pellets are not
tight, cell mass may be lost when the supernatant is poured off.
Glucose A Yellow Springs Instruments (Yellow Springs, Ohio) 2700 Select enzymatic
probe was used to measure glucose concentration in the bioreactor samples. To
avoid rapid clogging of the membrane, samples were centrifuged for 1 minute
at 3000 rpm before the YSI took an aliquot.
pH A Mettler-Toledo benchtop SevenEasy pH meter was calibrated daily and the
pH of the fermentation broth measured every few hours to monitor the drift of
the bioreactor pH probe. If the pH measured by the bioreactor probe and the
Mettler probe disagreed, the pH setpoint was changed to compensate for the
bioreactor probe drift.
Collagenase assay Developed by Yin, et al. [73] as a cheap, simple alternative to
an immunodetection assay. Protocol involves precipitation of insoluble proteins
and subsequent digestion of the remaining (soluble) collagen with collagenase.
The excess freed N- and C-terminus react with ninhydrin to form a purple
complex that absorbs light at 570 nm, allowing for a colorimetric assay using a
UV-VIS spectrophotometer. Gelatin is used to make the standard curve.
BCA assay Used BCA Protein Assay kit (Pierce Biotechnology, Cat. No. 23225) to
measure total intracellular protein in lysed samples. Assay uses Bovine Serum
Albumin (BSA) as protein standard. Mechanism involves the reduction of Cu2+
to Cu1+ which forms a complex with BCA and results in purple color. Specific
amino acid residues and the peptide bond act as reducing agents [69].
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HPLC An Agilent 1100 Series High Performance Liquid Chromatography instru-
ment was set up and run by Judy Yeh to assay carbohydrates and organic acids
from the course 10.28 fermentation samples. The HPLC can detect concentra-
tions as low as 1 mg/L, which made it useful for assaying fermentation products
such as acetate.
3.3.2 Oxygen mass transfer theory and experimental approach
Many calculations can be carried out on the process loop and growth kinetic data
to further analyze the process. These calculations will be introduced and carried
out in Section 4.3, where the actual fermentation data is presented. There is one
system parameter, though, whose measurement requires special instrumentation and
technique, the details of which are most appropriately described in this section. That
parameter is the volumetric oxygen mass transfer coefficient (kLa, units = hr
−1). The
kLa is a quantification of the fermentation system’s ability to encourage the transfer of
oxygen from the gas to the liquid phase. The higher the value of the kLa, the greater
the Oxygen Uptake Rate (OUR) of the culture can be. The kLa is the product of the
liquid side oxygen mass transfer coefficient, kL, and the gas-liquid interfacial area, a.
kL is dependent on the physical properties of the liquid. In this thesis, a is primarily
dependent on agitation (vigorous stirring means smaller bubbles and a larger surface
to area ratio) and sparging rate, while kL is effected by ionic strength and broth
composition (see Section 4.3.4 for a discussion of kLa data from this thesis in the
context of literature analyses).
The kLa appears in the oxygen mass transfer equation:
dCL
dt
= kla(C
∗ − CL)−OUR (3.1)
CL is the concentration of dissolved oxygen in the broth [
mol
L
], C∗ is the saturation
concentration of oxygen in the broth at the given operating temperature, and OUR
is the oxygen uptake rate [ mol
L·hr ].
Two methods were used to measure the kLa: the dynamic method and the off-gas
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method. Both of these methods are based on achieving conditions in the bioreactor
that allow for the simplification of the oxygen mass transfer equation so that it can
be easily rearranged and the kLa solved for.
Because of the dynamic method’s dependence on the dynamic response of the
polarographic dissolved oxygen (DO) probe, results of this method are most accu-
rate at low cell densities (< 1 g/L, OD600 ≤ 1−−2), when the DO probe can more
accurately track the relatively slower dynamics of the DO response. The first step
in this method is to turn off the bioreactor’s air supply when the DO is at a high
value (preferably at least 50–60% of air saturation). Assuming the experiment is ac-
complished within a small fraction of the doubling time of the culture, the dissolved
oxygen will be consumed at a constant rate equal to the OUR. When the DO ap-
proaches zero, the air flow is stepped back to its original rate and the recovery of the
DO is plotted until the DO stabilizes at some steady-state value. The kLa can be
calculated in two ways from this data: either by using the OUR (calculated above)
along with the steady-state driving force, as seen in Equation 3.2, or by plotting dCL
dt
versus (C∗−CL) and calculating the slope (kLa will be the negative slope of the plot).
In steady state :
dCL
dt
= 0 ⇒ kla = OUR
(C∗ − CL) (3.2)
Because the dynamic method is only useful for calculating the kLa for a small
fraction of the total fermentation time, the off-gas method of kLa analysis is a
particularly useful technique, applicable at any time there is a measurable amount
of oxygen consumption. The off-gas method is most accurate when a steady state
is achieved: a constant, measurable difference between the inlet and exhaust oxygen
percent compositions (%Oin2 , %O
out
2 ) is used to calculate the OUR (given the flow
rate of sparged gas), and the value of CL is used to calculate the driving force. The
resultant values can be plugged into Equation 3.2 to calculate the kLa. If there is
water vapor present in the exhaust gas, the calculated OUR will be artificially high
because the percent composition of %Oout2 is reduced because of the presence of water
vapor in the exhaust. To compensate for this effect, a normalization factor using inert
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nitrogen is introduced to the equation for the percentage OUR (OUR%), as shown
in Equation 3.3.
OUR% = %Oin2 −
(
%N in2
%N out2
)
%Oout2 (3.3)
It must be noted that emperical correlations between kLa and system parameters
such as agitation, aeration, and physical properties of the impellers, etc. are not
examined in this thesis; in the experimental analysis, more effort was devoted to
developing other aspects of the project.
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Chapter 4
Quantitative fermentation results
The overarching goal of this chapter is to present the data and analysis necessary to
implement repeatable E. coli fermentations. One of the unique contributions of this
thesis that defines the context for these analyses is the development of a cooling phase
to arrest the growth of fermentations for up to several days. To accomplish this goal,
the following study analyzes data spanning the topics of fermentation growth kinetics,
cooled fermentations (10–12◦C), and the oxygen mass transfer coefficient (kLa), and
carbon mass balance.
4.1 E. coli growth kinetics
Because of their relevance to an organism’s metabolic state, which directly impacts the
organism’s capacity for recombinant product production, a detailed study of growth
kinetics is essential to the definition of a viable bioprocess. In general, high growth
rates at the time of induction are desirable because they necessitate the buildup of
large amounts of protein-making machinery required for growth, which can be used
for product production at the time of induction. High cell densities are desirable be-
cause product quantity is usually related to the sheer amount of biomass accumulated
(E. coli densities of up to 100 g/L [OD600 ≈ 250] have been reported) [8]. The fol-
lowing sections report the kinetic data for E. coli shake flask cultures and bioreactor
fermentations. In addition, high time-resolution data from an on-line, noninvasive
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biomass sensor is presented.
4.1.1 Shake flask culture
In the context of fermentations, shake flasks are primarily used to multiply an E. coli
stock to generate an inoculum culture, hence the criteria for successful shake flask
growth processes are less stringent than those for fermentations. In general, E. coli
densities in shake flasks follow a logistic growth curve with four phases: lag (adjust-
ment to new conditions just after inoculation, low growth rate), log (once adjusted
to culture conditions, a constant growth rate is attained, leading to an exponential
increase in cell density while nutrients are plentiful), stationary (remaining nutrients
are not sufficient to maintain exponential growth), and death (cells die due to the de-
pletion of nutrients and accumulation of harmful waste products). By the end of the
log phase the available nutrients per cell has dramatically decreased, acetate waste
has accumulated,1 and the cells begin to lose their propensity for exponential growth.
Thus, in preparation for a fermentation in which rapid accumulation of biomass is
desired, the ideal inoculum must contain a high density of cells that are still in the
log phase of growth.
Shake flask cultures were grown in 500 mL baﬄed flasks with 100 mL of LB
medium and an appropriate antibiotic, and were inoculated with 100 µL of glycerol
stock (see Section 3.1.5). Using the lab’s Amersham 1100pro UV-VIS spectropho-
tometers, the maximum OD600 values attained in shake flasks permitted to reach
the stationary phase were in the range 5–6. The target optical density range for
inoculum shake flasks was 4–5. Strains containing an IPTG inducible CLP3.1 gene
(e.g. BL21(DE3)[pJY-1/pJY-2]) that were grown at 37◦C, 220 rpm, reached an OD600
in the range 4–5 within 10–12 hours. Thermally-inducible (BL21(DE3)[pJHL]), grown
1In a set of experiments for a separate, industry-related E. coli fermentation project (12/17/03),
shake flasks were inoculated with 50 mL bioreactor samples from different times in the fermentation.
Shake flasks inoculated with broth from the bioreactor with an initial OD600 ≈ 15 reached a final
pH in the range 5.1–5.5, while shake flasks with an initial OD600 ≈ 40 reached a final pH in the
range 4.7–5.0. (Because oxygen mass transfer is much more limited in the shake flask than in the
bioreactor, the biomass of these high cell density cultures did not significantly increase in the shake
flasks.)
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at 30◦C, 220 rpm, reached an OD600 in the targed range within 11–12 hours. Since
shake flask growth can vary significantly, it is best to measure the OD600 every hour
after 10 hours has elapsed.
Before testing the effect of cooling on a bioreactor culture, cooling experiments
were done with shake flask cultures (8/4/03–8/5/03). Shake flasks containing E. coli
strains BL21(DE3)[pJHL] and BL21(DE3)[pJY-2] were inoculated with one colony
each into 100 mL LB with an appropriate antibiotic (see Appendix A.1 for medium
and antibiotic compositions). The cultures were grown to a low cell density in the
beginning of the log phase, put into a refrigerator overnight, and returned to the
incubator the following day. The growth curves for the two strains are plotted in
Figure 4-1. When shake flasks are inoculated with a colony from an agar plate, the
lag phase may vary greatly (up to 8 hours) because of large differences in the number
of cells that are initially dislodged from the inoculation loop in the medium. The
growth curves of the two cultures in Figure 4-1 are synchronized; the time between
inoculation and the first data point for BL21(DE3)[pJHL] was 9.5 hours, and 2 hours
for BL21(DE3)[pJY-2]. The time associated with each OD600 value is the effective
elapsed time that the cultures spent in the incubator; the 6.3 hour period that the
samples spent in the refrigerator was effectively removed when the data was plot-
ted. It is evident that both cultures recovered from the cooling period and resumed
exponential growth. Also note that the OD600 doubled while the cells were in the
refrigerator. It is likely that the time it took the cells to cool to 4◦C while in the
refrigerator accounts for a significant amount of the additional growth, so that the
majority of growth that lead to the doubling of OD600 occured in the very beginning
of the time that the cells spent in the refrigerator. Based on the encouraging results
of this experiment, further cooling experiments were performed with bioreactors (see
Section 4.2).
A discussion of the effects of phage lytic enzymes on bacteria growth is also relevant
to this thesis. Inconsistent results and low growth rate and growth extent were
sometimes seen in shake flask cultures with strain BL21(DE3)[pUC18-S−RRz]. See
Section 6.1 for more detailed results and Chapter 6 for a general discussion of the
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Figure 4-1: Growth kinetics of shake flask cultures refrigerated at low cell densities.
effect of basal expression of bacteriophage lysozyme on cell growth.
4.1.2 Fermentation
The purpose of this section is to describe the general fermentation growth characteris-
tics of the BL21(DE3)/CLP3.1-producing family of strains. Detailed calculations are
performed on the data from the BL21(DE3)[pJHL] fermentation on 3/25/04, since
this is the primary fermentation that the design of the course 10.28 (Fall 2004) fermen-
tations was based on. Data from other fermentations is presented where applicable.
Data from the course 10.28 fermentations (Fall 2003 and Fall 2004) is primarily used
to analyze the efficacy of different cooling strategies (Section 4.2).
Data for several fermentations on the length of the batch, fed-batch, and induction
phases, as well as the OD600 at the end of each phase are listed in Table 4.1. In the
3/25/04 fermentation, the oxygen enrichment level was increased from 0% to 4.5%
over the course of the fed-batch phase and kept at 11% during the induction phase.
At the beginning of the fed-batch phase, the culture was fed in bursts until the feed
bottle and pump system were set up correctly; the culture alternately fed and starved
for about 1.5 hours while the feeding system was repaired, and oxygen enrichment
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Final OD600 and phase length
Date Strain Batch Fed-batch Induction
3/25/04 BL21(DE3)[pJHL] 14.88 (7.5 hr) 55.8 (7.1 hr) 70.9 (4 hr)
6/24/04 BL21(DE3)[pJHL] 36.03 (5.8) 54 (4.6) 102 (5.0)
7/25/04 (1) BL21(DE3)[pJY-2] 10.4 (4.7) 37.6 (4.3) 52.3 (4.75)
7/25/04 (2) BL21(DE3)[pJY-2] 10.9 (4.7) 42.9 (4.3) 65 (4.75)
10/4/04 BL21(DE3)[pJY-1] 9.1 (16) 46.4 (6) 96.7 (5.5)
Table 4.1: Summary of fermentation kinetics for various strains and fermentation
runs: phase length and final OD600 measurement for batch, fed-batch, and induction
phases.
was not begun until the feeding system was repaired.2
In contrast, to the 3/25/04 run, the fermentation conducted on 6/24/04 was imme-
diately fed and oxygen-enriched when the batch phase glucose was depleted. During
the fed-batch phase the oxygen enrichment level was steadily increased to 16% and
held at that level throughout induction. Most likely, because of the less stressful condi-
tions at the beginning of batch phase the 6/24/04 fermentation grew more vigorously
and consistently reached higher optical densities in less time than the 3/25/04 fermen-
tation. Since only one fermentation was completed with strain BL21(DE3)[pJY-1],
the reproducibility of long lag period during the batch phase is unknown. Because of
the accumulation of waste and consumption of unreplaced nutrients, the longevity of
a batch style culture is expected to be finite (in contrast to a continuous culture, in
which spent medium is continually replaced by fresh medium). In most fermentations
conducted during this project, the growth rate had dramatically slowed or stopped
by the end of the induction phase and the cultures were especially prone to foaming.
Since the fermentations performed on 3/25/04 and 6/24/04 were experimental
2When the feeding was started for the first time and tubing from the glucose feed bottle was put
into the peristaltic pump, the tubing was not unclamped downstream of the pump, so the tubing
eventually burst. In the 1.5 hour period that it took to prepare and sterilize another feed bottle
assembly, the broken feed tubing was patched and glucose periodically drained into the bioreactor.
Because there is slight back pressure in the bioreactor due to the restriction on the exhaust imposed
by the exhaust filter, the air supply had to be shut off in order for the bioreactor pressure to dissipate
and for the draining setup to work. Consequently, in addition to starving periods, there were periods
of oxygen deprivation.
3The final OD600 value reported for the batch phase of this fermentation (OD600= 36.0) is likely to
be an error; two hours into the fed-batch phase the OD600 was 30.9 and the subsequent measurements
were most consistent with the 30.9 value.
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fermentations whose results were used to develop a defined fermentation strategy
for course 10.28, a vigilant, care-intensive DO-stat feeding strategy was implemented
(see Section 3.2.4 for a general description of DO-stat feeding). This strategy involved
making minute adjustments to the feed addition rate as the culture grew while grad-
ually increasing the level of oxygen enrichment. The primary goal was to keep the
culture feed-limited at all times so that glucose would not accumulate. Table 4.2
summarizes the relationship between biomass increase and quantity of glucose added
for several fermentations. These ratios ( (g glucose)/(L broth)
OD600 unit
) were calculated by plotting
the cumulative amount of glucose added (i.e. the absolute mass of glucose, not the
mass of the glucose feed) versus OD600, and taking the slope of the linear regres-
sion on this data. Table 4.2 includes the R2 values for each linear regression. Note
that the BL21(DE3)[pJHL] fermentations (working volume for both fermentations
was 5 L) resulted in similar quantities of glucose consumed per unit of biomass in-
crease, while the BL21(DE3)[pJY-1] fermentation (10 L working volume) required
slightly more glucose. The increase in working volume over time due to feed addition
was not taken into account. A result of this simplification in the calculation is that
the amount of biomass increase per unit volume is overestimated, especially as the
elapsed fermentation time inceases. If a mean volume of 11 L during the fed-batch
and induction phases was used for the BL21(DE3)[pJY-1] fermentation, the glucose
consumption ratio would have been 1.46 g/(L broth)
OD600 unit
(significantly closer to the values
for the BL21(DE3)[pJHL] fermentations). The data used to calculate the values in
Table 4.2 remained linear (rather than beginning to plateau), even at high OD600
values. This result implies that the energy requirements for growth far outweigh the
requirement for cellular maintenance (otherwise, increasing cell density would have
required an increasing fraction of the glucose feed to be used for maintenance, rather
than for biomass increase). Therefore, assuming that the variability of the data in Ta-
ble 4.2 is purely experimental, the mean mass of glucose consumed per unit increase
is approximately 1.37± 0.40
[
(g glucose)/(L broth)
OD600 unit
]
.
Since a culture’s growth rate is never constant, designing the feeding and oxygen
enrichment strategies based on the rate of biomass increase is more straightforward;
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Date Strain Glucose consumed per OD600 unit R
2
3/25/04 BL21(DE3)[pJHL] 1.19 [g/(L broth)
OD600 unit
] 0.98
6/24/04 BL21(DE3)[pJHL] 1.30 0.95
10/4/04 BL21(DE3)[pJY-1] 1.61 0.98
Table 4.2: Specific glucose consumed [ g
L broth
] per unit OD600 increase in biomass;
obtained from slope of the linear regression on glucose added vs. OD600 data during
fed-batch and induction phases of various fermentations.
if a critical minimum growth rate for maximal induction is determined in the future,
then that value of µ can be used to calculate an acceptable rate of biomass increase
that satisfies range in µ necessary for effective induction, which can then be used to
develop a feeding strategy based on the results presented in this section.4 Thus, using
the results of the 3/25/04 and 6/24/04 fermentations, non-dynamic feeding strategies
were constructed for the course 10.28 (Fall 2004) fermentations. Implementing these
strategies involved calibrating the feed tubing with the controller pump to determine
the maxim flow rate, then making a program with the BioCommand Plus software
(New Brunswick Scientific Co.) that would increase the feeding rate linearly with
time. (The strategy for oxygen enrichment was to use the DO% process value to
manually respond to the change in oxygen demand caused by a change in feed rate
by changing the enrichment level about one percent at a time until a new equilibrium
was reached where the DO% was non-zero; often during the later phases of induction,
the feed demand would decrease, allowing the O2 enrichment to be concordantly
decreased.) Results of the Fall 2004 course 10.28 fermentations are described in
Section 4.2.
As a side note, an explanation of why we used the methodology described above to
develop fixed feeding programs rather than “simply” using DO-stat feeding control
programs for course 10.28 is relevant. Work concurrent to but unrelated to this
thesis was done with several E. coli fermentations in an attempt to implement a
DO-stat feeding program for an unmanned implementation of the fed-batch phase. A
combination of the DO probe time delay and delay in the BioFlo controller’s response
4The growth rate at the time of induction of the bacteriophage T4 t-holin protein is critical to
the efficiency and rapidity of lysis. Sections 2.2.3 and 6.3 discuss the effect of growth rate on induced
lysis in more detail.
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Figure 4-2: Growth curve for BL21(DE3)[pJHL] fermentation with cumulative glucose
added during the fed-batch and induction phases.
time caused the resultant “feed back controller” to feed in erratic patterns, resulting
in prolonged periods of starvation and glucose glut. We decided that developing
fixed feeding strategies based on data from several labor-intensive implementations of
glucose-limited feeding would allow us to develop fermentations with more predictable
growth kinetics, consequently causing them to be more robust.
In order to provide a detailed characterization of the relationship between growth
rate, feeding rate, and biomass accumulation rate, the 3/25/04 BL21(DE3)[pJHL]
fermentation is analyzed below. Figure 4-2 shows the growth curve for the 3/25/04
fermentation along with the cumulative amount of glucose added during the fed-
batch and induction phases.5 The trend in OD600 is qualitatively correlated with the
amount of glucose that has been fed; periods of relatively rapid increase in OD600 are
accompanied by periods of relatively rapid increase in the amount of glucose that has
been added.
The trends in Figure 4-3 are quantitative representations of this noticeable correla-
5The feed contained 700 g/L glucose with a density of almost exactly 1 g/mL. Thus, 0.7 g of
glucose was added per 1 mL of glucose feed. All plots of glucose-related data are in terms of glucose
mass, not the mass of glucose feed.
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tion between feeding and growth. Figure 4-3(a) shows the time courses of the growth
rate, µ, and the feed addition rate.6 Based on this data (unfortunately the data was
limited in this part of the fermentation), the highest growth rate was achieved in
the middle of the batch phase and steadily decreased as the fermentation progressed.
The decrease in growth rate was primarily due to limitations on the magnitude of the
OTR that can be achieved in the bioreactor; as the bacterial population increases, the
amount of oxygen available per cell decreases. This trend can be countered using oxy-
gen enrichment, but judging from the consistent decrease in growth rate with time
for all fermentations, an exponential growth rate is not sustainable. Figure 4-3(a)
demonstrates that feeding rate and growth rate are not analogous quantities (as are
the rate of biomass increase and the feeding rate). The maximum feed demand from
13–14 hours is the combined result of a relatively high biomass with a high metabolic
demand.
Figure 4-3(b) shows the time courses of the change in biomass and the feed ad-
dition rate. As expected, the shapes of the trends closely track one another. Since
the culture was glucose-limited (i.e. there was no glucose accumulation), the feed
was converted to biomass. The close correlation of these trends also implies that a
relatively constant fraction of the feed was converted to biomass (see Table 4.2).
The analysis of cell growth kinetics treats the OD600 measurement as a gold stan-
dard for biomass concentration in shake flasks and bioreactors.7 A brief discussion of
the validity of the assumption that OD600 and biomass are linearly related is presented
here. DCW measurements were performed on the BL21(DE3)[pJY-1] fermentation
(10/4/04). Because a sample volume of 1 mL was used for the assay, the differ-
ential mass measurements (masstube+cells −masstube) for samples with OD600 < 40
were not used because there was much more variability among these samples than
among the higher cell density samples. A linear regression on the five “usable”
6Ideal exponential growth satisfies the differential equation d(OD600)dt = µ · OD600. The growth
rate, µ, between each pair of OD600 data points was estimated by dividing the rate of biomass
increase (dOD600dt ) by the linearly-interpolated biomass (OD600) at the intermediate time between
OD600 data points.
7Since OD600 is significantly less work-intensive than dry cell weight (DCW) measurement, estab-
lishment of the validity of OD600 is convenient in order to obviate the need for DCW measurements
in all cultures.
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(DCW (g/L), OD600) ordered pairs from the BL21(DE3)[pJY-1] fermentation gave
a regression equation with R2 = 0.93. See Figure 4-4 for a plot of the ordered pairs,
the regression line, and the equation of the regression line. Considering that there
were only six sample points (five samples + the origin), the linearity of the DCW
vs. OD600 relationship (R
2 = 0.93) is strong, implying that OD600 is a good biomass
quantification method. Based on the slope of the linear regression model in Figure 4-4,
one may convert from OD600 to DCW by multiplying by 0.42
(g DCW)/(L broth)
OD600 unit
.
4.1.3 Non-invasive biomass probe results
Measurement of the optical density at a visible wavelength (e.g. 600 nm) is a standard
method of obtaining a relative measure of the cell density of microbial cultures. The
method is quick, easy, and sensitive (relative to dry cell weight, which requires large
volumes of sample at low cell densities; see Section 3.3.1 for notes on the OD600 assay).
On the other hand, this cell density assay requires several mililiters of sample for
every data point that is taken. With small bioreactors, such as those used in research
settings (e.g. 1 L working volume), taking too much volume out of the bioreactor in
order to keep track of the growth kinetics is undesirable. For example, lowering the
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surface of the liquid eventually exposes an impeller, resulting in excessive foaming.
Consequently, the total number of data points that can be taken to measure cell
density may be limited.
As an alternative to limited “invasive” methods such as the OD600 assay, biomass
probes that provide real-time, on-line measurements have been developed. A fixed
path length absorbance probe passes through the headplate and is submerged in the
fermentation broth. The end of the probe has an emitter and a dectector with a
notch between the windows of the two diodes that the fermentation broth can flow
through. As the cell density increases, the emitted light is absorbed and scattered
by the medium contents and cells, decreasing the amount of light that reaches the
detector. optek-Danulat, Inc. (www.optek.com) is a manufacturer of this type of
probe.
The BugEye noninvasive biomass probe (BugLab, Inc.) is another instrument
that can measure cell density in real-time. The BugEye is based on the principle
that particles in the fermentation medium will scatter light. The major particulate
component of the medium is cell mass; the more cells there are, the more light is
scattered. The BugEye shines infrared light into the fermentation vessel and quantifies
the amount of light that is scattered. Based on the scattering that it detects, the
BugEye outputs a number in BugEye units. Like OD600 readings, the numbers output
by the BugEye do not mean anything (beyond value for relative comparisons) without
being calibrated to a universally meaningful measurement such as DCW.
Since the BugEye output is simply based on scattering of light caused by the
contents of the medium, the bacteria are not the only medium components that
affect the BugEye measurement. The two major factors that affect measurements
are sparging and agitation, which both affect the size and amount of bubbles in the
medium, which also scatter the light the BugEye emits. Consequently, the BugEye
data will have sharp changes due to changes in agitation and/or sparging. When
interpreting and calibrating data, this effect must be taken into account.
The BugEye was used to monitor the fermentation conducted from 10/4/04–
10/6/04 with strain BL21(DE3)[pJY-1] grown in a 10 L BioFlo 110. Figure 4-5
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shows both the BugEye and OD600 data for the entire fermentation.
8 The BugEye
data is “messy” in several sections because of its sensitivity to changes in agitation and
aeration. At several points in the fermentation these parameters were changed and the
BugEye was even taken off of the bioreactor for several minutes. These disturbances
cause the unexpected artifacts in the BugEye data; the BugEye instrument recorded
data every 20 seconds, while the OD600 was recorded every couple of hours, so the
OD600 data artificially appears much more smooth.
Depending on which trend in Figure 4-5 is considered correct, during the later
stages of the fermentation (time > 20 hours) it could be concluded that the growth
rate increased or decreased, depending on which dataset is more accurate. The most
likely explanation is that the linearity of one of the measurement methods changes
at higher cell densities. Since neither the feed rate nor the oxygen enrichment levels
changed over the course of the late fed-batch and induction phases, it is expected
that as biomass increased, the ratio of feed energy used for growth to that used for
culture maintenance metabolism (i.e. just keeping the culture alive) would decrease,
thus resulting in a lower growth rate as the biomass accumulated. The BugEye
data reflects this predicted gradual decrease in growth rate while this behavior in
the OD600 curve is not readily apparent. But, these differences are subtle and more
data must be generated to determine their significance. The near-constant rate of
biomass accumulation from the late fed-batch phase through the remainder of the
fermentation is consistent with the fact that the feed rate remained constant and did
not change significantly.
Because of the noise introduced by the non-uniformity of the bubble mixture in
the broth, the BugEye employs a smoothing algorithm that takes the running average
of the previous n points (n ≈ 5). Even with smoothing, noise is still visible in the
data. However, the instrument still appears to be very sensitive to subtle changes in
the growth of the culture. For example, during the fed-batch and induction phases
of the fermentation the feed bottle repeatedly had to be refilled with the glucose feed
8The following data analysis considers the raw BugEye data and OD600 values without worrying
about calibrating these data to a physically significant value such as DCW. The discussion focuses on
relative differences in the data and does not make conclusions about absolute quantities of biomass.
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solution. Sometimes, due to complications with the fermentation setup (e.g. excessive
foaming, need to change exhaust filter, etc.), the feed bottle remained empty for
periods up to about 15 minutes before it could be refilled. Without the addition
of the carbon source, the culture’s biomass can not increase, and the culture will
theoretically stop growing. Halts in growth at times when the culture starved followed
by a recovery of growth once the feeding was resumed are reflected in the BugEye
data. Figure 4-6 shows such behavior over the course of three bottle refills. The first
and last bottle refill occurred after the culture had starved, while the intermediate
refill was done before the feed bottle was empty and no change in growth kinetics
was observed. The fluctuation in BugEye measurements in the hour leading up to
the third feed refill (hours 25–26) was probably due to a halt in air/O2 sparging due
to a clogged exhaust filter. The implications of using such finely-tuned monitoring
of bioreactor growth kinetics for process definition and control are far-reaching, and
further experiments with probes for the on-line monitoring of biomass must be done.
A first step will be to establish the repeatability of these results and to calibrate the
probe’s BugEye units to OD600 and DCW data.
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4.2 Fermentation cooling
Based on the successful shake flask cooling experiments described in Section 4.1.1,
fermentations implemented in course 10.28 (Fall 2003 and Fall 2004) included cooling
phases. The original purpose of the cooling phases was to allow students to inoculate
their bioreactors on one lab day then delay the post-batch phases of the fermentation
until the following lab day (40 hours later). (See Appendix B for a description of the
10.28 course structure and a brief summary of the fermentations that were conducted.)
The initially positive results of these experiments suggest that cooling can be used to
make a fermentation’s schedule more flexible for researchers (and possibly industry)
without affecting the quality of a fermentation run.
4.2.1 First experimental iteration: course 10.28, Fall 2003
The fermentations of the Fall 2004 offering of course 10.28 were the first to be cooled.
In order to design the cooling methodology, it was hypothesized that the best time to
cool the bioreactors was after lag phase had been completed and the culture was grow-
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ing vigorously, but before the cell density had increased greatly. The more healthy
the cells were at the time of cooling, the more likely they would be to recover quickly
when re-warmed. But, if the cell density was allowed to increase to a high enough
level, the agitation and aeration of the broth would have to be kept at a near-process
value in order to prevent the live but cold culture from being oxygen-limited, which
is a potentially unhealthy condition. Since the cooling phase was to last from 24–
48 hours, it was desirable to decrease the agitation and aeration as much as possible in
order to reduce the likelihood of foaming, the resultant complications, and therefore
the need for constant monitoring of the process.
During the Fall 2004 offering of 10.28, four fermentations were inoculated: two
with BL21(DE3)[pJHL] (both at 1 L working volume) and two with BL21(DE3)[pJY-
2] (one at 4 L and one at 10 L working volume. After about 3–4 hours of growth,
the bioreactors were cooled to 12◦C.9 While cooled, one of the 1 L fermentation
controllers failed and the fermentation was lost. About 36–40 hours after cooling,
the remaining three fermentations were warmed to their appropriate temperatures,
and growth resumed. The combination of an ineffective gas mixing system and an
inconsistent implementation of DO-stat feeding (see Section 3.2.4, page 57) limited
the OD600 of the 10 L culture to about 20. However, the 5 L culture grew vigorously
and reached an OD600 of approximately 55. The results from this set of fermentations
proved that full recovery (from a growth kinetics point of view) from a 36–40 hour
cooling phase is possible.
4.2.2 Cooling during batch and fed-batch phases
The design of the cooling phases of the Fall 2004 fermentations was based on the
Fall 2003 results. In order to maximize the amount of time that the students spent
with the bioreactors and to minimize the amount of work that the staff did to monitor
the bioreactors outside of class, the first set of 10 fermentations was designed with
9Because of the lack of insulation of the cool water lines leading from the chiller to the bioreactor
controller and the fact that the chiller could not cool below 0◦C, 12◦C (and not lower) was a
reasonable bioreactor temperature for the setup to sustain.
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OD600 at cooling phase Final OD600
Team No. Strain Batch cool Fed-batch cool (growth time)
G1 BL21(DE3)[pJY-2] 7.93 16.1 23.2 (5 hr)
H1 BL21(DE3)[pJY-2] 7.74 12.5 19.3 (4–5 hr)
J1 BL21(DE3)[pLysS][pJY-2] 5.58 7.225 8.42 (4–5 hr)
L1 BL21(DE3)[pLysS][pJY-2] 6.08 7.54 11.3 (3 hr)
G2 BL21(DE3)[pJY-2] (data missing) 15.9 20.6 (3 hr)
H2 BL21(DE3)[pJY-2] 5.80 14.4 15.1 (3 hr)
Table 4.3: Growth of fermentations subjected to cooling phase interuptions (10◦C)
of the batch and fed-batch phases.
two cooling stages. Students inoculated bioreactors on a Tuesday and Wednesday, the
bioreactors were cooled to 10◦C, all bioreactors were warmed back up on Thursday,
reached the end of the fed-batch phase during the lab session, were cooled down near
the end of the lab session, and were warmed back up on Friday to be induced. In
short, this set of 10 student fermentations was not successful: high cell densities were
not achieved, and after the second cooling phase (which arrested the cells in inter-
mediate fed-batch phase), only low growth rates were achieved in the most healthy
fermentations. Table 4.3 summarizes the optical densities at different stages of some
of the module 1 fermentations. Each cell density is the OD600 value at the time of
the respective cooling phase. The growth time (in parenthesis) is the time it took
the culture to grow from the listed OD600 at the fed-batch cooling phase to the final
OD600, when the fermentation was terminated.
In general, it was observed during the cooling experiments that as the temperature
decreased, the oxygen demand of the culture decreased, thus decreasing the neces-
sary driving force to sustain the lower oxygen uptake rate (OUR), which resulted
in an increase in dissolved oxygen concentration within the bioreactor. If the cell
density was low enough when the cooling phase was performed, a significant increase
in the dissolved oxygen concentration was seen when the culture was cooled. How-
ever, during the second cooling phase, the dissolved oxygen content of many cultures
consistently remained at 0%. Because of the higher cell density, the cultures’ oxygen
demand was larger than cultures cooled at lower densities. In addition, as mentioned
in Section 4.2.1, it is desirable to decrease the agitation and aeration during the cool-
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ing phase in order to minimize the likelihood of a disaster due to foaming while the
fermentation is left unattended. Before being cooled for a second time the agitation
ranges of the module 1 cultures were in the range 400-600 rpm, and the aeration was
uniformly at 1 vvm (0.9–1 lpm). During both cooling phases, these parameters were
arbitrarily reduced to 150 rpm and 0.5 vvm.10 It is because of the increased oxygen
demand of the higher density cultures and the imposed conditions causing lower oxy-
gen transfer rates (OTR) that the dissolved oxygen concentration was consistently at
0%. It is hypothesized that by imposing conditions that decreased the sustainable
OTR during the fed-batch cooling phase, the cultures were severely oxygen limited
and consequently damaged during this phase.
Based on the poor growth in the module 1 fermentations (Table 4.3) and the fact
that the second, higher cell density cooling phase was the primary culprit for causing
the poor growth, the module 2 fermentations were designed to have a single low cell
density cooling phase to try to reproduce the more successful results of the 10.28
Fall 2003 experiments.11 Consequently, the Fall 2003 fermentations were mimiced as
closely as possible, with one cooling phase (≈ 36 hours) inserted in the middle of the
batch phase. After inoculation, the bioreactor cultures were grown for 3.5–4 hours
(OD600 ≈ 2–4) before cooling to 10◦C. About 36 hours later, the bioreactors were
warmed to their process temperatures and reached the end of the batch phase after
1.5–2 hours. Because the fed-batch phase started in the morning (about 8:00 am),
before the students got to lab (1:00 pm), there were not enough staff present to
take measurements on the bioreactors during the initial part of fed-batch phase.
Consequently, limited data is available on early fed-batch phase. The growth results
for selected module 2 fermentations are shown in Table 4.4. To give an idea of the
growth rate during the later stages of the fermentations, the OD600 measurement
when the students entered lab (end of fed-batch phase) and several hours later (near
the beginning of induction) are given along with the growth time for this change in
10Such a reduction had worked succesfully for the Fall 2003 10.28 fermentations, so without further
data, the same reduction was used.
11Variability in culture behavior due to strain identity is unlikely since successful cooling experi-
ments were performed with both strains in module 2 of the 10.28 Fall 2004 offering.
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Team No. Strain OD600 change (growth time)
A1 BL21(DE3)[pJY-2] 44.0→ 59.1 (2.0 hr)
B1 BL21(DE3)[pJY-2] 41.5→ 53.4 (1.5 hr)
C1 BL21(DE3)[pJY-2] 48.4→ 70.0 (2.75 hr)
D1 BL21(DE3)[pLysS][pJY-2] 7.15→ 9.25 (1.25 hr)
E1 BL21(DE3)[pLysS][pJY-2] 21.9→ 27.0 (3.0 hr)
F1 BL21(DE3)[pLysS][pJY-2] 28.3→ 37.6 (2.25 hr)
A2 BL21(DE3)[pJHL] 53.7→ 80.4 (1.2 hr)
B2 BL21(DE3)[pHL] 18.0→ 26.0 (3.1 hr)
C2 BL21(DE3)[pLysS][pJHL] 32.7→ 42.3 (1.5 hr)
D2 BL21(DE3)[pLysS][pJHL] 26.1→ 29.7 (3.0 hr)
Table 4.4: Growth of course 10.28 module 2 fermentations subjected to a single
cooling phase interuption (10◦C) during the batch phase.
cell density. Most of the fermentations saw little growth during the induction phase.
The generally more vigorous growth of the module 2 bioreactors leads to the
conclusion that with the current experimental setup, a single cooling phase at low
cell density during the batch phase is the most robust design. Cooling at higher cell
densities or for longer periods of time could possibly be done if the bioreactors are
cooled to less than 10◦C, further slowing bacterial metabolism.
4.2.3 Glucose consumption during the cooling phase
A danger of allowing the fermentation to progress too far through the batch phase
before cooling is that there might not be enough glucose in the bioreactor to sustain
the culture until the fermentation is re-warmed. Even though E. coli metabolism is
slowed down greatly at 10◦C relative to a normal process temperature, thus drastically
reducing glucose consumption, 36–40 hours (the typical length of the cooling phase
required by the courses) is 2–3 times longer than the average process length; for
cooling phases of significant length, then, it is likely that glucose limitation becomes
a critical factor that must be addressed by the process design. For the first set
of cooled fermentations (course 10.28, Fall 2003), the cooling phase was arbitrarily
initiated after approximately 3 hours of fermentation had elapsed. Since the first
fermentations were successful, this strategy was not changed for the fermentations
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implemented in the Fall 2004 offering of course 10.28; all resultant fermentations
that were healthy at the time of batch-phase cooling recovered upon re-warming and
reached the fed-batch phase.
Because of the time constraints on the course, limitations on staff time outside
of course lab hours, and periods of intermittent chaos, complete sets of glucose mea-
surements bounding the start and end of the cooling phase were not taken for any of
the bioreactors during both module 1 and 2! As a result, the following information
is the best reconstruction of the experiments from the limited data available. In gen-
eral, batch phases with strains BL21(DE3)[pJHL] and BL21(DE3)[pJY-2] are about
5–7 hours long (see Section 4.1.2). The Fall 2004 course 10.28 fermentations began
with 10 g/L glucose at inoculation and were grown for approximately 3.5–4 hours
before cooling to 10
◦
C. Glucose concentrations at the beginning of the cooling phase
were approximately 5 g/L ± 1 g/L. After the 36–40 hour period at 10◦C, glucose
concentrations were in the approximate range 1.5–3 g/L. After warming back up to
the process temperature, batch phases lasted another 1–2 hours before the glucose
was completely consumed. Based on this approximate data, it appears that a mea-
surable amount of glucose was consumed. However, the length of the batch phase
does not seem to have been greatly affected. More useful conclusions, though, can
not be made without more rigorous experimentation. In addition to more thoroughly
defining the glucose consumption curve through the interrupted batch phase, it would
be interesting to prolong the cooling phase for several days to verify whether the glu-
cose consumption characteristics of a 36–40 hour cooling phase match those of an
extended phase; the idea being that glucose consumption over a longer period of time
at cold temperatures would be especially accurate, since the culture has more time
to consume glucose and establish a measurable glucose differential over time.
4.2.4 Effect of cooling on carbon dioxide evolution
In order to study the effect of temperature on culture metabolism, the response of dis-
solved oxygen and carbon dioxide evolution due to a steady decrease in temperature
were measured. During module 2 of course 10.28, after the induction phase was com-
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plete, the temperature setpoint of group C1’s fermentation was changed from 37◦C to
10◦C. In this fermentation, strain BL21(DE3)[pJY-2] was grown in a BioFlo 110 vessel
with a working volume of 0.9 L. The culture reached an OD600 of 70 (30 g/L) midway
through the induction phase and remained at that constant cell density throughout
the rest of the experiment.12 At the time this experiment was performed, the ag-
itation was 700 rpm, sparged air was enriched with pure oxygen 20% of the time,
and the gas flow rate was 1 vvm (0.9 lpm). Since the temperature in a BioFlo 110
is decreased by flowing cool water through a cooling coil submerged in the broth,
the temperature response due to a step change in the setpoint is a long and smooth
decrease (dT
dt
≈ −k(T −Tcooling coil)). Figure 4-7 shows the response of carbon dioxide
in the exhaust gas and dissolved oxygen due to the gradual temperature decrease.
Note that since the culture’s growth rate was near-zero at the time of this experi-
ment, the oxygen demand was much lower than that of a vigorously-growing culture.
This can be seen by the fact that at full temperature, the maximum level of carbon
dioxide in the exhaust gas was 4%, while near-10% values have been measured for
rapidly-growing cultures near that cell density.
One concern in the analysis of this data is the magnitude of time lags in the
data that is presented and the effect of these lags on the conclusions that can be
made. It should be explicitly noted that there was a two minute delay to the off-gas
measurements caused by the dead space in the stainless steel sampling lines (other
bioreactors had longer and shorter delays depending on their proximity to the mass
spectrometer). In the data processing steps leading up to the generation of Figure 4-7,
this delay was taken into account. The time between a change of temperature at the
probe and the registering of that change by the BioCommand Plus software was not
more than 10–20 seconds, and that delay combined with the inherent 30–40 second
DO probe measurment delay was not more than a minute. Based on the plotted data,
these delays relative to the rate of change of temperature are negligible. However, the
relationship between the temperature and the metabolism of a culture is more subtle.
12Since the cell density was constant throughout the cooling experiment described below, it is
assumed that the effect of changes in biomass on the culture’s oxygen consumption during the
experiment were negligible.
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Figure 4-7: Effect of cooling a high cell density culture on carbon dioxide evolution
in the off-gas and dissolved oxygen concentration in fermentation broth.
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It is a given that reducing the temperature affects the rate of metabolic processes
from a basic reaction kinetics standpoint. However, less is understood about longer
term responses of E. coli to cold temperatures. If the E. coli were allowed to stabilize
by fixing the temperature and not continually decreasing it, a shift in metabolic state
evidenced by an additional slower dynamic in the DO and %CO2 may have been seen.
In other words depending on the rate of the temperature drop, the DO and %CO2
responses that are measured may be dominated by the fast dynamics of reaction
kinetics or slower changes in bacterial state in response to the temperature change.
To study this further, a culture should be fixed at a range of below-process-setpoint
temperatures and the DO and %CO2 measured, plotted, and compared with the
shape of the curves obtained in the experiment implemented by this thesis.
Based on the data, the culture’s oxygen demand dramatically decreases with tem-
perature. It is interesting that the shape of the %CO2 curve closely tracks the de-
creasing temperature, but that the correlation between temperature and % CO2 is
not exactly linear; the rate of change of the %CO2 is slightly greater than that of
the temperature. This nonlinearity may be due to an unaccounted for mechanism in-
volved in the measurements, or it may be due to the effect of a biological process that
is activated by the falling temperature and augments the decline in CO2 production
due to slowed reaction kinetics. The %CO2 stabilizes at 0.32% as the temperature
asymptotes in the 11◦C range. Further experiments should be done with cultures of
varying growth vigor at the time of cooling to see if their carbon dioxide production
ends up stabilizing at the same low value. In addition, it would be useful to see the
effect of cooling the culture even further on the CO2 output.
It is also noteworthy that the percent dissolved oxygen rises to its maximum
value13 much sooner than the %CO2 reaches its minimum. Then the %DO begins
to decrease again, and as the %CO2 stabilizes at 0.32% (with a very slow rate of
continued decrease, mirroring the asymptotically decreasing temperature), the %DO
continues to fall slowly. The discrepancy between a falling %DO (implying increasing
13The maximum %DO is greater than 100% because the probe was calibrated with pure air, but
at the point in the fermentation when this experiment was done, air enriched with pure oxygen (20%
of the time) was being sparged, thus increasing the saturation concentration of O2.
87
oxygen consumption because of the increasing driving force) and the falling %CO2
in the off-gas (implying decreased aerobic metabolism) can not be explained by the
simple assumptions made thus far about the relationship between aerobic metabolism
and carbon dioxide evolution. This experiment should be repeated to determine
whether the results are reproducible.
4.3 Volumetric oxygen mass transfer coefficient (kLa)
Because oxygen mass transfer is most often the rate-limiting process in aerobic fer-
mentations, precise quantification of a process’ oxygen demand and the fermentation
system’s ability to supply that demand is important. This topic is especially relevant
to scale-up methodologies, which take processes from the laboratory “bench” scale
(0.2–100 L) to the industrial scale (10,000–100,000 L). Effective scale-up is not simply
a matter of scaling the dimensions of bioreactor components (e.g. impellers, baﬄes)
and the volume of gas per volume of liquid (vvm) sparged through the culture broth;
the relationship between dimensions and mass transfer at different scales is nonlinear
and difficult to predict. The correct scaled parameters are often result in immod-
erate dimensions which must be engineered to within acceptable ranges; because of
the complexity of the relationship between dimensions and mass transfer at different
scales, this engineering process may not ensure mass transfer sufficient for a particular
process [4]. In contrast to the physical dimension approach to scale-up, the volumet-
ric oxygen mass transfer coefficient (kLa), which appears in the oxygen mass transfer
equation (Equation 4.1), may be used to encapsulate a fermentation system’s ability
to sustain a particular oxygen transfer rate. The paradigm of kLa is fundamentally
scalable because it allows for variation in bioreactor design in order to accomodate
the varying constraints of different scales. Thus, maintenance of a particular value of
kLa at different scales is more likely to insure sufficient oxygen transfer rates than a
purely dimensional-based methodology of scaleup.
The calculations below are based on the theory described in Section 3.3.2. For
convenience, the oxygen mass transfer equation and it’s steady state simplifications
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are reproduced here as Equations 4.1 to 4.3. For a detailed description of the variable
definitions and discussion of these equations, see Section 3.3.2 (pages 61–63).14
dcL
dt
= kLa(c
∗ − cL)−OUR (4.1)
In steady state :
dcL
dt
= 0 ⇒ kLa = OUR
(c∗ − cL) (4.2)
%OUR = %Oin2 −
(
%N in2
%N out2
)
%Oout2 (4.3)
4.3.1 Determining the oxygen saturation concentration, c∗
Judging from Equations 4.1 and 4.2, the accuracy of the kLa calculation depends
on the accuracy of the value of the oxygen solubility at saturation. Under fixed
conditions, c∗ is linearly proportional to the partial pressure of oxygen in the sparged
gas and headspace. This relationship is described by Henry’s law in Equation 4.4 (kH
is the Henry’s law constant, c∗ is the saturation concentration of oxygen for a fixed
set of conditions, and pg is the partial pressure of oxygen in the sparged gas).
kH
def
=
c∗
pg
(4.4)
The primary factors affecting kH under fermentation conditions are temperature, ionic
strength, and composition of the fermentation medium [3].15 Thus, a different value
of kH must be used for 30
◦C and 37◦C processes. Because of the dependence of the
constant on broth composition, the kLa will also vary as the fermentation progresses:
cell density will increase and solute composition changes as cells consume/produce
substrates and lyse. Variation in kH over a range of conditions is shown in Table 4.5.
Based on this data, temperature and/or medium composition differences can cause
about 10–20% variation in kH depending on the conditions chosen. For the 37
◦C
14cL is the concentration of dissolved oxygen in the fermentation broth [molL ], c
∗ is the saturation
concentration of oxygen in the broth at the given operating temperature, and OUR is the oxygen
uptake rate [ molL·hr ]. Variables %O
in
2 , %O
out
2 , %N
in
2 , and %N
out
2 are the percentages of the respective
gas in the inlet or outlet gas.
15Oxygen solubility decreases with increasing ionic strength and temperature.
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Aqueous solution Henry’s constant Reference
Pure water (15◦C) 1.54 [mmol
atm·L ] MIT BE.360 handout, [42]
Pure water (25◦C) 1.3 Sander, NIST, [53], [39]
Pure water (35◦C) 1.09 MIT BE.360 handout, [42]
Pure water (35◦C) 1.11 Parente, et al., [43]
0.25 M NaSO3 (35
◦C) 0.92 Parente, et al., [43]
1 M NaCl (25◦C) 0.89 MIT BE.360 handout, [42]
Cell culture medium (37◦C) 0.93 MIT BE.360 handout, [42]
Table 4.5: Examples of variations in the Henry’s law constant (kH) for oxygen gas
for different temperatures and liquid compositions.
fermentation analyzed below, the value kH = 0.926
mmol
atm·L is used [42].
Depending on the particular experimental setup, it was sometimes not convenient
to set up a system for sampling the bioreactor inlet gas to directly measure the
inlet gas composition. Early in a fermentation batch phase, the lack of inlet gas
measurement was not an issue because the lab air could be sampled before or after
the fermentation. Later in the fermentation, though, when the sparged lab air was
enriched with pure oxygen, the gas composition at the inlet had to be approximated.
The New Brunswick BioFlo controllers mixed air and oxygen by alternately turning
on and off valves connected to these gas supplies. The controller defined the level of
oxygen enrichment by the percent of the time that pure oxygen, rather than air, was
flowing (the duty cycle of the system was on the order of one second). With these
parameters in mind, Equation 4.5 can be used to estimate the partial pressure of
oxygen in the inlet gas (%Oin2 , this is in terms of a volume percentage). %O
air
2 is the
percent oxygen in air (20.95%), %Oenrich2 is the percent of the time that pure oxygen
flows to the bioreactor, and %Oenrich2 is the percent of the time that the controller
sparges pure oxygen rather than air through the bioreactor.
%Oin2 =
(
1− %O
enrich
2
100
)
%Oair2 +%O
enrich
2 (4.5)
So, when calculating the kLa during times when oxygen enrichment was used, %O
in
2
from Equation 4.5 must be used as the partial pressure of oxygen used to calculate
c∗ rather than %Oair2 (see Equations 4.4 and 4.6).
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4.3.2 Dynamic method
The dynamic method analysis here will focus on the three dynamic method experi-
ments that were performed using the 10 L fermentation with strain BL21(DE3)[pJY-1]
(10/4/04–10/6/04, process temperature = 37◦C). The experiments were performed
early in the fermentation when the OD600 ranged from 0.45 to 0.68. Three exper-
iments were implemented by varying the agitation rate in the following order: 400
(run time = 1.3h, OD600 ≈ 0.4), 300 (run time = 1.7h, OD600 ≈ 0.5), and 500 rpm
(t = 3.1h, OD600 ≈ 0.7). The air flow rate was kept constant at 0.5 vvm. Because
the dynamic method experiments were performed early in the fermentation, oxygen
enrichment was not used. Therefore, the partial pressure of oxygen was that of the
atmosphere, and the saturation concentration of oxygen can be calculated as:
c∗ = pg · kH = (0.2095 atm)
(
0.926
mmol
atm · L
)
= 0.194× 10−3 mol
L
. (4.6)
In Figure 4-8 (400 rpm experiment), the slope of the OUR linear regression is−16.9 %DO
min
.
Convert to units of molarity per hour as follows:
mol O2
(L of broth) · hr =
(
%DO
min
)(
60 min
1hr
)(
c∗ [mol O2
L
]
100% saturation
)
(4.7)
OUR = 2.15× 10−3 M/hr (4.8)
The values of OUR for the 300 and 500 rpm experiments were calculated using the
same method, and the results of the three dynamic method experiments are summa-
rized in Table 4.6. The calculated values of OUR did not change significantly over the
course of the experiments; this trend is validated by the near constant growth curve
at the beginning of the fermentation (Figure 4-5). In Table 4.6, “OUR [ mol
L·hr ] (regres-
sion)” refers to the value of OUR calculated from the slope of a linear regression on
the initial decreasing trend in %DO (Figure 4-8(a)); “kLa [
1
hr
] (regression)” refers to
the value of kLa calculated from the slope of the regression on the plot of
d(DO)
dt
vs.
DO (Figure 4-8(b)); “kLa [
1
hr
] (steady-state)” refers to the value of kLa calculated
using the OUR (regression) and the steady state value that the %DO reaches after air
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Agitation (rpm) OUR [ mol
L·hr ] (regression) kLa [
1
hr
] (regression) kLa [
1
hr
] (steady-state)
300 2.15 · 10−3 (R2 = 0.999) 20 (R2 = 0.611) 37
400 1.97 · 10−3 (0.995) 42 (0.89) 145
500 2.22 · 10−3 (0.999) 63 (0.94) 286
Table 4.6: Dependence of kLa on agitation; OUR and kLa were calculated by linear
regression and steady-state analysis of dynamic method data.
sparging is recommenced (using Equation 4.2). Considering the fact that the experi-
ments were performed in the order 400, 300, and 500 rpm, and that the cell density
increased over that time period, the trend of increasing OUR with time is expected
and contributes to the level of confidence in the accuracy of these measurements.
In performing this dynamic analysis, nonlinear data bounding the critical sections
of the curves used for the calculations was intentionally not used because it is not
accounted for by the simplistic models described in Section 3.3.2. These models do
not take the dynamics of the DO probe into account, which are the cause of the
nonlinearities. First consider the data used for the linear regression to calculate the
OUR (i.e. the semi-linear decrease in DO% when the airflow was turned off, Figure 4-
8(a)). When the airflow was stopped at 78 minutes, the magnitude of the slope
gradually increased until it reached the magnitude of the slope of the regression line.
Near the “bottom” of this curve, where the DO% decreased to 25%, the magnitude
of the slope then began to decrease with time (i.e. the slope became more shallow).
The drawing in Figure 4-8(a) makes it clear that these nonlinear sections were not
used in the OUR regression calculation. Likewise, there is a brief lag in the onset
of the rapid rise in DO% when the airflow is turned on at 82.3 minutes, which is
not accounted for by the solution to the oxygen mass transfer (differential) equation
which has a single exponential term (Equation 4.1). Neither this nonlinear data at
the onset of the rise in DO% or the data when the DO% reaches steady-state after
88.5 minutes was used in the calculation of the kLa. Including more data points of
d(DO)
dt
vs. DO would only add more points to the cluster of points at (92%, 1%/min)
in Figure 4-8(b), which would minimally affect the slope of the regression line. It is
the points near the onset of the DO rise that most affect the slope, so the choice of
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the time at which to begin using the data in the kLa regression calculation is very
important.
As mentioned above, the nonlinearities not accounted for by the model used for
the calculations are caused by the nonideality of the DO probe. Because the DO probe
has an oxygen permeable membrane separating the electrode from the fermentation
broth, oxygen must diffuse through the membrane to the electrode. For diffusion to
take place, a concentration gradient must exist. This means that while the broth
concentration is changing, the concentration of oxygen at the probe electrode will
never equal that of the broth. In other words, there is a delay between the time that
the probe is presented with a specific broth concentration and the time at which the
probe’s signal reflects that concentration. Because the probe delay, τprobe, is governed
by diffusion, it can be modeled as a first order differential equation (Equation 4.10).
Incorporating the probe delay into the original oxygen mass transfer model results
in a set of coupled differential equations which can be solved to give the probe con-
centration as a function of time (Equations 4.9 and 4.10). The solution will not be
presented here, but it is important to recognize that the general form of the solution
has two exponential terms: the time constant of one term is the DO probe delay time
constant, τprobe (this term dominates at the onset of the rise in the DO% when the
airflow is turned on) and the other term’s time constant, τkLa, is the inverse of the
kLa (this term dominates after the initial rise in DO).
dcL
dt
=
1
τkLa
(c∗ − cL)−OUR; τkLa =
1
kLa
(4.9)
dcprobe
dt
=
1
τprobe
(cL − cprobe) (4.10)
If τprobe À τkLa, the oxygen concentration will reach steady state much faster than
the DO probe reading will change, and the resultant response of the DO probe will
approach the probe response that would be measured if there was a step change in
dissolved oxygen within the bioreactor. Thus, for values of kLa that are too large,
the method of performing a linear regression on the d(DO)
dt
vs. DO points would not
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work; the calculated kLa would closely approximate
1
τprobe
. The time constant, τprobe,
of the polarographic DO probe used in these kLa experiments was approximately
40 s−1, or 90 hr−1. Therefore, the dynamic method is only suitable for measuring the
OUR and kLa at low cell densities (< 0.5 g/L) and low values of kLa (¿ 90 hr−1),
when the dissolved oxygen dynamics induced by the experiment have time constants
significantly less than the probe delay. Reconsidering the OUR and kLa data in
Table 4.6, the values of OUR calculated from the regression are likely to be accurate
considering that the drop in DO spanned a period of 3.2 minutes (À τprobe = 0.7 min).
On the other hand, the values of kLa calculated from the regression on
d(DO)
dt
vs. DO
for the 400 and 500 rpm experiments were significant fractions of 90 hr−1. The kLa
values calculated using the OUR and the steady-state concentration differential are
likely to be much more accurate for the values of kLa corresponding to the 400 and
500 rpm experiments; see Section 4.3.4 for a comparison with published values. (The
two methods of kLa calcultion for the 300 rpm experiment resulted in values that were
at least on the same order of magnitude, which can not be claimed for the higher rpm
experiments. The discrepancy in the kLa values for the 300 rpm experiment is in
part due to the lack of abundant data; since the DO probe data was recorded once
every 12 seconds and most of the rise in DO took place over 1.5 minutes, there were
only 7–8 data points in the range that had the most influcence on the kLa regression
slope—see Figure 4-8(b).)
4.3.3 Off-gas method
The off-gas approach to calculating kLa is based on the same steady-state simplifi-
cation of the oxygen mass transfer equation as that used to calculate the kLa from
dynamic method data (Equation 4.2). Once a steady-state in the oxygen mass trans-
fer of the system is achieved,16 the OUR [M
hr
] is calculated by first measuring the
difference in oxygen composition of the inlet and exhaust gas flows to calculate the
%OUR [units = %O2 (volume)] (Equation 4.3) then converting the result to the cor-
16That is, constant %DO, constant OUR, constant process values; this is only a pseudo steady-
state since the culture is growing all of the time
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rect units using Equation 4.11.
OUR
[
M
hr
]
=
(
%Oin2
100%
) (
Qsparge [
L
min
]
) (
Vgas law [
L
mol
]
)−1 (
60 min
1 hr
)
Broth volume [L]
(4.11)
The value Qsparge is the gas flow rate through the bioreactor in L/min, and
Vgas law = 24.5 L/mol: the volume in liters occupied by 1 mol of ideal gas at room
temperature and 1 atmosphere of pressure.17
The off-gas method of determing the OUR is ideal for high cell density fermen-
tations; if the oxygen supply to the bioreactor were suddenly stopped (i.e. a step
change in the driving force, c∗ − cL; the partial pressure of O2 effectively goes to zero
⇒ c∗ = 0) the OUR of the culture would be large enough to deplete the dissolved oxy-
gen in the broth within a small fraction of the DO probe time delay (τprobe ≈ 40 sec).18
Consequently, the dynamics of the depletion of the dissolved oxygen if the gas supply
were turned off would be much too fast to be measured accurately by the DO probe.
An added benefit of the off-gas method is that there is no need to stress the culture
by limiting its oxygen supply in order to measure the kLa, as in the dynamic method.
However, in order to use the off-gas data to measure the OUR, the cell density must
be high enough to produce a measurable difference in oxygen composition between
the inlet and outlet. The following analysis concerns the fermentation from 10/4/04–
10/6/04 with strain BL21(DE3)[pJY-1] in order that the results may be compared
with the dynamic method calculations of OUR and kLa in Section 4.3.2.
One hour after inoculation, when the OD600 was approximately 0.55 (0.2 g/L),
17After passing through the exhaust condenser, the off-gas passes through about 2 feet of
PharMed r© tubing before the flow rate is measured. Thus, the off-gas is at approximately room
temperature when the flow rate is measured. Depending on the state of the exhaust filter, which
may be moist or clogged, the pressure within the bioreactor may be greater than 1 atm, which is
the pressure assumed for all calculations performed here.
18The solubility of glucose is > 700 g/L, which is much greater than the solubility of oxy-
gen (c∗= 0.93 mmol O2atm·L = 6.2
mg O2
atm·L ). The general, simplified equation for aerobic respiration
is C6H12O6 + 6 ·O2 → 6 ·H2O+ 6 · CO2. The stoichiometry of oxygen glucose consumption is
6 mol O2 consumed per 1 mol glucose, so O2 is severely limited. The fact that the respiratory
quotient (RQ = (volume of CO2 generated)/(Volume of O2 consumed)) may not equal 1 does not
affect this conclusion of oxygen limitation.
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there was a measurable %OUR of about 0.14%± 0.03% (measured using the Perkin
Elmer mass spectrometer). Since the working volume was 10 L, the inlet gas flow rate
of 0.5 vvm corresponds to 5 lpm. Plugging these values into Equation 4.11 gives an
OUR of about 3.4 ·10−3 M
hr
. Considering that the OUR is calculated from a %OUR at
the limit of detection of the mass spectrometer, this value is quite close to the OUR
range calculated using the dynamic method at approximately the same time in the
fermentation (2.0 · 10−3 M/hr, Table 4.6).
Next, consider data at later times in the fermentation, when the dynamic method
for calculating kLa was unusable because of high OUR values. Off-gas OUR cal-
culations, the resultant kLa, and relevant process values at different times in the
fermentation are listed in Table 4.7. The column “%Oenrich2 ” describes the amount
of time that pure oxygen, rather than air, was flowing into the bioreactor (see Sec-
tion 4.3.1, page 90 for a description of how oxygen enrichment works with a BioFlo
controller). The column “ c∗ ” describes the saturation concentration of oxygen at
37◦C after taking the increase in partial pressure due to oxygen enrichment into
account (Equation 4.5). Normalization of the measured oxygen in the off-gas to ac-
count for the effect of water vapor on the outlet gas compositions was not carried
out (Equation 4.3); in the BL21(DE3)[pJHL] fermentation on 6/24/04, the difference
between %N in2 and %N
out
2 was consistently < 0.5% of %N
in
2 (the 10
◦C exhaust con-
denser removed most of the vapor that came off of the warm fermentation broth.).
Thus, in the calculations done here, the effect of water vapor in the off-gas on the kla
and OUR calculations is considered negligible relative to the other measurment error
(e.g. sparging rate, which was accurate to within 0.2 lpm, ≈ 4% of the sparging rate).
When calculating the %OUR before calculating the OUR, the gas composition mea-
surments of both the mass spectrometer and the laser gas analyzer were compared;
composition measurements given by each instrument were within 1% (volume) for
each particular gas.
The calculated values of kLa in Table 4.7 are quite variable. It is clear that the
kLa increases as the agitation increases up to 800 rpm, but the value of 101 hr
−1
is anomalous considering that it is nearly one-third of the value calculated using
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OD600 Agitation %Dissolved O2 %O
enrich
2 c
∗(at 37◦C) OUR kLa
0.55 400 (rpm) 92% 0% 0.194 [mM] 3.4
[
mM
hr
]
219 [hr−1]
6.14 500 19 0 0.194 15.8 101
46.4 800 0 40 0.487 132 272
81.0 800 0 40 0.487 162 332
Table 4.7: Off-gas method of OUR calculation and kLa values at high cell densities
(fermentation with BL21(DE3)[pJY-1], 10/4/04).
the dynamic method (286 hr−1, Table 4.6) and considering the relatively high kLa
magnitudes calculated by the off-gas method at other points in the fermentation.
4.3.4 Discussion of results in the context of literature
Depending on whether the “regression” or “steady-state” method of calculating kLa
from the dynamic method data was used (Section 4.3.2), the dependence of kLa
on agitation varied significantly (Table 4.6). In order to evaluate the accuracy of
these two discordant sets of results, an emperical correlation developed by Van’t
Riet based on a large number of experiments in different vessels will be considered.
The correlation fits emperical data to within 20–40% (Equation 4.12) [3, 48]. The
correlation applies to noncoalescing fluids, which is typical of fermentation broths [1,
34].
kLa = 2.0× 10−3
(
P
V
)0.7
(ugs)
0.2 [s−1] (4.12)
ugs is the superficial gas velocity,
19 P/V is the volumetric power input, and kLa is the
volumetric mass transfer coefficient (units = s−1). Equation 4.12 is applicable under
the conditions: V ≤ 2600 L; 500 < P/V < 10, 000 W/m2. A correlation for the
volumetric power input for agitated vessels, P/V , is shown in Equation 4.13 [3, 51].
P
V
≈ const× ρlN
3
i D
5
i
D3i
for Rei ≥ 104 (4.13)
The subscript i denotes the relation of the variables to the impeller (i.e. rather than
another bioreactor component). ρi is the density of the liquid, Ni is the impeller
19ugs =
(gas feed volumetric flow rate)
(vessel cross section area)·(gas holdup)
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rotation rate (revolutions per time), Di is the diameter of the impeller, and “const”
is a proportionality constant dependent on other system parameters, including broth
viscosity.
The combination the Equations 4.12 and 4.13 suggests the following proportion-
ality:
kLa ∝ N2.1i (4.14)
Considering the results of the “regression” method of calculating the kLa from
the dynamic method data (Table 4.6, page 93),20 kLa and agitation appear to be
linearly related. Since the regression method depends on the dynamic response of the
dissolved oxygen probe, the accuracy of the kLa calculation depends on the ability
of the DO probe to track the true value of oxygen concentration in the broth. As
discussed in Section 4.3.2, the limits of the probe delay decrease the accuracy of kLa
calculations as the kLa approaches 90 hr
−1. This method will not result in a calculated
kLa greater than 90 hr
−1, no matter what the true value of kLa is. Considering that
the values of kLa at 400 and 500 rpm (42 and 63 hr
−1 respectively) are large fractions
of the 90 hr−1 limit, it is likely that these values are underestimates of the true kLa.
On the other hand, when kLa is calculated using the “steady-state” approach to
analyzing dynamic method data,21 only the accuracy of the OUR calculation depends
on the probe response being much faster than the change in oxygen concentration.
For low enough cell densities (OD600 < 1–2), this constraint on the change in oxygen
concentration due to consumption is satisfied. Even though the correlation between
kLa and agitation (Ni) appears to be governed by a polynomial of degree greater
than 2, the fact that the increase in kLa with agitation is more rapid than a linear
increase implies that the “steady-state” approach to the dynamic method gives more
physical results with typical fermentation setups (i.e. high agitation and aeration).
Relative to the values of kLa calculated with the dynamic method, the off-gas
20In the “regression” method, kLa is equal to the slope of the linear regression on the plot of
d(DO)
dt vs. DO after the oxygen supply was reintroduced to the culture.
21In the “steady-state” method, the kLa is equal to the quotient of the OUR and driving force
(c∗ − cL), where cL is the oxygen concentration when there is oxygen mass transfer equilibrium,
after the experiment to determine OUR has been performed.
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method calculations gave results that were less predictable (Table 4.7, page 98). The
most notable abberations are the low kLa value calculated at 500 rpm (101 hr
−1)
and the relatively large value calculated at 400 rpm (219 hr−1). Assuming the va-
lidity of the correlations in Equations 4.12 and 4.13, and disregarding the effect of
change in broth composition over time, one would expect the kLa values at 400 and
800 rpm to differ by a factor of approximately 4.22 However, the kLa values at 400
and 800 rpm only differ by a factor of approximately 1.5, implying a measurement
error or insufficiency in the correlation. The fact that both kLa measurements at
800 rpm deviate from the mean value (302 hr−1) by about 10% suggests that these
values are relatively accurate. It is likely that because the steady-state dissolved
oxygen concentration (92%) was near saturation during the 400 rpm kLa calculation,
error in the DO probe measurement was amplified since it is the difference (c∗ − cL)
that is used in the calculation.
If the kLa values resulting from the dynamic method and off-gas calculations are
at all relatable, the similarity of the magnitude of the dynamic method calculation
at 500 rpm (286 hr−1) and the off-gas calculations at 800 rpm (mean = 300 hr−1) is
unexpected considering the correlation predictions; one would expect the values at
800 rpm to be much higher than the value at 500 rpm, but instead they are quite
similar. As mentioned before, a major source of variability not taken into account
by the kLa correlation (Equation 4.12) is the effect of broth composition on kLa. In
a Bacillus subtilis bioreactor culture agitated at 700 rpm (6-blade Rushton impeller)
and 2 vvm, Richard, et al. observed the kLa increase to 154 hr
−1 during exponential
growth and decrease to 134 hr−1 as the maximum viscosity was reached. kLa was
measured using the dynamic gas-out/gas-in method [47].
At the lowest agitation rate (300 rpm), the kLa values calculated using the “regres-
sion” (20 hr−1) and “steady-state” (37 hr−1) methods of analyzing dynamic method
data were at their highest degree of agreement. These values are somewhat corrob-
orated by a study done by Nielsen, et al. [41], who found that there was a sharp
increase in kLa when the agitation was increased from 200 rpm to 400 rpm, the kLa
22From Equation 4.14, kLa at 800 rpmkLa at 400 rpm =
8002.1
4002.1 = 2
2.1 ≈ 4
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at 200 rpm was approximately 20 hr−1, and the maximum kLa attained was approx-
imately 180 hr−1 (800 rpm, 2.0 vvm).
In general, the values of kLa calculated using the “steady-state” dynamic method
approach and the off-gas method were about 100 hr−1 higher than the maximum
values obtained by Richard, et al. and Nielsen, et al.. Without a more complete set
of data, though, it is difficult to say why this discrepancy exists, and whether it is
due to measurement error or differences in the systems that were studied (i.e. both
physical parameters of the bioreactor and the broth composition).
4.4 Carbon mass balance
The carbon mass balance technique is used to ensure that all process substrates and
products are accounted for. Performing a mass balance serves as a check to make
sure that the assumptions about a fermentation’s reaction processes that govern the
transfer of carbon from one form to another (e.g. glucose to dry cell weight or CO2)
are correct and that the measurement techniques for process characterization are
sound. A carbon mass balance on the BL21(DE3)[pJY-1] fermentation from 10/4/04–
10/6/04 is performed here. The entire fermentation is considered, from time zero
(inoculation) to harvest. Spanning the entire fermentation with the mass balance
maximizes the error in mass balance closure, thus amplifying any cumulative error in
the calculation.
Table 4.8 lists the carbon-containing substrates added to the bioreactor from the
time of inoculation to the end of the fermentation, and Table 4.9 lists the reaction
products that were produced during the fermentation. It is assumed that citric acid
is fully consumed and converted to “products” over the course of the reaction. High
Performance Liquid Chromatrography (HPLC) analysis of sample supernatant (per-
formed by Judy Yeh) did not detect acetate in any of the samples.
Carbon dioxide output was measured with both the Perkin Elmer mass spectrome-
ter and the ARI laser gas analyzer. Both instruments agreed on the CO2 composition
to within 1% (volume %), so the measurements from the ARI were used for this mass
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balance. The differential amount of CO2 evolved between each successive set of time
points (sample frequency was 1 per 15–16 seconds) was calculated for the entire time
course of the fermentation using Equation 4.15 (note similarity to Equation 4.11 on
page 96).
COevolved2 [g] =
∑
dt
(
%COout2
100%
)
(Qsparge)(Vgas law)
−1
(
44.01 g
1 mol CO2
)
(dt [min]) (4.15)
COevolved2 is the total amount of carbon dioxide that exited the bioreactor over
the time course of the fermentation in grams, %COout2 is the percent of CO2 in the
outlet gas (volume %), Qsparge is the gas flow rate through the bioreactor in L/min,
23
Vgas law = 24.5 L/mol: the volume in liters occupied by 1 mol of ideal gas at room
temperature and 1 atmosphere of pressure, and dt is the differential amount of time
between off-gas samples (approximately 15–16 seconds). Using this methodology, the
total amount of evolved CO2 was calculated to be 689 g.
Thus, based on the calculations summarized in Tables 4.8 and 4.9, the carbon
mass balance was closed to within 78%. This is highly incomplete closure of the mass
balance. Possible sources of error include the reliance of the final DCW on a single
OD600 measurement,
24 the estimation of the flow rates over time based on limited
data from the fermentation log sheet, and the fact that cell debris and released cell
contents due to cell lysis were not taken into account. In addition, normalization
of the % CO2 in the off-gas to adjust for the effect of water vapor (analogous to
Equation 4.3 for O2) was not done, which could have led to an underestimate of the
CO2 evolved, expecially at points when the filter was clogged and wet.
The remaining discussion (unrelated to the 10/4/04 BL21(DE3)[pJY-1] fermen-
tation) pertains to mass balance in general, and considers interesting data on acetate
production experienced by several course fermentations. During course 10.28 module
23Qsparge varied with time because the exhaust filter would periodically get wet from condensation
and clogged with cells, causing the flow rate through it to decrease below 5 lpm. The change in flow
rate was taken into account based on the data recorded in the fermentation log sheet.
24The DCW measurement of 36.1 g/L for this time point would have resulted in even more
incomplete closure.
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Substrate Substrate quantity (g) % carbon Carbon mass (g)
Inoculum dry cell weight 1.0a 55% 0.55
Glucose (batch) 98b 40% 39.2
Glucose (fed-batch) 1332c 40% 533
Citric acid 8.5d 38% 3.23
Total carbon in: 576 g
a(4.73 OD600 units)
(
0.42 g/L DCWOD600 unit
)
(0.5 L shake flask inoculum) = 1.0 g DCW
b
(
9.8 gL
)
(10 L bioreactor volume) = 98 g
c(1903 g feed)
(
1 mL feedg feed
)(
0.7 g glucosemL feed
)
= 1332 g glucose
d
(
0.85 gL
)
(10 L bioreactor volume) = 8.5 g
Table 4.8: Mass of carbon contained in fermentation substrates (cumulative from
inoculation to harvest).
Product Substrate quantity (g) % carbon Carbon mass (g)
Dry cell weight (in bioreactor) 447a 55% 246
Dry cell weight (samples, foam) 27b 55% 15
CO2 689 27.3% 188
Acetate 0 40% 0
Total carbon out: 449 g
a(96.7 OD600 units)
(
0.42 g/L DCWOD600 unit
)
(11 L bioreactor volume) = 447 g DCW
b(71 OD600 units)
(
0.42 g/L DCWOD600 unit
)
(0.9 L bioreactor volume removed) = 27 g DCW; During in-
duction approximately 0.9 L of cumulative bioreactor volume was either sampled, discarded, or lost
due to foam. The approximate average OD600 value during this period was 71.
Table 4.9: Mass of carbon contained in fermentation products (cumulative from in-
oculation to harvest).
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Induction time (hours) OD600 Acetate concentration (g/L)
0.0 26.1 0.31
0.8 27.0 0.78
1.5 26.2 0.68
2.3 23.4 1.17
3.0 29.7 1.42
4.5 18.3 1.89
Table 4.10: Acetate production during anaerobic fermentation.
2 (Fall 2004), group D2 saw relatively high levels of acetate production in their fer-
mentation (E. coli BL21(DE3)[pLysS][pJHL]). When the culture recovered from its
cooling phase (early-mid batch phase) and the fed-batch phase began, the acetate
concentration was measured to be zero. For unknown reasons, the culture did not
metabolize glucose as quickly as other cultures during the fed-batch phase and glucose
accumulated to approximately 20 g/L by the beginning of induction phase (OD600 =
26.1). Also near the beginning of the induction phase, the exhaust filter was flooded,
clogging it and stopping air flow through the reactor during the remainder of the
induction phase. As seen in Table 4.10, the culture stopped growing, and acetate
steadily accumulated, implying that the culture entered anaerobic metabolism which
resulted in acetate production.
In contrast to the acetate production of group D2, group A2’s fermentation (E.
coli BL21(DE3)[pJHL]) reached the highest cell density of all course fermentations
(OD600 = 80.4) while appearing to remain glucose-limited throughout the fed-batch
and induction phases. HPLC analysis of group A2’s samples measured zero acetate
production.
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Chapter 5
Analysis of quantitative protein
assays
When quantifying the production of a specific protein such as a collagen-like polymer
(CLP), it is ideal to have an assay at one’s disposal that is specific to that protein.
To elucidate the motivation for a specific CLP protein assay, first consider an alter-
native method of CLP quantification. One approach could be to simply measure the
concentration of total protein before and after a purification step designed to remove
endogenous (non-CLP) protein, as done by Werten, et al. with the differential ace-
tone method [67]. However, this method assumes that interfering components in the
purified CLP mixture are minimal, that the measurement component due to CLP in
the purified mixture overwhelms the component due to interfering factors, and that
the purification step removes 100% of the endogenous protein. A more ideal system
would use a specific assay (e.g. the collagenase assay) whose measurement magnitude
is non-linearly amplified by CLP in the purified sample (relative to the remaining
impurities), in order to increase the signal to noise ratio of the measurement and thus
its accuracy.
This chapter analyzes experimental data from the collagenase and bicinchoninic
acid (BCA) assays in the context of their chemical reaction mechanisms (described in
Section 2.4.1). The purpose of this approach is to develop a case for their insufficiency
(in their current form) for product quantification. Rather than presenting all of the
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results of the fermentation sample assays here, only specific data that is useful for
analyzing the assays is shown. In addition, an experimental approach is outlined in
each relevant section for determining how the collagenase assay must be changed to
obtain useful results. The protocols discussed in this chapter are based on Yin, et al.
and the 10.28 manual (Fall 2004) [73, 68]. A list of the assay reagents is included in
Appendix A.2.
The use of the collagenase assay in course 10.28 resulted in a wide range of exper-
imental conditions that are useful in evaluating the assay. Unfortunately, because of
time constraints on the course, students were not able to perform duplicate experi-
ments on their samples, preventing each data set from carrying statistical information
on measurement variation. However, the existing data was useful in designing exper-
iments to improve the assay.
5.1 Efficacy of protein precipitation step
After cell debris are removed from the cell lysate, the samples contain soluble intra-
cellular proteins released during sonication. Since the assay is based on the binding of
ninhydrin to the exposed N- and C- termini of the proteins, the assay is more accurate
when non-collagen-related peptides are removed from the sample. The assay calls for
a 80–100◦C incubation for 15-20 minutes. The extreme heat denatures many of the
proteins which causes them to precipitate, much like a raw egg that becomes “hard”
when it is boiled. Collagen-like polymers remain soluble at high temperatures.
There was a large amount of variation among 10.28 teams’ results in the amount
of protein that was precipitated during the heating step. After pelleting the precip-
itate by centrifugation, some groups observed large pellets that reached the 0.1 ml
graduation on their 1.5 ml microfuge tubes. Other groups saw very faint pellets that
were less than 1 mm in diameter. This variation occurred despite the fact that some
of the teams were analyzing identical samples.1 In addition, one group was asked to
1In the first module of the Fall 2004 offering of 10.28, students did not analyze their own samples
because their fermentations did not reach high cell densities. Instead, they analyzed samples from
the 10 L BL21(DE3)[pJY-1] fermentation (10/4/2004–10/6/2004).
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perform the BCA total protein assay on fermentation samples before and after the
protein precipitation step. They observed an intermediate to low level of precipita-
tion after the heating step, but no significant difference in the BCA data due to the
precipitation.
These results draw attention to the fact that there is no rigorously quantitative
data associated with the reduction in non-CLP protein by the heating purification
step. Yin, et al. mention that “more than 80% of non-specific [CLP assay] reactions
can be eliminated” by thermal treatment [73]. Quantitative data on the amount of
protein removed during the heating step would lead to a more thorough understanding
of the degree of interference due to components that remain in solution throughout
the assay (see Section 5.3 for a discussion of other interfering factors).
In addition, it would be useful to evaluate a second method for removing endoge-
nous proteins from the sonication lysis supernatant. Werten, et al. describe a method
of differential acetone precipitation, in which cold acetone is added to the sample to
a concentration of 40% (v/v), endogenous proteins are pelleted, the acetone concen-
tration is increased to 80% (v/v), and the resultant CLP precipitate is pelleted and
washed once more with 80% (v/v) acetone. Werten, et al. achieved > 96% purity of
artificial P4 gelatin using acetone method to treat the Pichia Pastoris fermentation
supernatant. Like the protein precipitation method, this acetone-based technique
relies on the relatively high solubility of gelatin due to its highly polar amino acid
composition [67].
5.2 Length of incubation
The collagen assay protocol as described by Yin, et al. calls for a 5 hour incubation
of the samples with collagenase. During course 10.28, different sets of standards and
samples were incubated for varying lengths of time to determine whether reductions
in the incubation time have an effect on the linearity of the standard curve. Repre-
sentative standard curves from incubation times of 2h:30m and 4h:14m are plotted
in Figure 5-1.
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Figure 5-1: Collagenase assay gelatin standard curves from incubations of varying
length.
The consistent linearity of the standard curves despite drastically different incuba-
tion times suggests that times much shorter than 5 hours are sufficient for achieving
the same relative amounts of digested sample as in longer incubations, thus preserving
the linearity of the standard curve. This data supports a reduction of the incuba-
tion time called for by the protocol, but should not be done until more accurate
information about the concentration of CLP3.1 in the samples is found out.
Even if a shorter incubation time is sufficient for complete digestion of the stan-
dards, the effect of very high amounts of CLP3.1 on the accuracy of the assay must
be considered. The CLP3.1 concentration in samples from a successful fermenta-
tion is likely to be much higher than that of the gelatin in the standards (maximum
standard gelatin concentration = 1 g/L). Consequently, the standards are likely to
be more fully digested than the fermentation samples in a limited-time incubation.
The use of the linear relation between the fermentation and standard sample mea-
surements in order to quantify the amount of CLP3.1 in the fermentation samples
assumes that the amount of gelatin/CLP3.1 digested is proportional to the amount
of substrate present in the sample.
Additional considerations related to very short incubation times (¿ 2 hrs) are
concerned with determining whether the enzyme–substrate reaction kinetics are in
the saturated or linear ranges (as described by the Michaelis-Menten analysis). When
stopping the digestion reaction early, the linearity assumption discussed above is
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based on the assumption that the digestion kinetics are in the same range for all
samples. At high CLP concentrations, this may not be the case; CLP concentrations
may not allow the reaction to be in the linear range, causing the measured CLP values
to saturate past a certain real CLP concentration for a given incubation time.
One way to circumvent the error-introducing possibility of these considerations is
to allow enough time for samples at a maximum concentration to be fully digested.
After several experiments with a particular strain, it will be possible to estimate
the level of CLP in a fermentation sample (based on cell density and expected %
expression level) and to consequently dilute it to within a specified range for the
incubation time corresponding to a given set of incubation conditions. One way to
experimentally determine the critical incubation time for a specific CLP concentration
would be to make a set of identical samples of gelatin standard (concentration =
highest possible standard concentration, most likely 1-2 g/L). The samples would be
incubated for varying lengths of time, stopping the reaction by heating in boiling
water. The point at which the colorimetric assay data stops increasing is the point
at which the sample is fully digested.
5.3 Interference in the collagenase assay
To calculate the absorbance due to the added colorimetric binding of ninhydrin to the
liberated peptides of digested CLP/gelatin, the difference between the OD570 values
of the samples incubated with collagenase (“test samples”) and the undigested sam-
ples incubated with the enzyme solvent (“control samples”) was calculated (see Ap-
pendix A.2 for reagent details). However, the absolute magnitude of the absorbance
of each sample directly determines the significance of this difference. For example, if
the difference between two measurements remains constant as the magnitude of the
measurements increases, the size of the difference between the measurements is likely
to approach the same order of magnitude as the noise of the measurement, resulting
in the difference between the two measurements becoming statistically insignificant.
The magnitude of the collagenase assay OD570 measurements varied greatly de-
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Sample type OD570 range Uncertainty
Gelatin standard 0.1–5.0 ± 0.5
Washed E. coli samples (2 times with PBS) 10–20 ± 1–1.5
Washed E. coli samples (1 time with PBS) 20–50 ± 4–5
E. coli samples lysed in spent medium (no washing) 50–85 ± 5–10
Table 5.1: Effect of collagenase assay sample composition on magnitude of OD570
signal.
pending on the methods used to prepare the samples for the assay. General ranges
and estimates of the variability in the measurements are shown in Table 5.1. As the
degree of “cleanliness” of the sample increases due to either washing or to the baseline
purity of the standards, the OD570 of the samples as well as the magnitude of the
measurement variability decrease.2 The most likely cause of this data trend is the
presence of interfering factors both in the medium and within the cells. Here, and
interfering factor is a ninhydrin binding reaction with any non-CLP-derived species.
Before continuing the discussion further, the motivation for testing the collagenase
assay without washing the cells with PBS must be discussed. In light of one of the
objectives of this thesis—to create a lytic strain that is induced to lyse at the end
of the fermentation—it would be ideal to be able to use the collagenase assay (or
some variant, to be determined) to assay CLP in the lysate. Since the cells are lysed
in the bioreactor, without the option of a washing step, any assay for CLP must be
performed on the maximally impure broth mixture. Thus, if the pre-assay purification
steps and the collagenase assay itself can be made to work with samples that start off
with a composition similar to the broth, the collagenase assay would remain a cheap
and rapid alternative to immunobased methods of assaying specific proteins.
In their collagenase assay study, Yin, et al. grew BL21(DE3)[pPT0296]3 in shake
flasks containing MR medium. Based on the size of their absorbance increases, which
ranged from 0 to 0.8, as well as on the data in Table 5.1, their absolute absorbance
2Because the relationship between absorbance and concentration is only linear at relatively low
concentrations as described by Beer’s law (A = log
(
I0
I
)
= ln²cl), concentrated samples must be
diluted to the linear range of the UV-VIS spectrophotometer (0.1–1) and the resultant raw ab-
sorbance must then be multiplied by the dilution factor to get the estimated absorbance of the
undiluted sample.
3The precursor to the pJHL plasmid, thermally inducible expression of CLP3.1. In the creation
of pJHL, the 6-his tag was added to the C-terminus of CLP3.1.
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magnitudes were probably near 10. Based on experimental results obtained in this
thesis by performing the assay on fermentation samples, reproducible, confidence-
inspiring results have not yet been achieved. Even with fermentation samples washed
twice with PBS, the magnitude and variability of the OD570 measurements are large.
A thorough set of experiments must be performed to quantify the effects of interfering
factors on the assay results.
Despite the fact that MR medium was used in the experiments of both Yin, et
al. and of this thesis, the fact that Yin, et al. analyzed samples of E. coli grown in
shake flasks while this thesis’ samples came from high cell density fermentations is
a major experimental difference. The conditions in shake flasks are left uncontrolled
throughout the growth process, while fermentations receive base and feed solutions
throughout the process which is deliberately prolonged. Ammonium hydroxide is the
primary component of the based used to adjust pH; NH+4 interferes with the ninhydrin
binding reaction. In addition, large amounts of foam accumulate in the bioreactor in
the latter stages of a fermentation. Foam often arises because of decreased surface
tension due to intracellular proteins released by dead, lysed cells.
Another major difference between shake flask and fermentation experiments is the
initial cell density of the samples when they are resuspended just before sonication.
Based on his results from the development of the collagenase assay, Jin Yin recom-
mended that the cells from a 10 mL bioreactor sample at a cell density of about 15 g/L
Dry Cell Weight be resuspended in 2.5 mL of Buffer A (20 mM Tris, 5 mM CaCl2).
The resultant mixture of proteins and CLP is likely to be much more concentrated
than if the samples came from shake flasks. The high concentrations of intracellular
components in the lysate is probably a major source of the high OD570 values. In
future experiments with the collagenase assay, it will be necessary to find an optimal
resuspended cell density to dilute the bioreactor samples to. It is probable that the
cell density will be on the order of the density of a shake flask sample.
In addition, a range of assays on different medium formulations would be useful to
determine the effect of various medium components on the assay results. For example,
the assay can be performed on Buffer A alone (see above), MR medium, MR medium
111
and additional ammonium salt (e.g. extra (NH4)2HPO4), and spent medium from a
bioreactor and from a shake flask culture that was done in MR medium. It would also
be useful to reproduce the shake flask results of Yin, et al. with one of the CLP3.1-
producing strains as a baseline for the fermentation sample optimization experiments.
5.4 Use of gelatin and Bovine Serum Albumin (BSA)
as assay standards
The results of both the BCA total protein assay and the collagenase assay depend on
the standards used. The following sections analyze the validity of the use of BSA and
gelatin as standards for the assays and make suggestions for improving the protocols
and data interpretation.
5.4.1 Total protein assay standards
In their paper on the collagenase assay, Yin, et al. used the results of the BCA assay
(Pierce) to maintain the concentration of total protein in the crude cell lysate of a
BL21(DE3) shake flask culture constant at 1.20 g protein/L. The gelatin concentration
was varied from 0 to 0.835 g/L to simulate levels of CLP3.1 expression from 0% to 41%
of the total protein. While this is an effective approach to studying the interference
due to non-CLP proteins, the paper did not suggest methods of measuring total
protein in the crude cell lysate of a CLP expression system. Without accurate data
on the amount of total protein in the lysate (including CLP), a meaningful CLP
production level as a percent of total protein can not be measured. Based on the
discussion of the BCA and collagenase mechanisms (Sections 2.4.1 and 2.4.2), the
results of the assays are expected to vary depending on the relative amounts of the
amino acid constituents of the proteins being measured. In optimized CLP expression
systems such as those developed by Yin, et al. [72], CLP is expected to be expressed at
levels near 40-50% of the total protein. Therefore, the results of an ideal total protein
assay must not be skewed by differences in the CLP versus total protein composition.
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Figure 5-2: BCA assay standard curves using two different standards: Bovine Serum
Albumin (BSA) and gelatin.
Stated in another way, the protein standard used for the BCA assay should give the
same assay results as if CLP were used for the assay.4
Based on the data in Figure 5-2, it is clearly not the case that BSA and gelatin
are equivalent standards for the BCA assay.5 Relative to the results with BSA as a
standard, equivalent gelatin concentrations result in significantly lower OD562 mea-
surements. The slope of the curve from gelatin standards (1.86 g/L
OD562 unit
) is approxi-
mately twice the slope of the BSA standard curve (0.84 g/L
OD562 unit
). This implies that
the amino acid residues of natural gelatin caused much less reduction of Cu2+ to Cu+
than the residues of BSA. These results are consistent with the fact that gelatin has
less residues that are especially reactive in the assay than BSA (cystine, tyrosine,
4It is recognized that CLP is not the only protein that reacts significantly differently than BSA
in the BCA assay. The reasoning here is based on the assumption that the variation in protein
concentration across samples from a given experiment is constant, and that the large proportion
of the total protein comprised by BCA will dominate the effect of mis-measurement of any other
specific proteins due to the use of BSA as a standard.
5Note that in Figure 5-2 the standard curves do not pass through the origin. This is because the
data was not normalized for the non-zero absorbance caused by the reagents present in the blank
sample (which are present in the same quantity in the other samples). Whether or not the standard
curve is normalized does not matter, as long as the normalization is performed at some point in the
data analysis process.
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tryptophan) and CLP3.1 does not have any of these residues (see BSA and gelatin
compositions in Section 2.4, and CLP3.1 composition in Section 3.1.1). Thus, if BSA
was used as a standard for the measurement of a mixture of gelatin/CLP and common
bacterial proteins, the result would be an underestimate of the total protein content
and consequently an overestimate of the amount of CLP produced by the culture.
A method of grossly adjusting for the difference in reactivities of CLP and BSA,
without calling for an additional assay method, would be to take the difference in
reactivities into account in the total protein calculation. Rather than simply dividing
the result of the collagenase assay (CLP concentration) by the result of the BCA
assay (total protein concentration) to get percent CLP production, a second term
must be added to the measured total protein concentration. Equation 5.1 is the new
expression for the percent of total protein comprised by CLP.
CLP % total protein =
[CLP ]
[BCA] + (1−m)[CLP ] × 100% (5.1)
In Equation 5.1, [CLP ] is the concentration of CLP obtained from the collagenase
assay, [BCA] is the total protein concentration from the BCA assay (using BSA
as a standard), and m is the normalization factor accounting for the difference in
reactivities of gelatin and CLP, calculated by dividing the slope of the BCA assay
standard curve from a BSA standard by the slope of the curve from a gelatin standard.
The factorm is the effective fraction of CLP that was detected by the BCA assay using
BSA as the standard. The value (1−m), then, is the fraction of CLP “undetected”
by the BCA assay. Based on the information in Figure 5-2, m ≈ 0.84
1.86
= 0.45, implying
that the BCA assay with a BSA standard accounts for slightly less than half of the
gelatin present in a sample.
Even though the complexity added by Equation 5.1 is likely to improve the accu-
racy of the assay, the efficacy of this equation is based on the assumption that the
recombinant CLP and gelatin have similar reactivities when involved in the mecha-
nism of the BCA assay. However, this may not be a valid assumption depending on
the amino acid composition of the CLP. The ideal method of making a CLP standard
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for the BCA assay in order to calculate an accurate value of m would be to use the
CLP itself as a standard rather than gelatin. However, because it would be costly
and time consuming to obtain a purified, quantified sample of the CLP, this method
may not be feasible. Another approach to validating Equation 5.1 would be to use
theory to predict the differences in reactivity between the CLP and gelatin. Without
quantitative validation, though, this approach would render the results merely qual-
itative. The implications of a non-analogous gelatin standard are also discussed in
Section 5.4.2.
Finally, the most readily-implementable method of validating Equation 5.1 would
be to use a second total protein assay based on as different a mechanism as possible.
For example the experiments described above to determine the m-factor could be
performed with a Coomassie dye based protein assay and the results of the calculations
based on Equation 5.1 compared. The Coomassie dye based assay is primarily based
on the binding of basic amino acid residues (e.g. arginine, lysine, and histidine) to
the dye to produce a colored complex detectable using colorimetric methods. The
dye does not bind to short peptides or small proteins less than 3 kDa [45]. Thus,
an additional set of experiments aimed at determining the level of CLP in a sample
could be based on measuring the difference in dye binding between lysate samples
both undigested and digested with collagenase. Fully digested CLP should result in
zero contribution to the protein concentration values obtained by the Coomassie dye.
Results from such experiments performed on both pre- and post-protein precipitation
step samples would be useful.
5.4.2 Collagenase assay standards
The specificity of the particular type of collagenase used for the digestion of a par-
ticular collagen-like polymer must also be considered if other types of CLP are to be
measured with the assay. Yin, et al. “confidently predict that this collagenase assay
can be applied in the direct measurement of other types of CLP in E. coli cells.” [73].
However, depending on the peptide sequence of the CLP, the activity of the collage-
nase used may vary. One potential way to change collagenase activity would be to
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change the peptide sequence of the CLP substrate by substituting a charged amino
acid in place of the uncharged residue that normally flanks the cleavage site (see
mechanism details in Section 2.4.1). Decreased CLP relative to gelatin hydrolysis
would result in an underestimate of the amount of CLP present in a sample if gelatin
were used as the assay standard. In the current CLP3.1 system, this effect does not
seem to be a problem: in their paper on the assay, Yin, et al. showed that the mea-
surements of CLP3.1-his by the immunodetection assay closely matched the results
of the collagenase assay, proving that the use of gelatin as a standard for CLP3.1-his
digested with type III collagenase produces accurate results. But, the assay must be
revalidated if significant changes to the CLP sequence are made.
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Chapter 6
Design of lytic E. coli strain
This chapter describes the progress towards creating the lytic strain motivated by the
research in Section 2.2.3. Based on experimental results, use of the λ-phage genes in
the lytic strain design was rejected in favor of a system combining the T4 phage t-holin
and the T7 lysozyme. The experimental methodology for creating the final strain is
presented, followed by the primary considerations for optimizing a fermentation that
uses the final lytic strain.
6.1 Experiments with λ-phage fragment S−RRz
Because of its ready availability from Jin Yin of MIT’s BPEC and the demonstrated
lytic efficacy with host strain JM109, the design of the dual plasmid lytic strain
originally called for use of the λ phage fragment S−RRz.1 However, experiments using
the pUC18-S−RRz plasmid with host strain BL21(DE3) resulted in unsatisfactory
lytic behavior which motivated the new strain design described in Section 6.2. A
summary of the experiments follows.
1Refer to Section 2.3 for an explanation of the functions and mechanism of the S-gene (holin)
and R-gene (lysozyme). The Rz-gene product is unknown; it may be an endopeptidase [74]. The
“−” superscript in the λ fragment name means that the S-gene has been inactivated, so that it has
no activity as a membrane-permeablizing agent.
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6.1.1 Comparison of JM109 and BL21(DE3) lysis
Plasmids were purified from host strains JM109[pUC18-S−RRz] and BL21(DE3)[pJHL],
then the plasmids were reinserted into competent BL21(DE3) cells (see Section 3.1
for protocol details). The goal of the experiments with these strains was to determine
the dependence of lytic behavior on both host strain and whether the inducer (IPTG)
is added. The protocol was based on the course 10.28 lab manual (Fall 2003, Part A).
Appendix A.3 contains details on lysis Buffer A and control Buffer B.
In one experiment, two shake flasks were inoculated with JM109[pUC18-S−RRz].
IPTG (1 mM) was added to one of the flasks 5 hours before the end of the experiment,
and both cultures were harvested at an OD600 of 4.87. Each harvest was split into
two tubes, pelleted, and the supernatant was discarded. One pellet was resuspended
in lysis Buffer A (50 mM Tris, 2mM EDTA) and the other was resuspended in control
Buffer B (50 mM Tris). The OD600 of the tubes was measured every 20 minutes for
100 minutes. The experiment was repeated with strain BL21(DE3)[pUC18-S−RRz]
using BL21(DE3)[pJHL] as a control. The following OD600 values were reached before
harvesting the cultures: 5.68 (BL21(DE3)[pUC18-S−RRz], induced with IPTG), 5.53
(BL21(DE3)[pUC18-S−RRz], not induced with IPTG), and 6.78 (BL21(DE3)[pJHL]).
The results of these experiments are plotted in Figures 6-1 (JM109 cells) and 6-2
(BL21(DE3) cells). The fact that the mean OD600 values differ among samples is
not important; the value of the figures lies in the OD600 trends they show. The
variation in the mean values is due to variability in the initial cell densities, which
were resuspended in the same buffer volumes (21 mL). This assay is based on the
assumption that as the cells lyse, the resulting debris is unable to scatter as much
600 nm light as a suspension of completely intact cells.
The pUC18 host vector employs the lac operon (IPTG-inducible) to control ex-
pression of the λ-phage fragment. Jin Yin, et al. found that the addition of IPTG
had no effect on the fraction of host JM109 cells that were lysed, implying that high
basal levels of the R-gene lysozyme were produced regardless of the presence of the
inducer [74]. This result was verified by the experimental results in Figure 6-1. It
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Figure 6-1: Efficacy of the λ phage genes for lysis of E. coli strain
JM109[pUC18-S−RRz].
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was because of these results demonstrating the lack of effect of IPTG on lysis that no
IPTG was used in the experiments with strain BL21(DE3)[pUC18-S−RRz] (Figure 6-
2). The rapid drop in OD600 is consistent with data from Yin’s study that showed
lysis within 35 minutes of resuspension [74].
It is clear from Figure 6-2 that the BL21(DE3) cells are not lysed effectively; the
rapid drop in OD600 seen with JM109 is not present, and the trends are similar, re-
gardless of plasmid type. In addition, resuspensions of JM109[pUC18-S−RRz] in lysis
Buffer A were consistently more viscous than any of the other resuspensions, includ-
ing the lysis Buffer A resuspensions of BL21(DE3)[pUC18-S−RRz]. The viscosity is
primarily due to DNA released from lysed cells. The data is also consistent with the
increased difficulty of achieving BL21(DE3) lysis that Vasala, et al. experienced with
their experiments: treatment of BL21(DE3)[pLysS] and BL21(DE3)[pLysE] with thy-
mol, which was expected to make the inner membrane permeable to the T7 lysozyme,
did not result in lysis [61].
6.1.2 Effect of temperature on E. coli autolytic tendency
Even though the autolytic capability of E. coli is not as potent as the action of bac-
teriophages [61], the fact that the expression of CLP3.1 with plasmid pJHL requires
a temperature increase from 30◦C to 41◦C was cause for concern; temperature in-
crease can be an inducer of autolysis [61]. In addition, it was considered possible
that the presence of the R-gene product could augment the autolytic potency. To
test this hypothesis, 4 flasks were inoculated with BL21(DE3)[pUC18-S−RRz] and
grown at 30◦C for 11 hours to OD600 ≈ 3. Since it was concluded from the results
of Section 6.1.1 that the R-gene lysozyme was produced at significant basal levels,
IPTG was not added to the flasks. The incubation temperature was then increased to
42◦C and the OD600 was measured every hour for 3 hours. Over the 42◦C period, the
OD600 increased slightly to ≈ 4. No significant decrease in cell density was observed.
To complete the experiment, the contents of two flasks were resuspended separately
in Lysis Buffer A, and the contents of the other two flasks in Buffer B (buffer con-
tents listed in Appendix A.3). As in the experiments in Section 6.1.1, the OD600
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of the resuspensions did not decrease dramatically, as in the resuspensions of strain
JM109[pUC18-S−RRz]. It was concluded that the effect of the temperature increase
required for use of plasmid pJHL did not contribute to significant autolysis.
6.1.3 Limited fermentation growth
Four fermentations were run in parallel with a set of four DasGip r© FedBatchPro r©
bioreactors.2 The working volume of MR medium in each bioreactor was 0.5 L,
and the fermentations were implemented according to the protocols described in Sec-
tion 3.2 and the course 10.28 lab manual (Fall 2004) [68]. Two vessels were inoculated
with strain BL21(DE3)[pJY-2], and two with BL21(DE3)[pUC18-S−RRz]. All other
fermentation parameters were held constant. (Because of the slower growth in the
BL21(DE3)[pUC18-S−RRz] fermentations, glucose was consumed less quickly, and
the start of the fed-batch phase came later.) Growth curves of the cultures are shown
in Figure 6-3.
An advantage of using this miniaturized fermentation system is that duplicate
fermentations can be carried out with a minimal amount of extra work. The fact
that identical strains grew similarly implies that the results are reproducible. Thus,
considering the growth curves shown in Figure 6-3, the presence of the pUC18-S−RRz
plasmid impeded growth significantly more than the pJY-2 plasmid. As mentioned
in Section 6.1.1, Yin, et al. speculated that the pUC18/lac system lends to high
basal expression of the R-gene product [74]. It is likely that the high intracellular
levels of the λ-phage R-lysozyme prevented the vigorous growth seen with strain
BL21(DE3)[pJY-2]. This speculation is corroborated by the fact that the presence
of the pLysE plasmid in E. coli, which is explicitly engineered to express high basal
levels of the T7 phage lysozyme, causes significantly decreased growth rates [21].
2Conditions within these vessels were monitored and controlled in much the same way as those
in the stirred tank bioreactors described in Section 3.2.1. The results of numerous fermentations
performed in the lab with the DasGip r© system have shown that high cell densities analogous to
traditional STR fermentations can be consistently achieved. The experiments described in this
section were performed on 7/25/04.
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6.2 Lytic strain design
Since suboptimal results for the lysis of BL21(DE3) were obtained using the λ phage
lysin, an alternate design was developed. In order to have maximum confidence that
the lytic mechanism would be effective, previous work with successful results was
considered. Also in the theme of making the lystic mechanism as reliable as possible,
the new mechanism was designed to be more closely akin to the natural mechanism
of phage-induced lysis, which requires the presence of both the holin and lysozyme
enzymes. The study performed by Morita, et al. [38] was particularly effective and
in line with the goals of this thesis, so the design of the new lytic strain was based
on the constructions in their paper. Refer to Section 2.2.3 for an explanation of their
study.
In order to maximize the likelihood of a successful high cell density process, the
intermediate strains and experiments were designed with the following characteristics
in mind:
High cell density capability The final strain must be capable of growing to high
cell densities (30-40 g/L), expressing the product protein, and lysing efficiently.
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The behavior of a strain at high cell density is directly effected by its metabolic
state, which is a direct result of the fermentation design. If high cell densities
are not achievable, the process will not be industrially viable because absolute
production levels will be to low.
Lysis enzymes effective with host strain Efficient, rapid, and complete lysis must
be attained to make this system viable. Efficacy of particular lytic enzymes may
vary with host strain.
Stringent t-holin suppression The t-holin is extrememly toxic and even slight
overexpression is detrimental to cell growth, since it causes the inner membrane
to leak cellular constituents, adversely affecting cell health [61, 58]. Because
of its harmful effect, expression of the t-holin causes an immediate halt in cell
growth and lysis if a lysozyme is present [38, 58]. Thus, even low basal levels
of t-holin are unacceptable, motivating the need for the stringent suppression
of gene-t expression. Considering commercially available, stringent expression
systems with mechanisms independent of the lac or thermally-inducible operons,
the arabinose-inducible pBAD system (Invitrogen) is a good candidate because
its induction mechanism is different from that of the lac (pJY-1, pJY-2) or cIts
(pJHL) systems [25].
Independent induction of CLP3.1 and t-holin The induction of the two recom-
binant proteins must be entirely separate to make the process maximally opti-
mizable. As was seen in Section 2.2.3, process design was fundamentally limited
when the expression of the lytic and product proteins could not be indepen-
dently timed. In light of this requirement, the pBAD system continues to be a
good candidate.
The experiments outlined below for the design and validation of the lytic strain are
based on an iterative approach. This process begins with a set of simple, “working”
strains that are predictable and whose behavior is understood. Each successive exper-
imental iteration adds functionality to the strains characterized in the previous step,
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and the set of new strains is once again evaluated. This process is repeated until the fi-
nal target strain, BL21(DE3)[pLysS-t][pJHL], is achieved. The motivation for this ex-
perimental approach, rather than creating and evaluating BL21(DE3)[pLysS-t][pJHL]
at the outset, is that the effect of various design components on the overall process
mechanism can be isolated and studied in a set of intermediate strains. Detailed data
on individual design components will help in deciding how to alter the design, should
it not work at all, or how to tweak the design or process to further optimize it.
The following subsections describe the successive experimental iterations and the
experimental data expected from each iteration. The title of each subsection describes
the design goal its experiments are intended to accomplish. In general, once a strain is
created, a minimal amount of validation will be performed with shake flask cultures.
If encouraging results are produced by a set of shake flask experiments, a bioreactor
will be inoculated and the strain’s high cell density behavior characterized.
6.2.1 Growth kinetics of multiple plasmid strains
The first step of the lytic strain design is to evaluate the behavior of single plasmid
strains containing pJHL alone, pLysS alone, and both pJHL and pLysS. The copy
number of the pLysS plasmid (ori p15A) is expected to be generally lower than that
of the pJHL origin (ori pMB1) [5]. One possible effect on process growth kinetics is
that higher plasmid copy number could cause a noticeable increase in metabolic load
resulting in a decreased growth rate. However, the presence of a selection antibiotic
for which a particular plasmid has resistance can increase copy number [5]. Never-
theless, a dual-plasmid system is expected to impose more metabolic load than either
single-plasmid system. In shake flasks, Morita, et al. achieved specific growth rates of
0.62 and 0.53 [h−1] with their control (no plasmids) and dual plasmid strains respec-
tively [38]. These growth rates are as large as the maximum growth rate achieved
in the oyxgen-enriched fermentation with E. coli BL21(DE3)[pJHL] on 3/24/04 (Sec-
tion 4.1.2: µ = 0.52 hr−1), implying that multiple plasmids will not be a limiting
factor for fermentation growth rate. However, the effect of additional plasmids on
growth in the context of high cell density fermentations must be quantified: a set of
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initial high cell density control experiments will serve as both a reference point for
subsequent experiments as well as a relative study of the effect of plasmid type and
numbers on growth kinetics.
Initial fermentations with the BL21(DE3) host containing the following plasmids
have already been carried out in course 10.28 (Fall 2004): pJHL, pLysS + pJHL,
pJY-2, and pLysS + pJY-2. Even though the pJY-2 CLP3.1 expression system will
not be used in the final collagen-producing strain, the fermentation results are still
useful for general process quantification and validation. See Chapter 4 for the results.
6.2.2 Choice of host strain
The experimental results of this thesis (Section 6.1) combined with Vasala’s unsuc-
cessful attempt to use the T7 lysozyme to lyse BL21(DE3) [61] imply that BL21(DE3)
is “hardier” than other strains, which would make it an undesirable host strain for the
process designed in this thesis. On the other hand, Morita, et al. reported efficient
BL21(DE3) lysis using the T7 lysozyme and T4 t-holin [58] and found efficient means
of chemical lysis using T7 as the lytic agent. Since Yin, et al. has already optimized
CLP3.1 production with BL21(DE3) [72], BL21(DE3) would be ideal to use as the
host for the final lytic strain designed in this paper (thus removing host strain as a
source of experimental variability which could effect product production). However,
in case BL21(DE3) does not meet the requirements of the host strain listed at the
beginning of Section 6.2, JM109(DE3) should also be considered a potential host
strain in the experiments described below. The selection of JM109(DE3) as another
possible host strain is based on the lytic successes of Tanji, et al. and Morita, et al.
using JM109(DE3) with the T4 lysis genes [58, 38].
6.2.3 Insertion of bacteriophage T4 t-holin gene into the
pBAD system
The pBAD expression system was chosen because of its commercial availability (In-
vitrogen, Inc.), the stringent suppression capability of the araBAD promoter, and its
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induction mechanism which is entirely unrelated to the lac (pJY-1, pJY-2) or cIts
(pJHL) systems. Many variants of the pBAD vector are offered by Invitrogen that
add amino acid sequences to the C- and N-termini of the product protein to aid in
protein detection and purification. Another variant of the vector insures directional
insertion of the product gene, thereby obviating the screening step to determine in-
sertion orientation. One consideration introduced by the extra DNA sequences that
are not necessary for product function but are intended to be “helpful” is that the
resulting extra peptide sequences added to the protein will interfere with the pro-
tein’s active site. Thus, depending on the variant of pBAD vector that is chosen, the
biological activity of the t-holin product may vary. A call to Invitrogen technical sup-
port (September 22, 2004) verified that there is no dependable way of predicting the
effect of the additional peptide sequences, and that indeed, interference with product
activity had been observed before.3 In order to minimize the chance of a negative
outcome, the pBAD TOPO r© TA Expression Kit (Invitrogen, Part No. K4300-01)
was chosen because it had the minimal amount of extra sequence relative to other
pBAD systems.4
The Polymerase Chain Reaction (PCR) will be used to amplify the t-holin from
T4 phage DNA (Nippon Gene Co./Wako Chemicals USA, Inc.; T4GT7 DNA, Part.
No. 318-037971) using the primers listed in Table 6.1 (Operon, Inc.) and Taq DNA
Polymerase. The amplified fragment will be 654 base pairs long. As described in the
pBAD TOPO r© TA manual, the primers must be designed to preserve the N-terminal
reading frame; Taq DNA Polymerase adds a 3’ A-overhang to the PCR product that
binds to the sticky T-overhangs of the pBAD vector. The reverse primer includes
the native stop codon to prevent the inclusion of the V5 epitope and six-histidine
tag. The resultant plasmid, pBAD-t, will be 4780 base pairs long. Following the
Invitrogen protocol, pBAD-t will be screened, amplified with the competent E. coli
3Note that this consideration is not important with the CLP3.1 product because there is no
biological activity of the protein that is assayed.
4The t-gene product is 219 amino acids long. The pBAD TOPO r© TA vector would add 14 amino
acids to the N-terminus and 28 amino acids to the C-terminus of t-holin—making the resultant
protein about 20% larger than the natural form of the t-holin [40, 24]. Retaining the native stop
codon in the reverse primer will cause the 28 C-terminus amino acids to be left out.
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Orientation Promoter sequence Length (bp) % GC
Forward 5’ GCAGCACCTAGAATATCATTTTCGCCCTCT 3’ 30 47%
Reverse 5’ TTATTTAGCCCTTCCTAATATTCTGGCCGC 3’ 30 43%
Table 6.1: Primers for cloning the bacteriophage T4 t-holin gene.
provided with the kit, purified, and quantified (See Section 3.1).
Host strains BL21(DE3) and BL21(DE3)[pLysS], as well as JM109(DE3) and
JM109(DE3)[pLysS] will then be transformed with pBAD-t.5 In order to increase
plasmid stability, the antibiotics for the selection marker included in each vector
(pLysS-t: Chloramphenicol, pJHL: Kanamycin, pJY-1/2: Ampicillin) must be added
to every step of the transformation and growth process for the remainder of the exper-
iments described in this chapter. The shake flask experiments described in Section 6.1
will be performed on these strains to determine the degree of difference between the
lytic suceptibility of the two potential host strains (see Section 6.2.2). If both strains
lyse equally well, BL21(DE3) will be chosen as the host since CLP3.1 expression in
this strain has been proven. If JM109(DE3) is lysed more efficiently, experiments
must be performed to evaluate the expression of CLP3.1 in JM109(DE3) relative to
BL21(DE3). Ideally, one of the two strains will be a clear choice for the future exper-
iments. If effective lysis is not achieved with either strain, pLysS should be replaced
with pLysE and the experiments repeated. Plasmid pLysE is identical to pLysS ex-
cept that the T7 lysozyme gene is inserted opposite to its orientation in the pLysS
plasmid, resulting in higher levels of basal expression (in pLysS, the lysozyme gene is
inserted in the antisense direction relative to the tet promoter) [57].
6.2.4 Combining the pBAD-t and pLysS: creation of pLysS-t
Once the lysozyme/holin lytic mechanism has been proven viable, the constituents
of the lytic system will be condensed into a single plasmid. This is motivated both
by the increased simplicity of having the lytic capibility incorporated into one rather
than two plasmids and by the predicted decrease in metabolic load as total amount
5Note that pLysS and pBAD-t are compatible because they contain the p15A and pMB1 origins
of replication respectively.
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of DNA decreases. In order to combine the plasmids, PCR will be used to copy the
pBAD fragment containing araC and the araBAD promoter + t-gene. The araC
gene must be copied because its product is a repressor of the araBAD system; strict
regulation of the t-gene must be maintained. The fragment will then be inserted into
the pLysS plasmid (or pLysE, if dictated by the results of Section 6.2.3). Note that
the araBAD–t-gene fragment must be inserted into pLysS because the pMB1 origin
of replication of the pBAD vector is incompatible with the same origin in the CLP3.1
vector plasmids (see Section 3.1.1).
6.2.5 Addition of capability to produce CLP3.1
Once pLysS-t is validated as permissive of high cell density growth and an effective
lytic system at high cell density, a plasmid containing the CLP3.1 gene will be in-
serted into the strain. This will be achieved by purchasing competent BL21(DE3)
or JM109(DE3) cells (Promega) and transforming them with a mixture of pLysS-t
and the CLP3.1 plasmid. Based on the current data, pJHL and pJY-1 are the most
promising candidates for the final lytic strain. Yin, et al. found that CLP3.1 produc-
tion levels are drastically reduced from 45% to 5% when pJY-2 (T7lac) is used with
a pLysS system rather than pJY-1 (lac) or pJHL (cIts) [72]. Plasmid pJY-1 achieves
expression levels of near 40% regardless of whether or not pLysS is present. How-
ever, in a fermentation experiment with BL21(DE3)[pJY-1], the strain’s lag phase
was about 8 hours longer than in fermentations using BL21(DE3)[pJHL] (see Sec-
tion 4.1.2, Table 4.1). The significant increase in process length was undesirable, but
may be a worthwhile tradeoff for the nearly four-fold increase in CLP3.1 expression
using pJY-1 (40% of total protein) versus pJHL (12% of total protein). Additional
experiments must be performed with plasmid pJY-1 to verify the long lag phase.
6.3 High cell density process design
This section builds on the strain design ideas of Section 6.2 to develop a methodol-
ogy for the optimization of a high cell density fermentation that uses the product-
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producing, lytic strain of this chapter. The issues addressed in this section focus on
optimizing the growth and induction phases of the CLP3.1 and t-holin proteins.
6.3.1 Effect of growth rate on lytic efficiency
It is clear from a review of previous work that the growth rate at the time of t-
holin induction greatly effects lytic efficiency; both the completeness (% of culture
that is lysed) and the required length of a lytic phase (time needed to achieve lysis
in a certain fraction of the culture) are affected. In shake flask cultures, Vasala
described decreased lytic efficiency in late-logarithmic and stationary growth phases
when bacteriophage LL-Hmur (lysozyme) and hol (holin) genes were coexpressed [61].
Bla¨si, et al. found that efficient lysis of E. coli due to expression of phage φX174 holin
was only achieved at cell densities below 5× 1010 cells/mL [6]. Also in shake flask
cultures, Tanji, et al. and Morita, et al. found that in BL21(DE3)[pLysS] host strains,
induction of the phage T4 t-holin in mid-log phase (OD600 = 0.5) resulted in complete
lysis within 2 hours of induction, while late-log phase induction required 6 hours to
reach lysis in 100% of the culture. Induction of the t-holin during the stationary phase
resulted in partial lysis and larger cell debris than cultures lysed at higher growth
rates. [58].
In order to optimize the fermentation process, then, it will be necessary to quantify
the relationship between growth rate and lytic efficiency to a greater degree than
has been done by the prior work described above. The bench-top scale stirred-tank
bioreactors used thus far in this thesis combined with the continuous and precise
measurement capability of an on-line biomass probe comprise an ideal system for
pursuing this study. This experiment proposes the use of both on-line biomass probes
available to the laboratory:6 the BugEye r© non-invasive biomass probe (BugLab,
LLC.), and a fixed path length absorbance probe that must be submerged in the
culture broth (Optek, Inc.). Once enough calibration data is collected to correlate
the probe measurements to OD600 and DCW values, accounting for variation due to
6MIT Chemical Engineering Department Undergraduate Teaching Laboratory/Hamel Labora-
tory.
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changes in agitation and aeration, the online data can be used to measure sensitive
changes in the growth rate of the culture. Section 4.1.3 describes preliminary results
that demonstrate the sensitivity of the BugEye r© instrument. Based on these results,
the implications of the emperical power for culture growth characterization conferred
by these on-line probes are very positive.
Correlating high resolution growth rate curves calculated from the on-line biomass
probe data (analogous to the one in Figure 4-3(a) which used OD600 measurements)
with the efficiency of lytic t-holin induction phases initiated at a variety of times in
various fermentations will give a precise relationship between growth rate and lytic
efficiency. Such a curve would present a significant improvement over the current
qualitative knowledge of this correlation. In addition, the curve would be essential
for analalyzing the tradeoff between the time of t-holin induction (earlier induction
causes more rapid and complete lysis) and the length of the CLP3.1 induction phase
(a longer phase allows more time to accumulate the product protein). Since the
culture’s growth rate diminishes as a fermentation progresses (Figure 4-3(a), page 74),
it is conceivably worthwhile to boost the growth rate just before the t-holin induction
(e.g. 30 minutes to 1 hour prior to induction). Assuming that oxygen transfer rate
from the gas to liquid phases is the primary factor limiting growth rate at high cell
densities, sharply increasing the level of oxygen enrichment in the sparged gas may
be a viable way of prolonging the CLP3.1 induction phase while still being able to
boost the growth rate into a range appropriate for efficient lysis.
In order to simplify the molecular biology of this experiment and to closely model
the proven dual-plasmid systems of Tanji and Morita, et al., E. coli BL21(DE3)[pLysS]
may be directly transformed with pBAD-t (Section 6.2.3) rather than transforming
E. coli BL21(DE3) with pLysS-t (Section 6.2.4). Plasmids pLysS and pLysS-t have
compatible origins of replication. However, whether pLysS-t or pBAD-t is used for
this study is not critical.
To measure the degree of culture lysis, a total protein assay as well as a turbidity
assay should be used. For example, the 100% intracellular protein baseline can be
established by sonicating a duplicate sample (i.e. an appropriate sonication protocol is
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assumed to be a gold standard cell disruption technique) and comparing the results of
a total protein assay (e.g. BCA assay) on the sonicated and induced-to-lyse duplicate
samples. The OD600 assay is a sufficient turbidity assay, and was used by Tanji and
Morita, et al. to quantify rates of lysis [58, 38].
6.3.2 Competition for gene expression machinery upon co-
expression of CLP3.1 and t-holin products
A limitation on the universality of the conclusions that can be drawn from the exper-
iments proposed in Section 6.3.1 is the fact that the t-holin is the only recombinant
product produced in the experimental fermentations. However, once a plasmid vec-
tor with the CLP3.1 gene is introduced to the system, induction of both recombinant
genes at the same time7 may result in competition for available transcription and
translation machinery, which could decrease the amount of t-holin produced during
the lytic phase. Such a decrease in t-holin production would result in a decrease in
lytic efficiency. Therefore, even though the results of the Section 6.3.1 fermentations
will be essential for designing the lytic phase of the CLP3.1 production process, it
may be the case that the lytic phase efficiency predictions (both length and degree of
lysis) of these fermentations will be over-optimistic relative to a double-recombinant
strain.
7Once the CLP3.1 gene has been induced with IPTG or a temperature change, it would be
difficult if not impossible to turn off its expression.
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Chapter 7
Conclusion
This thesis comprises several necessary steps towards the implementation of a novel,
optimized collagen-like polymer (CLP3.1) production process. In addition, detailed
quantification of the process and its use in three bioprocess engineering course of-
ferings (MIT courses 10.28, Biological Engineering Laboratory, Fall 2003 and Fall
2004, and 10.26, Chemical Engineering Projects Laboratory, Spring 2004) allowed
the development of a robust, schedule-friendly process for academic use.
7.1 Advancements made by this thesis
Robust fermentation protocol: Three CLP3.1-producing strains were character-
ized in high cell density fed-batch fermentations (E. coli BL21(DE3) with plas-
mids pJHL, pJY-1, and pJY-2). The quantitative results presented in this the-
sis are necessary for the design of predictable fermentations required by courses
with strict schedules. With E. coli BL21(DE3)[pJY-1], a peak maximum growth
rate of 0.53 hr−1 during mid batch phase was observed which steadily decreased
to approximately 0.50 hr−1 at the end of induction. Combining the results of
three fermentations, the factor for the conversion of glucose consumption to
biomass increase was estimated to be 1.37± 0.40 (g glucose)/(L broth)
OD600 unit
. The OD600
to dry cell weight conversion factor was estimated to be 0.42 (g DCW)/(L broth)
OD600 unit
.
Dynamic method calculation of the oxygen uptake rate (OUR) early in the
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fermentation (OD600 < 1) resulted in values of the volumetric mass transfer co-
efficient (kLa) of 37 hr
−1 (300 rpm), 145 hr−1 (400 rpm), and 286 hr−1 (500 rpm).
OUR calculations based on off-gas analysis resulted in kLa values in the range
272–332 hr−1 at 800 rpm (OD600 = 46.4–81.0).
Analysis of collagenase assay with high cell density fermentation samples:
The collagenase assay for recombinant collagen-like polymers developed by Yin,
et al. [73] in shake flasks can not be used for analysis of fermentation samples
without modification. Depending on the amount of washing of the E. coli with
Phosphate Buffer Saline (PBS), the magnitude of the OD570 measurements in
this colorimetric assay ranged from 4 to 10 times the measurement values for
pure gelatin standards (OD570 ≈ 0.1–5.0). Cell samples washed twice with PBS
resulted in high absorbance values with significant variation (10–20 ± 1–1.5),
and samples resuspended in spent medium resulted in OD570 values of 50–85
± 5–10. Calibration curves for the bicinchoninic acid assay differed by a fac-
tor of two depending on whether gelatin or Bovine Serum Albumin standards
were used. A methodology for taking differences in amino acid composition
and consequent protein reactivity in the total protein assay into account was
presented.
Fermentation cooling phase: Motivated by the desire to prolong E. coli fermen-
tations (which last 15–25 hours without interruption) so that students could be
exposed to more parts of the same fermentation during course lab hours, fer-
mentation cooling strategies were implemented in the Fall 2003 and Fall 2004
offerings of MIT course 10.28 (Biological Engineering Laboratory). Fermen-
tations that were cooled to 10◦C in early to mid batch phase (OD600 = 2–4)
recovered from 36–40 hour cooling phases to reach high cell densities (up to
OD600 = 80) during the induction phase. Fermentations that were cooled once
in early to mid batch phase and again in early fed-batch phase (OD600 = 14–16)
only saw up to a 50% increase in biomass after the second cooling phase, re-
gardless of growth time. Consequently, the most successful cooled fermentations
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were those that were cooled once during early batch phase.
Design of lytic strain: A two plasmid strain of E. coli capable of collagen-like poly-
mer production followed by inducible lysis in the bioreactor was designed based
on the results of Tanji and Morita, et al. [58, 38]. While CLP3.1 was the recom-
binant product of interest in this thesis, the design ideals of this lytic process
is intended to be applied to other recombinant products. In the dual plasmid
strain, one plasmid contains the CLP3.1 gene (either an IPTG-inducible pET
vector [pJY-1] or a thermally-inducible cIts system [pJHL]), and the other plas-
mid contains the lytic genes. To create this lytic plasmid, the bacteriophage T4
t-gene (a holin enzyme) will be inserted into the pBAD vector (Invitrogen). The
entire araBAD operon with t-gene and the araC gene will be cloned by PCR
and inserted into plasmid pLysS, which is engineered for low basal expression
of phage T7 lysozyme. The presence of the resultant plasmid in an E. coli host
will result in the accumulation of T7 lysozyme, which will be permitted to reach
(and consequently digest) the bacterial cell wall by the expression of the inner
cell membrane-disrupting t-holin.
7.2 Future work
Modification of the collagenase assay for high cell density sample analysis:
Because of the inapplicability of the current form of the collagenase assay to the
reliable measurement of CLP3.1 in high cell density fermentation samples, this
rapid and inexpensive assay will be modified. Based on the results in Section 5,
a study will be implemented to decrease the signal to noise ratio observed with
samples originating from high cell density fermentations.
Evaluation of lytic strains of E. coli: Section 6.2 describes an iterative approach
to the construction of a dual-plasmid E. coli strain capable of induced lysis
within the bioreactor. In order to assess the effect of each successive complica-
tion of the design as it converges to the final strain, the growth kinetics, product
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production (CLP3.1) levels, and lytic behavior of each strain will be evaluated
in shake flasks (increased experimental simplicity) before their introduction into
bioreactors.
Effect of growth rate on lytic efficiency: Induction of recombinant lytic protein
in shake flask cultures at low growth rates during the late logarithmic and
stationary phases results in incomplete culture lysis (about 20% in stationary
phase) and prolonged lytic periods (up to 6 hours). On the other hand, induc-
tion at the higher growth rates of mid log phase (OD600 = 0.5) results in rapid
and complete lysis (100% lysis within 1 hour) [58, 38, 61]. In order to engineer
an optimal, reproducible production process ending with efficient lysis, a study
that provides detailed quantification of the correlation between growth rate and
lytic efficiency must be performed. E. coli strain BL21(DE3)[pLysS][pBAD-t]
will be constructed and its growth in bioreactors monitored by on-line biomass
probes (manufactured by BugLab, LLC. and optek-Danulat, Inc.) which af-
ford high time granularity for precise measurement of growth rate (preliminary
results with the BugEye r© sensor are discussed in Section 4.1.3). Detailed con-
siderations for high cell density lytic process design are discussed in Section 6.3.
The results of this project will be combined with the gross strain behaviors
observed in the “Evaluation of lytic strains of E. coli” future work project to
optimize the lytic phase of the final collagen-like polymer production process.
136
Appendix A
Media and reagents
This appendix contains detailed information on the composition of all media and
reagents used in a fermentation and other assays. What follows is a near-exact re-
production of the lab manual written by Whittemore, et al. for course 10.28 [68].
Buffers for the lysis of strain JM109[pUC18-S−RRz] come from the lab manual for
the Fall 2003 offering of 10.28 [62]. NOTE: All solutions are prepared with deionized
water (dH2O).
A.1 Fermentation
LB medium ( /L) (for shake flask cultures)
NaCl 10 g
Tryptone 10 g
Yeast extract 5 g
• Tryptone varies considerably between manufacturer and even lot number.
The tryptone used in this thesis was manufactured by BD Biosciences:
Bacto
TM
Tryptone, pancreatic digest of caesin, part no. 211705.
• pH is adjusted to 7.5 by 1 M NaOH (Mw = 40), added 1 ml at a time.
• 100 ml LB / 500ml flask, autoclaved at 121◦C, 30 min (no dry time).
• Pre-pH adjustment, pH = 6.8–6.9; after adding about 1.2 mL of 1M NaOH,
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pH increases to 7.5.
Trace metal solution (TE) ( /L) (for MR medium)
ZnSO4 · 7H2O 2.2 g
MnCl2 · 4H2O 0.5 g
CuSO4 · 5H2O 1.0 g
Na2MoO4 · 2H2O 0.1 g
Na2B4O7 · 10H2O 0.02 g
• pH is adjusted to 2.0 by 1 M HCl (Mw = 36.5).
Ferrous sulfate solution ( /L) (for MR medium)
FeSO4 · 7H2O 10 g
• pH is adjusted to 2.0 by 1 M HCl.
Calcium chloride solution ( /L) (for MR medium)
CaCl2 · 2H2O 20 g
1X MR medium ( /L) (for bioreactors)
KH2PO4 13.5 g
(NH4)2HPO4 4.0 g
MgSO4 · 7H2O 0.7 g
Citric acid 0.85 g
Ferrous sulfate solution 10 ml
Trace metal solution (TE) 10 ml
Calcium chloride solution 1 ml
• All salts are soluble after mixing and before pH adjustment (pH = 5.2)
• pH is adjusted after autoclaving; do not adjust pH initially. (Note that in-
creasing pH causes precipitation of magnesium salts, e.g. MgSO4 and MgPO4,
this is expected).
Antifoam (to prevent bioreactor foam)
pure polypropylene glycol, PPG-2000
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• Autoclaved at 121◦C, for 30 min.
Base solution (for pH adjustment during fermentation)
4 M (NH4OH:NaOH:KOH = 2M:1M:1M)
• Sterilization is not necessary.
Phosphoric acid solution (for pH adjustment during fermentation)
1 M H3PO4
• Sterilized by filtration with 0.2 µm filter: in a biosafety cabinet, a vac-
uum pump is used to draw a vacuum in a sterile bottle with the filter
screwed to the bottle mouth. The vacuum speeds up the filtration process
significantly.
Glucose-Magnesium Sulfate Solution (/L) (fermentation carbon source)
Glucose 700 g
MgSO4 · 7H2O 14 g
• Sterilized with 0.2 µm vacuum filtration while still very warm.
Ampicillin (sodium salt) (selection marker, resistance conferred by pJY-1 and
pJY-2 plasmids)
25 mg/ml in deionized water
• Plan to use about 2 mL of ampicillin stock per 1 L of final bioreactor
volume and 200 µL for each 100 mL shake flask (final concentration is
always 50 µg/mL).
• Sterilize by filtration with 0.2 µm filter. Store at -20◦C. Use at 50 µg/ml.
Kanamycin (selection marker, resistance conferred by pJHL plasmid)
15 mg/ml in deionized water
• Plan to use about 2 mL of kanamycin stock per 1 L of final bioreactor
volume and 200 µL for each 100 mL shake flask (final concentration is
always 30 µg/mL).
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• Sterilize by filtration with 0.2 µm filter. Store at -20◦C. Use at 30 µg/ml.
Chloramphenicol (selection marker, resistance conferred by pLysS plasmid)
10 mg/ml in deionized water
• Plan to use about 2 mL of chloramphenicol stock per 1 L of final bioreactor
volume and 200 µL for each 100 mL shake flask (final concentration is
always 50 µg/mL).
• Sterilize by filtration with 0.2 µm filter. Store at 4◦C. Use at 20 µg/ml.
• Chloramphenicol will precipitate at room temperature, so reheat in a boil-
ing water bath before taking aliquots.
IPTG (isopropyl-β-D-thiogalactoside, lac operon inducing agent)
1 M stock solution in deionized water
• Prepare IPTG as a filter-sterilized (0.2 µm) 1 M stock solution (Mw =
238.3 g/mol). Will use 1 mL for every 1 L of working volume.
• Stored at -20◦C until use.
• IPTG is used at 1 mM in the bioreactors.
100% Glycerol (for cell bank E. coli stock)
• Autoclaved at 121◦C, for 30 min.
A.2 Collagenase assay
Collagenase assay reagents from collagenase assay protocol [73, 68]:
• Gelatin: Sigma (P-0959, 2 mg/ml in 0.9% NaCl containing 0.05% sodium
azide).
• Buffer A: 20 mM Tris (adjust pH to 7.5 by HCl) with 5 mM CaCl2.
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• Buffer B: 0.5 M acetic acid, 0.1M citric acid, pH was adjusted to 5.0 by 1 M
NaOH.
• Ninhydrin (triketohydrindenhydrate) reagent: 20 mg SnCl2 and 200 mg
ninhydrin are mixed with 10 ml methyl cellosolve (ethylene glycol monomethyl
ether), followed by the addition of 10 ml Buffer B. This mixture is prepared
freshly each time.
• 50% n-Propanol: n-Propanol / water = 1 : 1 (v/v).
• Collagenase type VII: (Sigma Cat. NO. C 0773, Lot 77H8609. Collage-
nase digestion activity: 1600 units/mg solid. FALGPA hydrolysis activity: 10
units/mg solid. 1.0 mg solid). Dissolved into 0.5 ml Buffer A and 0.5 ml glyc-
erol. Stored at -20◦C.
A.3 JM109[pUC18-S−RRz] lysis buffers
Adjust pH of all buffers to 8.0 with 1 M HCl.
Lysis Buffer A 50 mM Tris, 2 mM EDTA, pH 8.0
Control Buffer B 50 mM Tris, pH 8.0
TE Buffer 10 mM Tris, 1 mM EDTA, pH 8.0
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Appendix B
Thesis chronology and relation to
undergraduate courses
This Appendix provides a chronological list of the experiments carried out over the
course of this thesis, organized by seasonal unit. Much of the work of this thesis was
carried out in conjunction with courses offered by the MIT Chemical Engineering
department, so descriptions of the logistical structure of the courses is also presented
in order to give a complete context for the experiments.
B.1 Summer 2003
Work with E. coli strains was begun in order to implement the fermentation that
would be used by the fermentation module of course 10.28 (Part B, Fall 2003).
B.2 Fall 2003
Course 10.28 (Biological Engineering Laboratory) was offered for the first time. The
course was composed of a microbiology module that lasted two-thirds of the term,
and a fermentation module that lasted for the final one-third of the term. There
were 16 students in total. In the fermentation module, students were divided into
four teams (four students per team). The fermentations carried out by each team are
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Team Number E. coli strain Fermenter
1 BL21(DE3)[pJHL] 1 L BioFlo 3000
2 BL21(DE3)[pJHL] 1 L BioFlo 3000
3 BL21(DE3)[pJY-2] 5 L BioFlo 3000
4 BL21(DE3)[pJY-2] 10 L BioFlo 110
Table B.1: Descriptions of fermentations implemented in the Fall 2003 offering of
course 10.28.
summarized in Table B.1.
B.3 Spring 2004
Course 10.26 (Independent Projects Laboratory) offered a fermentation engineering
project to a group of four students: Bashira Chowdhury, Johanna Salazar-Lazaro,
Terence Tai-Weng Sio, and Jessica Zaman. The project asked the students to evaluate
the dynamic and off-gas methods for evaluating the volumetric oxygen mass transfer
coefficient, kLa. One successful E. coli fermentation was carried out with strain
BL21(DE3)[pJHL] on 3/25/04.
B.4 Fall 2004
The Fall 2004 offering of 10.28 was divided into two modules: cell culture and fer-
mentation, and had 39 students. Half of the students were in a module at a time, and
they switched half way through the term. In each module, there were two sections:
Tuesday/Thursday and Wednesday/Friday. The Tuesday/Thursday section had six
teams with two students per team. The Wednesday/Friday section had four teams
with two students per team. This structure allowed for a total of 20 fermentations
to be implemented throughout the course (10 fermentations per module). Table B.2
describes the fermentations carried out in this course. Teams G–L participated in
the module 1 fermentation module, and teams A–F participated in the module 2
fermentations. Team names are composed of a letter and section number (1 for Tues-
day/Thursday, 2 for Wednesday/Friday). All teams used 0.9 L BioFlo 110 fermenters,
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Strain Team Numbers
BL21(DE3)[pJY-2] G1–I1, G2–H2, A1–C1
BL21(DE3)[pLysS][pJY-2] J1–L1, I2–J2, D1–F1
BL21(DE3)[pJHL] A2–B2
BL21(DE3)[pLysS][pJHL] C2–D2
Table B.2: Descriptions of fermentations implemented in the Fall 2004 offering of
course 10.28.
except for teams K1, L1, E1, and F1, who used 1 L BioFlo 3000 units.
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Appendix C
Microscope images of E. coli
Looking at samples through a microscope is often the most direct way of determining
whether a culture is healthy, whether contamination is present, or whether a particular
sample treatment is working. The following figures show images of E. coli at 400×
magnification. E. coli are rod shaped and are approximately 1 µm in length.
Many individual bacteria are visible in Figure C-1 at 1000× magnification. The
samples came from a BL21(DE3)[pJHL] fermentation’s shake flask inoculum (3/25/04),
and were at an OD600 of 3.88. The 1000× lens combination is an oil-immersion setup;
for these images no oil was available, so the images are slightly fuzzy. The long fila-
ments are daughter E. coli that did not quite complete division. The filaments only
grow at the ends. Breaking a filament kills the entire chain because the intracellular
spaces are continuous. Filaments form more often with recombinant strains than with
non-recombinant strains [20, 63].
Pictures in Figure C-2 were taken over the course of the BL21(DE3)[pJHL] fer-
mentation of 3/25/04. Samples were not diluted prior to putting them on the slide.
E. coli can secrete polysaccharides under stressful conditions that cause them to stick
together, forming conglomerations [20]. The healthy growth throughout this fermen-
tation (discussion of fermentation results interspersed throughout Chapter 4) implies
that the cells were not as “sick” as the images shown here may lead one to believe.
It is possible that the cell densities in the samples were simply much too high for
them to not conglomerate because of their proximity, and without the influence of
147
(a) OD600 = 3.88, 1000× magnification (b) OD600 = 3.88, 1000× magnification
Figure C-1: E. coli from shake flask inoculum (BL21(DE3)[pJHL], 3/25/04).
the vigorously agitated environment within the bioreactor, they rapidly stuck to-
gether. Notice the increase in size of the conglomerations as OD600 increases. The
presence of filaments in the OD600 = 3.45 sample but apparent absence in the higher
cell density samples may be due to the reduced shear due to lower agitation (500 rpm
for OD600 = 3.45; 700 rpm for OD600 = 51.3, 66.7).
Figure C-3 shows a sample before and after sonication with a Branson Ultrasonics
sonifier (5 min; 70%, 1 sec duty cycle; 70% intensity). The samples originated from
the course 10.28, module 1, group I1 fermentation with strain BL21(DE3)[pJY-2].
Many intact cells are visible in Figure C-3(a) while Figure C-3(b) shows primarily
cell debris, indicating effective disruption.
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(a) OD600 = 3.45 (b) OD600 = 51.3
(c) OD600 = 66.7 (d) OD600 = 66.7
Figure C-2: E. coli at varying densities over the course of a fermentation.
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(a) Before sonication, 400×, phase contrast.
(b) After sonication, 400×, phase contrast.
Figure C-3: E. coli before and after sonication.
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